*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 1 3 # 1 A 29 ASP A 52 ASP.? 24.46 O1 PEG B2002 A 117 LYS A 81 LYS~? 24.71 CA CA B1002 A 150 CYH A 53 CYH.? 25.46 O1 PEG B2002 coo 37.97 47.82 5.46 38.65 48.02 7.40 -2.05 -17.27 6.89 -0.38 -16.21 6.11 coo 41.02 51.33 13.36 40.18 47.06 9.99 -10.43 -20.23 7.61 -6.19 -24.16 5.61 coo 39.17 42.30 8.54 40.94 44.26 7.78 -3.99 -14.24 10.25 -6.51 -13.04 10.75 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 2 3 # 2 A 29 ASP B 52 ASP.? 24.24 O4 PEG B2003 A 117 LYS B 81 LYS~? 24.83 O4 PEG B2003 A 150 CYH B 53 CYH.? 19.65 O4 PEG B2003 coo 37.97 47.82 5.46 38.65 48.02 7.40 -21.39 -30.03 6.82 -22.77 -31.26 5.81 coo 41.02 51.33 13.36 40.18 47.06 9.99 -13.27 -27.12 7.60 -17.56 -23.53 5.05 coo 39.17 42.30 8.54 40.94 44.26 7.78 -19.64 -33.35 10.08 -17.03 -34.49 10.54 3uao_o00 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o00 naa= 3 ULMN 4 1b8f_c00 HISTIDINE AMMONIA-LYASE user 1 4 # 1 A 142 ALA A 22 ALA.? 17.13 C1 PEG B2003 A 144 GLY A 65 GLY.? 18.86 C1 PEG B2003 A 280 TYR B 73 TYR.? -26.42 O4 PEG B2003s A 414 GLU A 61 GLU.? 19.08 C1 PEG B2003 coo 8.90 -17.98 11.65 7.53 -18.34 11.16 -9.61 -11.57 35.52 -8.52 -10.48 35.41 coo 11.65 -18.01 12.88 11.72 -18.24 12.53 -9.86 -7.46 33.11 -10.61 -7.04 33.04 coo -3.84 22.59 11.63 -6.55 23.25 11.72 -15.40 -46.09 10.22 -13.89 -48.32 11.05 coo 7.29 -23.46 8.78 9.26 -22.73 8.47 -3.95 -8.85 34.10 -5.28 -10.35 33.41 1b8f_c00 source 1b8f HISTIDINE AMMONIA-LYASE : 1 hits 1b8f_c00 naa= 4 ULMN 4 1fuq_c01 FUMARASE C user 1 4 # 1 A 187 THR A 19 THR^? 17.40 C1 PEG A2001 A 188 HIS A 21 HIS.? 16.23 C1 PEG B2003 B 324 LYS A 68 LYS^? 23.30 O1 PEG A2001 B 331 GLU A 61 GLU.? 19.08 C1 PEG B2003 coo 129.74 131.38 71.57 131.00 129.90 70.56 -14.60 -7.97 30.22 -15.86 -6.22 29.97 coo 126.65 128.38 73.20 126.33 126.91 71.74 -9.66 -11.83 31.16 -7.90 -10.69 31.12 coo 132.83 126.01 79.21 131.24 127.86 74.38 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo 121.10 128.95 74.81 122.81 127.96 74.05 -3.95 -8.85 34.10 -5.28 -10.35 33.41 1fuq_c01 source 1fuq FUMARASE C : 1 hits 1fuq_c01 naa= 4 ULMN 4 1og1_c00 T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2user 1 4 # 1 A 147 SER A 15 SER^? 21.14 O1 PEG A2001 A 159 GLU A 87 GLU~? 17.34 CA CA A1001 A 184 ARG A 8 ARG^? 17.40 CA CA A1001 A 189 GLU A 14 GLU^? 25.75 O1 PEG A2001 coo 53.09 24.63 27.00 51.51 25.19 25.28 -14.21 -8.14 16.70 -15.25 -5.93 17.19 coo 52.64 14.17 18.05 51.99 14.09 16.04 -18.57 -18.33 12.01 -20.23 -17.06 12.53 coo 45.78 18.05 21.49 44.51 17.88 18.72 -22.63 -11.55 11.44 -21.49 -14.30 12.11 coo 49.07 22.26 28.01 48.95 23.27 26.11 -15.45 -7.36 10.85 -15.33 -5.53 9.81 ULMN 4 1og1_c00 T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2user 2 4 # 2 A 147 SER A 72 SER.? 25.71 O1 PEG A2001 A 159 GLU A 87 GLU~? 17.34 CA CA A1001 A 184 ARG A 8 ARG^? 17.40 CA CA A1001 A 189 GLU A 14 GLU^? 25.75 O1 PEG A2001 coo 53.09 24.63 27.00 51.51 25.19 25.28 -11.42 -4.87 11.47 -12.93 -4.20 13.23 coo 52.64 14.17 18.05 51.99 14.09 16.04 -18.57 -18.33 12.01 -20.23 -17.06 12.53 coo 45.78 18.05 21.49 44.51 17.88 18.72 -22.63 -11.55 11.44 -21.49 -14.30 12.11 coo 49.07 22.26 28.01 48.95 23.27 26.11 -15.45 -7.36 10.85 -15.33 -5.53 9.81 1og1_c00 source 1og1 T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2 : 2 hits 1og1_c00 naa= 4 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 457 ALA B 34 ALA~? 4.64 O2 PEG B2003 A 458 ALA B 35 ALA~? 8.44 O2 PEG B2003 B 193 ALA B 22 ALA.? 10.36 C4 PEG B2003 B 194 GLY B 23 GLY.? 10.56 C4 PEG B2003 coo 43.27 124.32 20.47 43.79 125.29 21.53 -12.29 -27.34 32.52 -12.53 -26.18 33.47 coo 39.57 123.53 20.89 38.42 124.25 20.20 -9.96 -26.03 29.75 -8.50 -25.64 29.95 coo 47.95 129.15 20.31 47.81 128.95 18.79 -13.45 -35.76 34.31 -14.03 -37.13 34.56 coo 50.40 126.23 20.48 50.46 127.00 20.75 -11.52 -34.07 37.14 -11.49 -34.90 37.06 1pix_c02 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 1 hits 1pix_c02 naa= 4 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 193 ALA B 22 ALA.? 10.36 C4 PEG B2003 A 194 GLY B 23 GLY.? 10.56 C4 PEG B2003 B 457 ALA B 34 ALA~? 4.64 O2 PEG B2003 B 458 ALA B 35 ALA~? 8.44 O2 PEG B2003 coo 61.89 87.20 13.50 62.59 88.00 12.38 -13.45 -35.76 34.31 -14.03 -37.13 34.56 coo 59.34 89.99 13.88 59.24 89.18 13.73 -11.52 -34.07 37.14 -11.49 -34.90 37.06 coo 65.50 91.13 17.77 64.65 89.88 18.00 -12.29 -27.34 32.52 -12.53 -26.18 33.47 coo 68.56 91.15 20.03 69.95 90.68 19.64 -9.96 -26.03 29.75 -8.50 -25.64 29.95 1pix_c03 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 1 hits 1pix_c03 naa= 4 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 1 3 # 1 252 THR A 19 THR^? 17.40 C1 PEG A2001 350 PHE A 29 PHE~? 10.36 O1 PEG B2003 357 CYH A 33 CYH~? 10.72 C1 PEG B2003 coo 17.85 20.47 14.62 16.85 19.84 12.80 -14.60 -7.97 30.22 -15.86 -6.22 29.97 coo 7.92 21.96 13.27 8.57 20.30 15.42 -16.52 -16.10 37.98 -15.88 -14.02 36.22 coo 8.82 20.77 7.90 10.59 19.75 9.80 -13.26 -18.01 33.48 -11.40 -16.21 34.23 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 2 3 # 2 252 THR A 105 THR^? 7.70 C1 PEG A2001 350 PHE A 29 PHE~? 10.36 O1 PEG B2003 357 CYH A 33 CYH~? 10.72 C1 PEG B2003 coo 17.85 20.47 14.62 16.85 19.84 12.80 -23.59 -12.52 29.06 -24.89 -11.07 29.94 coo 7.92 21.96 13.27 8.57 20.30 15.42 -16.52 -16.10 37.98 -15.88 -14.02 36.22 coo 8.82 20.77 7.90 10.59 19.75 9.80 -13.26 -18.01 33.48 -11.40 -16.21 34.23 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 3 3 # 3 252 THR B 19 THR^? 16.39 O4 PEG B2003 350 PHE B 29 PHE~? 13.33 C4 PEG B2003 357 CYH B 33 CYH~? 9.84 C4 PEG B2003 coo 17.85 20.47 14.62 16.85 19.84 12.80 -8.63 -39.92 29.57 -7.43 -41.72 29.21 coo 7.92 21.96 13.27 8.57 20.30 15.42 -6.26 -32.33 37.47 -7.01 -34.41 35.76 coo 8.82 20.77 7.90 10.59 19.75 9.80 -9.83 -30.15 33.15 -9.47 -32.30 34.84 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 4 3 # 4 252 THR B 105 THR^? 7.36 C4 PEG B2002 350 PHE B 29 PHE~? 13.33 C4 PEG B2003 357 CYH B 33 CYH~? 9.84 C4 PEG B2003 coo 17.85 20.47 14.62 16.85 19.84 12.80 0.42 -35.31 28.37 1.77 -36.76 29.26 coo 7.92 21.96 13.27 8.57 20.30 15.42 -6.26 -32.33 37.47 -7.01 -34.41 35.76 coo 8.82 20.77 7.90 10.59 19.75 9.80 -9.83 -30.15 33.15 -9.47 -32.30 34.84 1akd_c01 source 1akd CYTOCHROME P450CAM : 4 hits 1akd_c01 naa= 3 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 1 3 # 1 33 ASP A 52 ASP.? 24.46 O1 PEG B2002 187 GLU B 80 GLU~? 28.00 O4 PEG B2003 229 LYS B 81 LYS~? 24.83 O4 PEG B2003 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -2.05 -17.27 6.89 -0.38 -16.21 6.11 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -9.74 -26.27 4.08 -9.78 -24.63 2.72 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -13.27 -27.12 7.60 -17.56 -23.53 5.05 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 2 3 # 2 33 ASP A 79 ASP~? 30.35 CA CA B1002 187 GLU B 80 GLU~? 28.00 O4 PEG B2003 229 LYS B 81 LYS~? 24.83 O4 PEG B2003 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -9.53 -15.68 5.14 -8.10 -15.06 3.67 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -9.74 -26.27 4.08 -9.78 -24.63 2.72 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -13.27 -27.12 7.60 -17.56 -23.53 5.05 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 3 3 # 3 33 ASP B 52 ASP.? 24.24 O4 PEG B2003 187 GLU A 80 GLU~? 27.45 O4 PEG B2003 229 LYS A 81 LYS~? 24.71 CA CA B1002 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -21.39 -30.03 6.82 -22.77 -31.26 5.81 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -13.74 -20.99 4.34 -13.41 -22.52 2.91 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -10.43 -20.23 7.61 -6.19 -24.16 5.61 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 4 3 # 4 33 ASP B 79 ASP~? 26.06 O4 PEG B2003 187 GLU A 80 GLU~? 27.45 O4 PEG B2003 229 LYS A 81 LYS~? 24.71 CA CA B1002 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -14.12 -31.44 4.95 -15.54 -32.00 3.54 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -13.74 -20.99 4.34 -13.41 -22.52 2.91 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -10.43 -20.23 7.61 -6.19 -24.16 5.61 1ald_c00 source 1ald ALDOLASE A (E.C.4.1.2.13) : 4 hits 1ald_c00 naa= 3 ULMN 3 1amo_c00 NADPH-CYTOCHROME P450 REDUCTASE user 1 3 # 1 A 457 SER B 24 SER.? 15.05 C4 PEG B2003 A 630 CYH B 33 CYH~? 9.84 C4 PEG B2003 A 675 ASP B 30 ASP~? 11.37 C2 PEG B2003 coo 2.70 -0.05 22.31 2.42 1.39 24.24 -9.88 -35.35 40.32 -7.72 -34.26 40.45 coo 0.87 7.55 27.28 1.82 5.91 25.24 -9.83 -30.15 33.15 -9.47 -32.30 34.84 coo 0.10 3.62 28.03 1.23 2.44 26.67 -10.72 -29.17 38.90 -10.74 -31.13 39.77 1amo_c00 source 1amo NADPH-CYTOCHROME P450 REDUCTASE : 1 hits 1amo_c00 naa= 3 ULMN 3 1amo_c01 NADPH-CYTOCHROME P450 REDUCTASE user 1 3 # 1 B 457 SER B 24 SER.? 15.05 C4 PEG B2003 B 630 CYH B 33 CYH~? 9.84 C4 PEG B2003 B 675 ASP B 30 ASP~? 11.37 C2 PEG B2003 coo 48.68 26.05 22.04 49.09 24.42 23.79 -9.88 -35.35 40.32 -7.72 -34.26 40.45 coo 50.83 17.98 26.05 49.75 19.82 24.27 -9.83 -30.15 33.15 -9.47 -32.30 34.84 coo 51.67 21.81 27.15 50.44 23.13 26.00 -10.72 -29.17 38.90 -10.74 -31.13 39.77 1amo_c01 source 1amo NADPH-CYTOCHROME P450 REDUCTASE : 1 hits 1amo_c01 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 30 ASP~? 11.64 C1 PEG B2003 214 ASP B 70 ASP^? 21.22 O4 PEG B2003 289 ASP B 30 ASP~? 11.37 C2 PEG B2003 coo -0.62 65.95 29.97 0.31 67.47 31.05 -12.34 -20.31 39.33 -11.75 -18.93 40.82 coo 26.86 59.76 46.36 25.42 58.23 45.92 -13.56 -42.18 16.17 -12.44 -43.52 14.94 coo 9.42 68.07 30.27 7.35 68.27 30.10 -10.72 -29.17 38.90 -10.74 -31.13 39.77 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP B 30 ASP~? 11.37 C2 PEG B2003 214 ASP A 70 ASP^? 25.92 O1 PEG A2001 289 ASP A 30 ASP~? 11.64 C1 PEG B2003 coo -0.62 65.95 29.97 0.31 67.47 31.05 -10.72 -29.17 38.90 -10.74 -31.13 39.77 coo 26.86 59.76 46.36 25.42 58.23 45.92 -9.86 -5.53 16.91 -10.88 -4.17 15.65 coo 9.42 68.07 30.27 7.35 68.27 30.10 -12.34 -20.31 39.33 -11.75 -18.93 40.82 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 2 hits 1amy_c01 naa= 3 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 B 325 ARG A 9 ARG^? 23.91 O1 PEG A2001 B 342 ASP A 70 ASP^? 25.92 O1 PEG A2001 B 531 ARG A 8 ARG^? 17.40 CA CA A1001 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -17.92 -3.27 10.91 -16.40 -3.09 13.61 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -9.86 -5.53 16.91 -10.88 -4.17 15.65 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -22.63 -11.55 11.44 -21.49 -14.30 12.11 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 B 325 ARG B 9 ARG^? 23.79 O4 PEG B2002 B 342 ASP B 70 ASP^? 21.22 O4 PEG B2003 B 531 ARG B 8 ARG^? 17.27 CA CA B1002 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -5.44 -44.19 10.09 -7.02 -44.36 12.75 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -13.56 -42.18 16.17 -12.44 -43.52 14.94 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -0.83 -35.82 10.68 -1.93 -33.11 11.68 1asy_c00 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 2 hits 1asy_c00 naa= 3 ULMN 3 1b02_c02 THYMIDYLATE SYNTHASE user 1 3 # 1 A 71 GLU A 80 GLU~? 27.45 O4 PEG B2003 A 161 CYH A 53 CYH.? 25.46 O1 PEG B2002 A 192 ASN A 76 ASN.? 27.74 O1 PEG B2002 coo 1.71 48.67 0.56 0.18 47.85 1.75 -13.74 -20.99 4.34 -13.41 -22.52 2.91 coo -2.78 50.68 10.78 -4.68 50.49 8.71 -3.99 -14.24 10.25 -6.51 -13.04 10.75 coo -0.10 43.44 8.03 -1.33 45.05 7.36 -6.69 -12.45 4.90 -5.54 -13.05 6.59 1b02_c02 source 1b02 THYMIDYLATE SYNTHASE : 1 hits 1b02_c02 naa= 3 ULMN 3 1b5d_c00 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 A 148 CYH A 53 CYH.? 25.46 O1 PEG B2002 A 179 ASP A 79 ASP~? 30.35 CA CA B1002 A 183 GLN A 83 GLN~? 23.05 CA CA A1001 coo 21.87 3.71 21.27 20.32 3.55 23.64 -3.99 -14.24 10.25 -6.51 -13.04 10.75 coo 17.09 11.24 20.19 17.85 10.05 21.76 -9.53 -15.68 5.14 -8.10 -15.06 3.67 coo 19.54 13.23 15.90 21.64 12.89 15.61 -14.86 -14.93 8.21 -15.33 -13.67 9.86 ULMN 3 1b5d_c00 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 2 3 # 2 A 148 CYH B 53 CYH.? 19.65 O4 PEG B2003 A 179 ASP B 79 ASP~? 26.06 O4 PEG B2003 A 183 GLN B 83 GLN~? 22.59 O4 PEG B2003 coo 21.87 3.71 21.27 20.32 3.55 23.64 -19.64 -33.35 10.08 -17.03 -34.49 10.54 coo 17.09 11.24 20.19 17.85 10.05 21.76 -14.12 -31.44 4.95 -15.54 -32.00 3.54 coo 19.54 13.23 15.90 21.64 12.89 15.61 -8.60 -32.34 7.87 -8.11 -33.73 9.38 1b5d_c00 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 2 hits 1b5d_c00 naa= 3 ULMN 3 1b5d_c01 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 B 148 CYH A 53 CYH.? 25.46 O1 PEG B2002 B 179 ASP A 79 ASP~? 30.35 CA CA B1002 B 183 GLN A 83 GLN~? 23.05 CA CA A1001 coo 30.30 0.93 3.58 31.01 1.18 0.88 -3.99 -14.24 10.25 -6.51 -13.04 10.75 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 -9.53 -15.68 5.14 -8.10 -15.06 3.67 coo 24.68 -8.53 5.16 25.68 -8.09 7.00 -14.86 -14.93 8.21 -15.33 -13.67 9.86 ULMN 3 1b5d_c01 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 2 3 # 2 B 148 CYH B 53 CYH.? 19.65 O4 PEG B2003 B 179 ASP B 79 ASP~? 26.06 O4 PEG B2003 B 183 GLN B 83 GLN~? 22.59 O4 PEG B2003 coo 30.30 0.93 3.58 31.01 1.18 0.88 -19.64 -33.35 10.08 -17.03 -34.49 10.54 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 -14.12 -31.44 4.95 -15.54 -32.00 3.54 coo 24.68 -8.53 5.16 25.68 -8.09 7.00 -8.60 -32.34 7.87 -8.11 -33.73 9.38 1b5d_c01 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 2 hits 1b5d_c01 naa= 3 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 A 60 GLU A 80 GLU~? 27.45 O4 PEG B2003 A 148 CYH B 53 CYH.? 19.65 O4 PEG B2003 A 179 ASP B 79 ASP~? 26.06 O4 PEG B2003 coo 20.47 15.77 27.32 19.04 14.27 26.94 -13.74 -20.99 4.34 -13.41 -22.52 2.91 coo 21.87 3.71 21.27 20.32 3.55 23.64 -19.64 -33.35 10.08 -17.03 -34.49 10.54 coo 17.09 11.24 20.19 17.85 10.05 21.76 -14.12 -31.44 4.95 -15.54 -32.00 3.54 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 2 3 # 2 A 60 GLU B 80 GLU~? 28.00 O4 PEG B2003 A 148 CYH A 53 CYH.? 25.46 O1 PEG B2002 A 179 ASP A 79 ASP~? 30.35 CA CA B1002 coo 20.47 15.77 27.32 19.04 14.27 26.94 -9.74 -26.27 4.08 -9.78 -24.63 2.72 coo 21.87 3.71 21.27 20.32 3.55 23.64 -3.99 -14.24 10.25 -6.51 -13.04 10.75 coo 17.09 11.24 20.19 17.85 10.05 21.76 -9.53 -15.68 5.14 -8.10 -15.06 3.67 1b5d_c04 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 2 hits 1b5d_c04 naa= 3 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 B 60 GLU A 80 GLU~? 27.45 O4 PEG B2003 B 148 CYH B 53 CYH.? 19.65 O4 PEG B2003 B 179 ASP B 79 ASP~? 26.06 O4 PEG B2003 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 -13.74 -20.99 4.34 -13.41 -22.52 2.91 coo 30.30 0.93 3.58 31.01 1.18 0.88 -19.64 -33.35 10.08 -17.03 -34.49 10.54 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 -14.12 -31.44 4.95 -15.54 -32.00 3.54 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 2 3 # 2 B 60 GLU B 80 GLU~? 28.00 O4 PEG B2003 B 148 CYH A 53 CYH.? 25.46 O1 PEG B2002 B 179 ASP A 79 ASP~? 30.35 CA CA B1002 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 -9.74 -26.27 4.08 -9.78 -24.63 2.72 coo 30.30 0.93 3.58 31.01 1.18 0.88 -3.99 -14.24 10.25 -6.51 -13.04 10.75 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 -9.53 -15.68 5.14 -8.10 -15.06 3.67 1b5d_c05 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 2 hits 1b5d_c05 naa= 3 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 A 145 TYR A 73 TYR.? -31.47 O1 PEG A2001s A 230 ASP A 70 ASP^? 25.92 O1 PEG A2001 A 273 LYS A 77 LYS.? 28.85 O1 PEG A2001 coo 9.23 21.44 106.88 10.18 19.34 105.31 -8.12 -1.41 10.87 -9.66 0.82 11.59 coo 1.45 22.80 104.16 2.58 21.02 104.01 -9.86 -5.53 16.91 -10.88 -4.17 15.65 coo 2.97 11.64 107.87 6.59 15.13 107.03 -10.44 -10.90 7.82 -13.04 -5.00 7.61 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 A 145 TYR B 73 TYR.? -26.42 O4 PEG B2003s A 230 ASP B 70 ASP^? 21.22 O4 PEG B2003 A 273 LYS B 77 LYS.? 27.21 O4 PEG B2003 coo 9.23 21.44 106.88 10.18 19.34 105.31 -15.40 -46.09 10.22 -13.89 -48.32 11.05 coo 1.45 22.80 104.16 2.58 21.02 104.01 -13.56 -42.18 16.17 -12.44 -43.52 14.94 coo 2.97 11.64 107.87 6.59 15.13 107.03 -13.11 -36.51 7.32 -10.61 -42.26 6.72 1b8g_c04 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 2 hits 1b8g_c04 naa= 3 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 B 145 TYR A 73 TYR.? -31.47 O1 PEG A2001s B 230 ASP A 70 ASP^? 25.92 O1 PEG A2001 B 273 LYS A 77 LYS.? 28.85 O1 PEG A2001 coo 11.81 13.41 73.03 10.00 13.03 75.12 -8.12 -1.41 10.87 -9.66 0.82 11.59 coo 19.17 11.01 76.14 17.26 10.42 76.77 -9.86 -5.53 16.91 -10.88 -4.17 15.65 coo 11.10 2.31 76.60 10.24 7.24 75.62 -10.44 -10.90 7.82 -13.04 -5.00 7.61 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 B 145 TYR B 73 TYR.? -26.42 O4 PEG B2003s B 230 ASP B 70 ASP^? 21.22 O4 PEG B2003 B 273 LYS B 77 LYS.? 27.21 O4 PEG B2003 coo 11.81 13.41 73.03 10.00 13.03 75.12 -15.40 -46.09 10.22 -13.89 -48.32 11.05 coo 19.17 11.01 76.14 17.26 10.42 76.77 -13.56 -42.18 16.17 -12.44 -43.52 14.94 coo 11.10 2.31 76.60 10.24 7.24 75.62 -13.11 -36.51 7.32 -10.61 -42.26 6.72 1b8g_c05 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 2 hits 1b8g_c05 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 58 GLN^? 26.34 C1 PEG B2003 A 91 LEU A 57 LEU^? 21.58 O1 PEG B2002 A 133 GLU A 17 GLU^? 20.10 C1 PEG A2001 coo 43.58 43.67 66.73 42.32 42.78 68.15 -6.45 -3.45 22.17 -8.38 -2.63 21.65 coo 38.58 45.09 70.44 38.28 45.21 72.59 -4.56 -9.28 20.86 -5.20 -10.67 22.43 coo 44.05 36.87 70.65 43.15 38.64 69.97 -14.61 -5.23 24.51 -15.43 -3.28 24.45 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 83 GLN~? 23.05 CA CA A1001 A 91 LEU A 85 LEU~? 19.34 O4 PEG B2003 A 133 GLU A 80 GLU~? 27.45 O4 PEG B2003 coo 43.58 43.67 66.73 42.32 42.78 68.15 -14.86 -14.93 8.21 -15.33 -13.67 9.86 coo 38.58 45.09 70.44 38.28 45.21 72.59 -10.79 -19.89 13.57 -9.21 -21.36 13.32 coo 44.05 36.87 70.65 43.15 38.64 69.97 -13.74 -20.99 4.34 -13.41 -22.52 2.91 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN A 83 GLN~? 23.05 CA CA A1001 A 91 LEU A 85 LEU~? 19.34 O4 PEG B2003 A 133 GLU A 87 GLU~? 17.34 CA CA A1001 coo 43.58 43.67 66.73 42.32 42.78 68.15 -14.86 -14.93 8.21 -15.33 -13.67 9.86 coo 38.58 45.09 70.44 38.28 45.21 72.59 -10.79 -19.89 13.57 -9.21 -21.36 13.32 coo 44.05 36.87 70.65 43.15 38.64 69.97 -18.57 -18.33 12.01 -20.23 -17.06 12.53 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN B 58 GLN^? 17.24 O4 PEG B2003 A 91 LEU B 57 LEU^? 12.43 O4 PEG B2003 A 133 GLU B 17 GLU^? 19.22 O4 PEG B2003 coo 43.58 43.67 66.73 42.32 42.78 68.15 -17.30 -44.64 23.75 -19.41 -45.03 23.98 coo 38.58 45.09 70.44 38.28 45.21 72.59 -18.85 -38.61 20.19 -18.30 -37.35 21.95 coo 44.05 36.87 70.65 43.15 38.64 69.97 -8.67 -42.47 23.80 -7.95 -44.48 23.69 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN B 83 GLN~? 22.59 O4 PEG B2003 A 91 LEU B 71 LEU.? 19.74 O4 PEG B2003 A 133 GLU B 87 GLU~? 17.51 CA CA B1002 coo 43.58 43.67 66.73 42.32 42.78 68.15 -8.60 -32.34 7.87 -8.11 -33.73 9.38 coo 38.58 45.09 70.44 38.28 45.21 72.59 -13.07 -38.19 11.73 -13.74 -36.17 12.14 coo 44.05 36.87 70.65 43.15 38.64 69.97 -5.10 -29.50 11.76 -3.27 -30.54 11.89 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 6 3 # 6 A 50 GLN B 83 GLN~? 22.59 O4 PEG B2003 A 91 LEU B 85 LEU~? 16.47 O4 PEG B2003 A 133 GLU B 80 GLU~? 28.00 O4 PEG B2003 coo 43.58 43.67 66.73 42.32 42.78 68.15 -8.60 -32.34 7.87 -8.11 -33.73 9.38 coo 38.58 45.09 70.44 38.28 45.21 72.59 -12.73 -27.78 13.51 -14.31 -26.32 13.35 coo 44.05 36.87 70.65 43.15 38.64 69.97 -9.74 -26.27 4.08 -9.78 -24.63 2.72 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 7 3 # 7 A 50 GLN B 83 GLN~? 22.59 O4 PEG B2003 A 91 LEU B 85 LEU~? 16.47 O4 PEG B2003 A 133 GLU B 87 GLU~? 17.51 CA CA B1002 coo 43.58 43.67 66.73 42.32 42.78 68.15 -8.60 -32.34 7.87 -8.11 -33.73 9.38 coo 38.58 45.09 70.44 38.28 45.21 72.59 -12.73 -27.78 13.51 -14.31 -26.32 13.35 coo 44.05 36.87 70.65 43.15 38.64 69.97 -5.10 -29.50 11.76 -3.27 -30.54 11.89 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 7 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN A 58 GLN^? 26.34 C1 PEG B2003 B 591 LEU A 57 LEU^? 21.58 O1 PEG B2002 B 633 GLU A 17 GLU^? 20.10 C1 PEG A2001 coo 88.06 44.34 57.19 89.06 45.53 55.74 -6.45 -3.45 22.17 -8.38 -2.63 21.65 coo 86.70 48.66 52.61 87.15 48.69 50.51 -4.56 -9.28 20.86 -5.20 -10.67 22.43 coo 95.42 44.52 54.43 93.46 45.31 54.70 -14.61 -5.23 24.51 -15.43 -3.28 24.45 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 2 3 # 2 B 550 GLN A 83 GLN~? 23.05 CA CA A1001 B 591 LEU A 85 LEU~? 19.34 O4 PEG B2003 B 633 GLU A 80 GLU~? 27.45 O4 PEG B2003 coo 88.06 44.34 57.19 89.06 45.53 55.74 -14.86 -14.93 8.21 -15.33 -13.67 9.86 coo 86.70 48.66 52.61 87.15 48.69 50.51 -10.79 -19.89 13.57 -9.21 -21.36 13.32 coo 95.42 44.52 54.43 93.46 45.31 54.70 -13.74 -20.99 4.34 -13.41 -22.52 2.91 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 3 3 # 3 B 550 GLN A 83 GLN~? 23.05 CA CA A1001 B 591 LEU A 85 LEU~? 19.34 O4 PEG B2003 B 633 GLU A 87 GLU~? 17.34 CA CA A1001 coo 88.06 44.34 57.19 89.06 45.53 55.74 -14.86 -14.93 8.21 -15.33 -13.67 9.86 coo 86.70 48.66 52.61 87.15 48.69 50.51 -10.79 -19.89 13.57 -9.21 -21.36 13.32 coo 95.42 44.52 54.43 93.46 45.31 54.70 -18.57 -18.33 12.01 -20.23 -17.06 12.53 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 4 3 # 4 B 550 GLN B 58 GLN^? 17.24 O4 PEG B2003 B 591 LEU B 57 LEU^? 12.43 O4 PEG B2003 B 633 GLU B 17 GLU^? 19.22 O4 PEG B2003 coo 88.06 44.34 57.19 89.06 45.53 55.74 -17.30 -44.64 23.75 -19.41 -45.03 23.98 coo 86.70 48.66 52.61 87.15 48.69 50.51 -18.85 -38.61 20.19 -18.30 -37.35 21.95 coo 95.42 44.52 54.43 93.46 45.31 54.70 -8.67 -42.47 23.80 -7.95 -44.48 23.69 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 5 3 # 5 B 550 GLN B 83 GLN~? 22.59 O4 PEG B2003 B 591 LEU B 71 LEU.? 19.74 O4 PEG B2003 B 633 GLU B 87 GLU~? 17.51 CA CA B1002 coo 88.06 44.34 57.19 89.06 45.53 55.74 -8.60 -32.34 7.87 -8.11 -33.73 9.38 coo 86.70 48.66 52.61 87.15 48.69 50.51 -13.07 -38.19 11.73 -13.74 -36.17 12.14 coo 95.42 44.52 54.43 93.46 45.31 54.70 -5.10 -29.50 11.76 -3.27 -30.54 11.89 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 6 3 # 6 B 550 GLN B 83 GLN~? 22.59 O4 PEG B2003 B 591 LEU B 85 LEU~? 16.47 O4 PEG B2003 B 633 GLU B 80 GLU~? 28.00 O4 PEG B2003 coo 88.06 44.34 57.19 89.06 45.53 55.74 -8.60 -32.34 7.87 -8.11 -33.73 9.38 coo 86.70 48.66 52.61 87.15 48.69 50.51 -12.73 -27.78 13.51 -14.31 -26.32 13.35 coo 95.42 44.52 54.43 93.46 45.31 54.70 -9.74 -26.27 4.08 -9.78 -24.63 2.72 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 7 3 # 7 B 550 GLN B 83 GLN~? 22.59 O4 PEG B2003 B 591 LEU B 85 LEU~? 16.47 O4 PEG B2003 B 633 GLU B 87 GLU~? 17.51 CA CA B1002 coo 88.06 44.34 57.19 89.06 45.53 55.74 -8.60 -32.34 7.87 -8.11 -33.73 9.38 coo 86.70 48.66 52.61 87.15 48.69 50.51 -12.73 -27.78 13.51 -14.31 -26.32 13.35 coo 95.42 44.52 54.43 93.46 45.31 54.70 -5.10 -29.50 11.76 -3.27 -30.54 11.89 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 7 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN A 58 GLN^? 26.34 C1 PEG B2003 C1091 LEU A 57 LEU^? 21.58 O1 PEG B2002 C1133 GLU A 17 GLU^? 20.10 C1 PEG A2001 coo 68.29 34.44 43.03 66.67 34.74 44.37 -6.45 -3.45 22.17 -8.38 -2.63 21.65 coo 65.83 38.95 47.05 65.46 38.90 49.20 -4.56 -9.28 20.86 -5.20 -10.67 22.43 coo 63.14 29.39 46.25 63.84 31.31 45.74 -14.61 -5.23 24.51 -15.43 -3.28 24.45 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 2 3 # 2 C1050 GLN A 83 GLN~? 23.05 CA CA A1001 C1091 LEU A 85 LEU~? 19.34 O4 PEG B2003 C1133 GLU A 80 GLU~? 27.45 O4 PEG B2003 coo 68.29 34.44 43.03 66.67 34.74 44.37 -14.86 -14.93 8.21 -15.33 -13.67 9.86 coo 65.83 38.95 47.05 65.46 38.90 49.20 -10.79 -19.89 13.57 -9.21 -21.36 13.32 coo 63.14 29.39 46.25 63.84 31.31 45.74 -13.74 -20.99 4.34 -13.41 -22.52 2.91 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 3 3 # 3 C1050 GLN A 83 GLN~? 23.05 CA CA A1001 C1091 LEU A 85 LEU~? 19.34 O4 PEG B2003 C1133 GLU A 87 GLU~? 17.34 CA CA A1001 coo 68.29 34.44 43.03 66.67 34.74 44.37 -14.86 -14.93 8.21 -15.33 -13.67 9.86 coo 65.83 38.95 47.05 65.46 38.90 49.20 -10.79 -19.89 13.57 -9.21 -21.36 13.32 coo 63.14 29.39 46.25 63.84 31.31 45.74 -18.57 -18.33 12.01 -20.23 -17.06 12.53 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 4 3 # 4 C1050 GLN B 58 GLN^? 17.24 O4 PEG B2003 C1091 LEU B 57 LEU^? 12.43 O4 PEG B2003 C1133 GLU B 17 GLU^? 19.22 O4 PEG B2003 coo 68.29 34.44 43.03 66.67 34.74 44.37 -17.30 -44.64 23.75 -19.41 -45.03 23.98 coo 65.83 38.95 47.05 65.46 38.90 49.20 -18.85 -38.61 20.19 -18.30 -37.35 21.95 coo 63.14 29.39 46.25 63.84 31.31 45.74 -8.67 -42.47 23.80 -7.95 -44.48 23.69 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 5 3 # 5 C1050 GLN B 83 GLN~? 22.59 O4 PEG B2003 C1091 LEU B 71 LEU.? 19.74 O4 PEG B2003 C1133 GLU B 87 GLU~? 17.51 CA CA B1002 coo 68.29 34.44 43.03 66.67 34.74 44.37 -8.60 -32.34 7.87 -8.11 -33.73 9.38 coo 65.83 38.95 47.05 65.46 38.90 49.20 -13.07 -38.19 11.73 -13.74 -36.17 12.14 coo 63.14 29.39 46.25 63.84 31.31 45.74 -5.10 -29.50 11.76 -3.27 -30.54 11.89 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 6 3 # 6 C1050 GLN B 83 GLN~? 22.59 O4 PEG B2003 C1091 LEU B 85 LEU~? 16.47 O4 PEG B2003 C1133 GLU B 80 GLU~? 28.00 O4 PEG B2003 coo 68.29 34.44 43.03 66.67 34.74 44.37 -8.60 -32.34 7.87 -8.11 -33.73 9.38 coo 65.83 38.95 47.05 65.46 38.90 49.20 -12.73 -27.78 13.51 -14.31 -26.32 13.35 coo 63.14 29.39 46.25 63.84 31.31 45.74 -9.74 -26.27 4.08 -9.78 -24.63 2.72 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 7 3 # 7 C1050 GLN B 83 GLN~? 22.59 O4 PEG B2003 C1091 LEU B 85 LEU~? 16.47 O4 PEG B2003 C1133 GLU B 87 GLU~? 17.51 CA CA B1002 coo 68.29 34.44 43.03 66.67 34.74 44.37 -8.60 -32.34 7.87 -8.11 -33.73 9.38 coo 65.83 38.95 47.05 65.46 38.90 49.20 -12.73 -27.78 13.51 -14.31 -26.32 13.35 coo 63.14 29.39 46.25 63.84 31.31 45.74 -5.10 -29.50 11.76 -3.27 -30.54 11.89 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 7 hits 1bs4_c02 naa= 3 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 58 GLN^? 26.34 C1 PEG B2003 A 91 LEU A 57 LEU^? 21.58 O1 PEG B2002 A 133 GLU A 17 GLU^? 20.10 C1 PEG A2001 coo 38.23 53.34 67.59 38.84 53.87 69.56 -6.45 -3.45 22.17 -8.38 -2.63 21.65 coo 35.40 53.22 73.30 35.37 54.87 74.74 -4.56 -9.28 20.86 -5.20 -10.67 22.43 coo 45.08 56.04 70.60 43.15 55.19 70.77 -14.61 -5.23 24.51 -15.43 -3.28 24.45 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 83 GLN~? 23.05 CA CA A1001 A 91 LEU A 71 LEU.? 25.14 C3 PEG B2003 A 133 GLU A 87 GLU~? 17.34 CA CA A1001 coo 38.23 53.34 67.59 38.84 53.87 69.56 -14.86 -14.93 8.21 -15.33 -13.67 9.86 coo 35.40 53.22 73.30 35.37 54.87 74.74 -10.29 -9.42 12.33 -9.50 -11.34 13.01 coo 45.08 56.04 70.60 43.15 55.19 70.77 -18.57 -18.33 12.01 -20.23 -17.06 12.53 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN A 83 GLN~? 23.05 CA CA A1001 A 91 LEU A 85 LEU~? 19.34 O4 PEG B2003 A 133 GLU A 80 GLU~? 27.45 O4 PEG B2003 coo 38.23 53.34 67.59 38.84 53.87 69.56 -14.86 -14.93 8.21 -15.33 -13.67 9.86 coo 35.40 53.22 73.30 35.37 54.87 74.74 -10.79 -19.89 13.57 -9.21 -21.36 13.32 coo 45.08 56.04 70.60 43.15 55.19 70.77 -13.74 -20.99 4.34 -13.41 -22.52 2.91 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN B 58 GLN^? 17.24 O4 PEG B2003 A 91 LEU B 57 LEU^? 12.43 O4 PEG B2003 A 133 GLU B 17 GLU^? 19.22 O4 PEG B2003 coo 38.23 53.34 67.59 38.84 53.87 69.56 -17.30 -44.64 23.75 -19.41 -45.03 23.98 coo 35.40 53.22 73.30 35.37 54.87 74.74 -18.85 -38.61 20.19 -18.30 -37.35 21.95 coo 45.08 56.04 70.60 43.15 55.19 70.77 -8.67 -42.47 23.80 -7.95 -44.48 23.69 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN B 83 GLN~? 22.59 O4 PEG B2003 A 91 LEU B 85 LEU~? 16.47 O4 PEG B2003 A 133 GLU B 80 GLU~? 28.00 O4 PEG B2003 coo 38.23 53.34 67.59 38.84 53.87 69.56 -8.60 -32.34 7.87 -8.11 -33.73 9.38 coo 35.40 53.22 73.30 35.37 54.87 74.74 -12.73 -27.78 13.51 -14.31 -26.32 13.35 coo 45.08 56.04 70.60 43.15 55.19 70.77 -9.74 -26.27 4.08 -9.78 -24.63 2.72 1bsj_c00 source 1bsj PEPTIDE DEFORMYLASE : 5 hits 1bsj_c00 naa= 3 ULMN 3 1bu7_c02 CYTOCHROME P450 user 1 3 # 1 A 268 THR A 19 THR^? 17.40 C1 PEG A2001 A 393 PHE A 29 PHE~? 10.36 O1 PEG B2003 A 400 CYH A 33 CYH~? 10.72 C1 PEG B2003 coo 45.81 71.19 43.26 47.70 70.19 43.25 -14.60 -7.97 30.22 -15.86 -6.22 29.97 coo 48.54 63.17 48.16 46.74 64.99 49.22 -16.52 -16.10 37.98 -15.88 -14.02 36.22 coo 53.76 64.39 46.87 52.06 66.55 47.33 -13.26 -18.01 33.48 -11.40 -16.21 34.23 ULMN 3 1bu7_c02 CYTOCHROME P450 user 2 3 # 2 A 268 THR B 19 THR^? 16.39 O4 PEG B2003 A 393 PHE B 29 PHE~? 13.33 C4 PEG B2003 A 400 CYH B 33 CYH~? 9.84 C4 PEG B2003 coo 45.81 71.19 43.26 47.70 70.19 43.25 -8.63 -39.92 29.57 -7.43 -41.72 29.21 coo 48.54 63.17 48.16 46.74 64.99 49.22 -6.26 -32.33 37.47 -7.01 -34.41 35.76 coo 53.76 64.39 46.87 52.06 66.55 47.33 -9.83 -30.15 33.15 -9.47 -32.30 34.84 ULMN 3 1bu7_c02 CYTOCHROME P450 user 3 3 # 3 A 268 THR B 105 THR^? 7.36 C4 PEG B2002 A 393 PHE B 29 PHE~? 13.33 C4 PEG B2003 A 400 CYH B 33 CYH~? 9.84 C4 PEG B2003 coo 45.81 71.19 43.26 47.70 70.19 43.25 0.42 -35.31 28.37 1.77 -36.76 29.26 coo 48.54 63.17 48.16 46.74 64.99 49.22 -6.26 -32.33 37.47 -7.01 -34.41 35.76 coo 53.76 64.39 46.87 52.06 66.55 47.33 -9.83 -30.15 33.15 -9.47 -32.30 34.84 1bu7_c02 source 1bu7 CYTOCHROME P450 : 3 hits 1bu7_c02 naa= 3 ULMN 3 1bu7_c03 CYTOCHROME P450 user 1 3 # 1 B 268 THR A 19 THR^? 17.40 C1 PEG A2001 B 393 PHE A 29 PHE~? 10.36 O1 PEG B2003 B 400 CYH A 33 CYH~? 10.72 C1 PEG B2003 coo 37.20 116.32 52.00 35.18 117.07 52.13 -14.60 -7.97 30.22 -15.86 -6.22 29.97 coo 33.81 121.65 59.26 35.49 119.55 59.81 -16.52 -16.10 37.98 -15.88 -14.02 36.22 coo 28.79 121.15 57.00 30.51 118.99 56.70 -13.26 -18.01 33.48 -11.40 -16.21 34.23 ULMN 3 1bu7_c03 CYTOCHROME P450 user 2 3 # 2 B 268 THR B 19 THR^? 16.39 O4 PEG B2003 B 393 PHE B 29 PHE~? 13.33 C4 PEG B2003 B 400 CYH B 33 CYH~? 9.84 C4 PEG B2003 coo 37.20 116.32 52.00 35.18 117.07 52.13 -8.63 -39.92 29.57 -7.43 -41.72 29.21 coo 33.81 121.65 59.26 35.49 119.55 59.81 -6.26 -32.33 37.47 -7.01 -34.41 35.76 coo 28.79 121.15 57.00 30.51 118.99 56.70 -9.83 -30.15 33.15 -9.47 -32.30 34.84 1bu7_c03 source 1bu7 CYTOCHROME P450 : 2 hits 1bu7_c03 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 30 ASP~? 11.64 C1 PEG B2003 264 GLU B 61 GLU~? 8.88 O4 PEG B2003 328 ASP B 30 ASP~? 11.37 C2 PEG B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 -12.34 -20.31 39.33 -11.75 -18.93 40.82 coo 59.69 92.71 39.85 58.53 92.03 41.47 -19.12 -38.78 33.18 -18.13 -37.00 32.57 coo 45.39 90.72 40.63 45.07 89.14 41.90 -10.72 -29.17 38.90 -10.74 -31.13 39.77 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP B 60 ASP^? 15.62 O4 PEG B2003 264 GLU B 26 GLU~? 17.91 O2 PEG B2003 328 ASP B 63 ASP~? 19.91 O4 PEG B2003 coo 45.62 80.42 43.69 45.65 82.01 45.07 -17.89 -43.42 30.19 -15.92 -44.27 30.31 coo 59.69 92.71 39.85 58.53 92.03 41.47 -6.16 -32.66 43.57 -5.34 -34.32 42.59 coo 45.39 90.72 40.63 45.07 89.14 41.90 -11.65 -45.32 36.37 -13.02 -46.95 36.09 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 2 hits 1cdg_c00 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY B 20 GLY.? 13.48 O4 PEG B2003 A 228 SER B 24 SER.? 15.05 C4 PEG B2003 A 549 ASP B 30 ASP~? 11.37 C2 PEG B2003 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -8.55 -38.17 33.00 -9.08 -37.90 32.50 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -9.88 -35.35 40.32 -7.72 -34.26 40.45 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -10.72 -29.17 38.90 -10.74 -31.13 39.77 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 A 198 GLY B 64 GLY~? 14.60 C4 PEG B2003 A 228 SER B 24 SER.? 15.05 C4 PEG B2003 A 549 ASP B 30 ASP~? 11.37 C2 PEG B2003 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -11.18 -40.43 35.51 -11.83 -40.72 35.13 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -9.88 -35.35 40.32 -7.72 -34.26 40.45 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -10.72 -29.17 38.90 -10.74 -31.13 39.77 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 2 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY A 20 GLY.? 14.96 C1 PEG B2003 B1228 SER A 24 SER.? 17.49 O1 PEG B2003 B1549 ASP A 30 ASP~? 11.64 C1 PEG B2003 coo 126.34 72.75 125.66 125.95 73.27 126.11 -14.40 -9.93 33.49 -13.82 -10.08 32.97 coo 131.65 74.68 129.41 130.31 72.73 128.82 -12.33 -13.11 41.22 -10.91 -12.04 42.92 coo 134.72 69.43 130.42 133.03 70.65 130.08 -12.34 -20.31 39.33 -11.75 -18.93 40.82 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 B1198 GLY B 20 GLY.? 13.48 O4 PEG B2003 B1228 SER B 24 SER.? 15.05 C4 PEG B2003 B1549 ASP B 30 ASP~? 11.37 C2 PEG B2003 coo 126.34 72.75 125.66 125.95 73.27 126.11 -8.55 -38.17 33.00 -9.08 -37.90 32.50 coo 131.65 74.68 129.41 130.31 72.73 128.82 -9.88 -35.35 40.32 -7.72 -34.26 40.45 coo 134.72 69.43 130.42 133.03 70.65 130.08 -10.72 -29.17 38.90 -10.74 -31.13 39.77 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 B1198 GLY B 64 GLY~? 14.60 C4 PEG B2003 B1228 SER B 24 SER.? 15.05 C4 PEG B2003 B1549 ASP B 30 ASP~? 11.37 C2 PEG B2003 coo 126.34 72.75 125.66 125.95 73.27 126.11 -11.18 -40.43 35.51 -11.83 -40.72 35.13 coo 131.65 74.68 129.41 130.31 72.73 128.82 -9.88 -35.35 40.32 -7.72 -34.26 40.45 coo 134.72 69.43 130.42 133.03 70.65 130.08 -10.72 -29.17 38.90 -10.74 -31.13 39.77 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 3 hits 1cjy_c01 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU A 87 GLU~? 17.34 CA CA A1001 A 89 GLU A 14 GLU^? 25.75 O1 PEG A2001 A 120 SER A 78 SER.? 29.96 CA CA A1001 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -18.57 -18.33 12.01 -20.23 -17.06 12.53 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -15.45 -7.36 10.85 -15.33 -5.53 9.81 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -13.07 -12.34 5.42 -12.90 -11.48 3.24 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU A 87 GLU~? 17.34 CA CA A1001 A 89 GLU A 80 GLU~? 27.45 O4 PEG B2003 A 120 SER A 78 SER.? 29.96 CA CA A1001 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -18.57 -18.33 12.01 -20.23 -17.06 12.53 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -13.74 -20.99 4.34 -13.41 -22.52 2.91 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -13.07 -12.34 5.42 -12.90 -11.48 3.24 ULMN 3 1cns_c00 CHITINASE user 3 3 # 3 A 67 GLU B 80 GLU~? 28.00 O4 PEG B2003 A 89 GLU B 87 GLU~? 17.51 CA CA B1002 A 120 SER B 78 SER.? 28.23 O4 PEG B2003 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -9.74 -26.27 4.08 -9.78 -24.63 2.72 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -5.10 -29.50 11.76 -3.27 -30.54 11.89 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -10.61 -34.92 4.88 -11.23 -35.54 2.64 ULMN 3 1cns_c00 CHITINASE user 4 3 # 4 A 67 GLU B 87 GLU~? 17.51 CA CA B1002 A 89 GLU B 14 GLU^? 25.81 O4 PEG B2002 A 120 SER B 78 SER.? 28.23 O4 PEG B2003 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -5.10 -29.50 11.76 -3.27 -30.54 11.89 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -7.72 -40.18 10.13 -8.30 -41.79 8.90 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -10.61 -34.92 4.88 -11.23 -35.54 2.64 ULMN 3 1cns_c00 CHITINASE user 5 3 # 5 A 67 GLU B 87 GLU~? 17.51 CA CA B1002 A 89 GLU B 80 GLU~? 28.00 O4 PEG B2003 A 120 SER B 78 SER.? 28.23 O4 PEG B2003 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -5.10 -29.50 11.76 -3.27 -30.54 11.89 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -9.74 -26.27 4.08 -9.78 -24.63 2.72 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -10.61 -34.92 4.88 -11.23 -35.54 2.64 ULMN 3 1cns_c00 CHITINASE user 6 3 # 6 A 67 GLU B 102 GLU.? 8.57 C3 PEG B2002 A 89 GLU B 26 GLU~? 17.91 O2 PEG B2003 A 120 SER B 0 SER.? 16.90 C4 PEG B2002 coo -24.35 9.53 67.64 -25.07 11.29 68.60 1.59 -29.80 36.90 1.85 -28.01 35.77 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -6.16 -32.66 43.57 -5.34 -34.32 42.59 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -4.49 -37.15 38.21 -5.08 -35.61 39.96 1cns_c00 source 1cns CHITINASE : 6 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU A 87 GLU~? 17.34 CA CA A1001 B 89 GLU A 14 GLU^? 25.75 O1 PEG A2001 B 120 SER A 78 SER.? 29.96 CA CA A1001 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -18.57 -18.33 12.01 -20.23 -17.06 12.53 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -15.45 -7.36 10.85 -15.33 -5.53 9.81 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -13.07 -12.34 5.42 -12.90 -11.48 3.24 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU B 87 GLU~? 17.51 CA CA B1002 B 89 GLU B 14 GLU^? 25.81 O4 PEG B2002 B 120 SER B 78 SER.? 28.23 O4 PEG B2003 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -5.10 -29.50 11.76 -3.27 -30.54 11.89 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -7.72 -40.18 10.13 -8.30 -41.79 8.90 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -10.61 -34.92 4.88 -11.23 -35.54 2.64 ULMN 3 1cns_c01 CHITINASE user 3 3 # 3 B 67 GLU B 102 GLU.? 8.57 C3 PEG B2002 B 89 GLU B 26 GLU~? 17.91 O2 PEG B2003 B 120 SER B 0 SER.? 16.90 C4 PEG B2002 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 1.59 -29.80 36.90 1.85 -28.01 35.77 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -6.16 -32.66 43.57 -5.34 -34.32 42.59 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -4.49 -37.15 38.21 -5.08 -35.61 39.96 1cns_c01 source 1cns CHITINASE : 3 hits 1cns_c01 naa= 3 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 1 3 # 1 A 1 ALA A 46 ALA~? 18.56 C3 PEG B2003 A 74 ASN A 42 ASN~? 14.52 C3 PEG B2003 A 75 GLY B 92 GLY~? 13.28 C4 PEG B2002 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -5.29 -20.84 15.78 -6.67 -21.55 16.01 coo 1.20 66.40 122.20 2.03 64.53 121.46 -7.85 -22.02 21.46 -7.56 -23.56 20.01 coo 4.68 65.84 125.52 4.11 65.60 126.05 -5.06 -26.04 22.12 -4.64 -26.71 21.94 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 2 3 # 2 A 1 ALA A 88 ALA~? 14.78 O4 PEG B2003 A 74 ASN B 42 ASN~? 10.30 O4 PEG B2003 A 75 GLY A 92 GLY~? 9.36 C3 PEG B2003 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -16.29 -21.70 16.40 -15.07 -22.59 16.11 coo 1.20 66.40 122.20 2.03 64.53 121.46 -15.54 -25.88 21.48 -16.00 -24.28 20.16 coo 4.68 65.84 125.52 4.11 65.60 126.05 -18.31 -21.80 22.45 -18.72 -21.11 22.30 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 3 3 # 3 A 1 ALA B 46 ALA~? 13.59 O4 PEG B2003 A 74 ASN B 42 ASN~? 10.30 O4 PEG B2003 A 75 GLY A 92 GLY~? 9.36 C3 PEG B2003 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -18.26 -26.86 15.83 -16.87 -26.16 16.00 coo 1.20 66.40 122.20 2.03 64.53 121.46 -15.54 -25.88 21.48 -16.00 -24.28 20.16 coo 4.68 65.84 125.52 4.11 65.60 126.05 -18.31 -21.80 22.45 -18.72 -21.11 22.30 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 4 3 # 4 A 1 ALA B 88 ALA~? 16.55 O4 PEG B2003 A 74 ASN A 42 ASN~? 14.52 C3 PEG B2003 A 75 GLY B 92 GLY~? 13.28 C4 PEG B2002 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -7.16 -26.01 16.22 -8.36 -25.17 15.98 coo 1.20 66.40 122.20 2.03 64.53 121.46 -7.85 -22.02 21.46 -7.56 -23.56 20.01 coo 4.68 65.84 125.52 4.11 65.60 126.05 -5.06 -26.04 22.12 -4.64 -26.71 21.94 1ct9_c04 source 1ct9 ASPARAGINE SYNTHETASE B : 4 hits 1ct9_c04 naa= 3 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 1 3 # 1 B 1 ALA A 46 ALA~? 18.56 C3 PEG B2003 B 74 ASN A 42 ASN~? 14.52 C3 PEG B2003 B 75 GLY B 92 GLY~? 13.28 C4 PEG B2002 coo 39.21 14.97 27.55 40.19 16.01 27.08 -5.29 -20.84 15.78 -6.67 -21.55 16.01 coo 43.06 12.94 25.74 42.26 11.81 27.44 -7.85 -22.02 21.46 -7.56 -23.56 20.01 coo 46.38 13.54 29.18 46.14 14.29 29.26 -5.06 -26.04 22.12 -4.64 -26.71 21.94 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 2 3 # 2 B 1 ALA A 88 ALA~? 14.78 O4 PEG B2003 B 74 ASN B 42 ASN~? 10.30 O4 PEG B2003 B 75 GLY A 92 GLY~? 9.36 C3 PEG B2003 coo 39.21 14.97 27.55 40.19 16.01 27.08 -16.29 -21.70 16.40 -15.07 -22.59 16.11 coo 43.06 12.94 25.74 42.26 11.81 27.44 -15.54 -25.88 21.48 -16.00 -24.28 20.16 coo 46.38 13.54 29.18 46.14 14.29 29.26 -18.31 -21.80 22.45 -18.72 -21.11 22.30 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 3 3 # 3 B 1 ALA B 46 ALA~? 13.59 O4 PEG B2003 B 74 ASN B 42 ASN~? 10.30 O4 PEG B2003 B 75 GLY A 92 GLY~? 9.36 C3 PEG B2003 coo 39.21 14.97 27.55 40.19 16.01 27.08 -18.26 -26.86 15.83 -16.87 -26.16 16.00 coo 43.06 12.94 25.74 42.26 11.81 27.44 -15.54 -25.88 21.48 -16.00 -24.28 20.16 coo 46.38 13.54 29.18 46.14 14.29 29.26 -18.31 -21.80 22.45 -18.72 -21.11 22.30 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 4 3 # 4 B 1 ALA B 88 ALA~? 16.55 O4 PEG B2003 B 74 ASN A 42 ASN~? 14.52 C3 PEG B2003 B 75 GLY B 92 GLY~? 13.28 C4 PEG B2002 coo 39.21 14.97 27.55 40.19 16.01 27.08 -7.16 -26.01 16.22 -8.36 -25.17 15.98 coo 43.06 12.94 25.74 42.26 11.81 27.44 -7.85 -22.02 21.46 -7.56 -23.56 20.01 coo 46.38 13.54 29.18 46.14 14.29 29.26 -5.06 -26.04 22.12 -4.64 -26.71 21.94 1ct9_c05 source 1ct9 ASPARAGINE SYNTHETASE B : 4 hits 1ct9_c05 naa= 3 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 1 3 # 1 C 1 ALA A 46 ALA~? 18.56 C3 PEG B2003 C 74 ASN A 42 ASN~? 14.52 C3 PEG B2003 C 75 GLY B 92 GLY~? 13.28 C4 PEG B2002 coo 16.14 15.08 36.63 15.28 14.65 37.81 -5.29 -20.84 15.78 -6.67 -21.55 16.01 coo 11.60 16.13 36.70 12.80 17.74 35.96 -7.85 -22.02 21.46 -7.56 -23.56 20.01 coo 10.99 19.23 40.32 11.50 18.77 40.74 -5.06 -26.04 22.12 -4.64 -26.71 21.94 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 2 3 # 2 C 1 ALA A 88 ALA~? 14.78 O4 PEG B2003 C 74 ASN B 42 ASN~? 10.30 O4 PEG B2003 C 75 GLY A 92 GLY~? 9.36 C3 PEG B2003 coo 16.14 15.08 36.63 15.28 14.65 37.81 -16.29 -21.70 16.40 -15.07 -22.59 16.11 coo 11.60 16.13 36.70 12.80 17.74 35.96 -15.54 -25.88 21.48 -16.00 -24.28 20.16 coo 10.99 19.23 40.32 11.50 18.77 40.74 -18.31 -21.80 22.45 -18.72 -21.11 22.30 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 3 3 # 3 C 1 ALA B 46 ALA~? 13.59 O4 PEG B2003 C 74 ASN B 42 ASN~? 10.30 O4 PEG B2003 C 75 GLY A 92 GLY~? 9.36 C3 PEG B2003 coo 16.14 15.08 36.63 15.28 14.65 37.81 -18.26 -26.86 15.83 -16.87 -26.16 16.00 coo 11.60 16.13 36.70 12.80 17.74 35.96 -15.54 -25.88 21.48 -16.00 -24.28 20.16 coo 10.99 19.23 40.32 11.50 18.77 40.74 -18.31 -21.80 22.45 -18.72 -21.11 22.30 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 4 3 # 4 C 1 ALA B 88 ALA~? 16.55 O4 PEG B2003 C 74 ASN A 42 ASN~? 14.52 C3 PEG B2003 C 75 GLY B 92 GLY~? 13.28 C4 PEG B2002 coo 16.14 15.08 36.63 15.28 14.65 37.81 -7.16 -26.01 16.22 -8.36 -25.17 15.98 coo 11.60 16.13 36.70 12.80 17.74 35.96 -7.85 -22.02 21.46 -7.56 -23.56 20.01 coo 10.99 19.23 40.32 11.50 18.77 40.74 -5.06 -26.04 22.12 -4.64 -26.71 21.94 1ct9_c06 source 1ct9 ASPARAGINE SYNTHETASE B : 4 hits 1ct9_c06 naa= 3 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 1 3 # 1 D 1 ALA A 46 ALA~? 18.56 C3 PEG B2003 D 74 ASN A 42 ASN~? 14.52 C3 PEG B2003 D 75 GLY B 92 GLY~? 13.28 C4 PEG B2002 coo -13.31 41.90 116.45 -13.05 40.39 116.25 -5.29 -20.84 15.78 -6.67 -21.55 16.01 coo -16.85 39.36 115.26 -17.55 40.58 116.90 -7.85 -22.02 21.46 -7.56 -23.56 20.01 coo -17.65 36.37 119.00 -16.85 36.22 119.00 -5.06 -26.04 22.12 -4.64 -26.71 21.94 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 2 3 # 2 D 1 ALA B 46 ALA~? 13.59 O4 PEG B2003 D 74 ASN B 42 ASN~? 10.30 O4 PEG B2003 D 75 GLY A 92 GLY~? 9.36 C3 PEG B2003 coo -13.31 41.90 116.45 -13.05 40.39 116.25 -18.26 -26.86 15.83 -16.87 -26.16 16.00 coo -16.85 39.36 115.26 -17.55 40.58 116.90 -15.54 -25.88 21.48 -16.00 -24.28 20.16 coo -17.65 36.37 119.00 -16.85 36.22 119.00 -18.31 -21.80 22.45 -18.72 -21.11 22.30 1ct9_c07 source 1ct9 ASPARAGINE SYNTHETASE B : 2 hits 1ct9_c07 naa= 3 ULMN 3 1cwy_c00 AMYLOMALTASE user 1 3 # 1 A 293 ASP A 60 ASP^? 23.70 C1 PEG B2003 A 340 GLU A 61 GLU.? 19.08 C1 PEG B2003 A 395 ASP A 63 ASP.? 23.22 C1 PEG B2003 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 -5.40 -4.16 30.61 -7.36 -3.38 30.96 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 -3.95 -8.85 34.10 -5.28 -10.35 33.41 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 -11.50 -2.39 37.13 -13.46 -2.26 37.99 ULMN 3 1cwy_c00 AMYLOMALTASE user 2 3 # 2 A 293 ASP B 60 ASP^? 15.62 O4 PEG B2003 A 340 GLU B 61 GLU~? 8.88 O4 PEG B2003 A 395 ASP B 63 ASP~? 19.91 O4 PEG B2003 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 -17.89 -43.42 30.19 -15.92 -44.27 30.31 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 -19.12 -38.78 33.18 -18.13 -37.00 32.57 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 -11.65 -45.32 36.37 -13.02 -46.95 36.09 1cwy_c00 source 1cwy AMYLOMALTASE : 2 hits 1cwy_c00 naa= 3 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 173 TYR A 27 TYR~? 9.22 O1 PEG B2003 A 243 ASP B 60 ASP^? 15.62 O4 PEG B2003 A 272 LYS B 68 LYS^? 20.92 O4 PEG B2003 coo 2.03 68.31 21.46 0.66 68.36 23.90 -14.90 -24.31 42.27 -14.00 -26.56 40.85 coo 16.93 55.67 9.65 17.16 54.23 11.19 -17.89 -43.42 30.19 -15.92 -44.27 30.31 coo 14.13 45.79 13.40 14.25 49.41 18.30 -12.94 -40.63 21.91 -10.06 -45.25 18.80 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 173 TYR B 27 TYR~? 13.40 C1 PEG B2003 A 243 ASP A 60 ASP^? 23.70 C1 PEG B2003 A 272 LYS A 68 LYS^? 23.30 O1 PEG A2001 coo 2.03 68.31 21.46 0.66 68.36 23.90 -8.19 -24.57 42.59 -8.72 -22.12 41.34 coo 16.93 55.67 9.65 17.16 54.23 11.19 -5.40 -4.16 30.61 -7.36 -3.38 30.96 coo 14.13 45.79 13.40 14.25 49.41 18.30 -10.36 -7.13 22.60 -13.43 -2.53 19.68 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 3 # 3 A 173 TYR B 27 TYR~? 13.40 C1 PEG B2003 A 243 ASP B 60 ASP^? 15.62 O4 PEG B2003 A 272 LYS B 68 LYS^? 20.92 O4 PEG B2003 coo 2.03 68.31 21.46 0.66 68.36 23.90 -8.19 -24.57 42.59 -8.72 -22.12 41.34 coo 16.93 55.67 9.65 17.16 54.23 11.19 -17.89 -43.42 30.19 -15.92 -44.27 30.31 coo 14.13 45.79 13.40 14.25 49.41 18.30 -12.94 -40.63 21.91 -10.06 -45.25 18.80 1d7r_c02 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 3 hits 1d7r_c02 naa= 3 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 A 145 LYS A 81 LYS~? 24.71 CA CA B1002 A 177 GLU A 87 GLU~? 17.34 CA CA A1001 A 201 LEU A 84 LEU~? 20.51 O4 PEG B2003 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -10.43 -20.23 7.61 -6.19 -24.16 5.61 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -18.57 -18.33 12.01 -20.23 -17.06 12.53 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -13.95 -21.75 9.86 -14.60 -23.80 10.09 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 A 145 LYS A 81 LYS~? 24.71 CA CA B1002 A 177 GLU A 87 GLU~? 17.34 CA CA A1001 A 201 LEU A 85 LEU~? 19.34 O4 PEG B2003 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -10.43 -20.23 7.61 -6.19 -24.16 5.61 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -18.57 -18.33 12.01 -20.23 -17.06 12.53 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -10.79 -19.89 13.57 -9.21 -21.36 13.32 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 A 145 LYS A 81 LYS~? 24.71 CA CA B1002 A 177 GLU B 87 GLU~? 17.51 CA CA B1002 A 201 LEU A 50 LEU~? 18.52 CA CA B1002 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -10.43 -20.23 7.61 -6.19 -24.16 5.61 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -5.10 -29.50 11.76 -3.27 -30.54 11.89 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -4.54 -23.04 11.81 -4.06 -24.91 12.83 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 A 145 LYS A 81 LYS~? 24.71 CA CA B1002 A 177 GLU B 87 GLU~? 17.51 CA CA B1002 A 201 LEU B 84 LEU~? 21.47 O4 PEG B2003 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -10.43 -20.23 7.61 -6.19 -24.16 5.61 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -5.10 -29.50 11.76 -3.27 -30.54 11.89 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -9.60 -25.70 9.76 -8.83 -23.67 10.10 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 A 145 LYS B 81 LYS~? 24.83 O4 PEG B2003 A 177 GLU A 87 GLU~? 17.34 CA CA A1001 A 201 LEU A 84 LEU~? 20.51 O4 PEG B2003 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -13.27 -27.12 7.60 -17.56 -23.53 5.05 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -18.57 -18.33 12.01 -20.23 -17.06 12.53 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -13.95 -21.75 9.86 -14.60 -23.80 10.09 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 6 3 # 6 A 145 LYS B 81 LYS~? 24.83 O4 PEG B2003 A 177 GLU A 87 GLU~? 17.34 CA CA A1001 A 201 LEU B 50 LEU~? 17.69 O4 PEG B2003 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -13.27 -27.12 7.60 -17.56 -23.53 5.05 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -18.57 -18.33 12.01 -20.23 -17.06 12.53 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -19.02 -24.53 11.89 -19.33 -22.74 13.06 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 7 3 # 7 A 145 LYS B 81 LYS~? 24.83 O4 PEG B2003 A 177 GLU B 87 GLU~? 17.51 CA CA B1002 A 201 LEU B 84 LEU~? 21.47 O4 PEG B2003 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -13.27 -27.12 7.60 -17.56 -23.53 5.05 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -5.10 -29.50 11.76 -3.27 -30.54 11.89 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -9.60 -25.70 9.76 -8.83 -23.67 10.10 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 8 3 # 8 A 145 LYS B 81 LYS~? 24.83 O4 PEG B2003 A 177 GLU B 87 GLU~? 17.51 CA CA B1002 A 201 LEU B 85 LEU~? 16.47 O4 PEG B2003 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -13.27 -27.12 7.60 -17.56 -23.53 5.05 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -5.10 -29.50 11.76 -3.27 -30.54 11.89 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -12.73 -27.78 13.51 -14.31 -26.32 13.35 1daa_c00 source 1daa D-AMINO ACID AMINOTRANSFERASE : 8 hits 1daa_c00 naa= 3 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 B 145 LYS A 81 LYS~? 24.71 CA CA B1002 B 177 GLU A 87 GLU~? 17.34 CA CA A1001 B 201 LEU A 84 LEU~? 20.51 O4 PEG B2003 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -10.43 -20.23 7.61 -6.19 -24.16 5.61 coo 27.00 6.35 51.01 26.30 4.53 50.18 -18.57 -18.33 12.01 -20.23 -17.06 12.53 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -13.95 -21.75 9.86 -14.60 -23.80 10.09 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 B 145 LYS A 81 LYS~? 24.71 CA CA B1002 B 177 GLU B 87 GLU~? 17.51 CA CA B1002 B 201 LEU A 50 LEU~? 18.52 CA CA B1002 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -10.43 -20.23 7.61 -6.19 -24.16 5.61 coo 27.00 6.35 51.01 26.30 4.53 50.18 -5.10 -29.50 11.76 -3.27 -30.54 11.89 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -4.54 -23.04 11.81 -4.06 -24.91 12.83 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 B 145 LYS A 81 LYS~? 24.71 CA CA B1002 B 177 GLU B 87 GLU~? 17.51 CA CA B1002 B 201 LEU B 84 LEU~? 21.47 O4 PEG B2003 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -10.43 -20.23 7.61 -6.19 -24.16 5.61 coo 27.00 6.35 51.01 26.30 4.53 50.18 -5.10 -29.50 11.76 -3.27 -30.54 11.89 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -9.60 -25.70 9.76 -8.83 -23.67 10.10 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 B 145 LYS B 81 LYS~? 24.83 O4 PEG B2003 B 177 GLU A 87 GLU~? 17.34 CA CA A1001 B 201 LEU A 84 LEU~? 20.51 O4 PEG B2003 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -13.27 -27.12 7.60 -17.56 -23.53 5.05 coo 27.00 6.35 51.01 26.30 4.53 50.18 -18.57 -18.33 12.01 -20.23 -17.06 12.53 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -13.95 -21.75 9.86 -14.60 -23.80 10.09 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 B 145 LYS B 81 LYS~? 24.83 O4 PEG B2003 B 177 GLU A 87 GLU~? 17.34 CA CA A1001 B 201 LEU B 50 LEU~? 17.69 O4 PEG B2003 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -13.27 -27.12 7.60 -17.56 -23.53 5.05 coo 27.00 6.35 51.01 26.30 4.53 50.18 -18.57 -18.33 12.01 -20.23 -17.06 12.53 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -19.02 -24.53 11.89 -19.33 -22.74 13.06 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 6 3 # 6 B 145 LYS B 81 LYS~? 24.83 O4 PEG B2003 B 177 GLU B 87 GLU~? 17.51 CA CA B1002 B 201 LEU B 84 LEU~? 21.47 O4 PEG B2003 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -13.27 -27.12 7.60 -17.56 -23.53 5.05 coo 27.00 6.35 51.01 26.30 4.53 50.18 -5.10 -29.50 11.76 -3.27 -30.54 11.89 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -9.60 -25.70 9.76 -8.83 -23.67 10.10 1daa_c01 source 1daa D-AMINO ACID AMINOTRANSFERASE : 6 hits 1daa_c01 naa= 3 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 1 3 # 1 B 141 GLY A 28 GLY~? 6.46 O1 PEG B2003 B 144 GLU A 26 GLU~? 10.48 O1 PEG B2003 B 164 GLU A 102 GLU.? 7.49 O1 PEG B2003 coo 88.87 114.43 152.30 88.45 115.15 152.32 -17.99 -21.92 39.59 -17.39 -21.34 39.70 coo 85.20 111.99 152.05 86.60 110.89 150.91 -18.91 -18.64 42.47 -20.88 -19.31 42.77 coo 88.14 113.46 145.73 86.79 113.92 147.30 -24.41 -18.40 37.33 -24.92 -20.20 36.28 1dub_c13 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c13 naa= 3 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 1 3 # 1 C 141 GLY A 28 GLY~? 6.46 O1 PEG B2003 C 144 GLU A 26 GLU~? 10.48 O1 PEG B2003 C 164 GLU A 102 GLU.? 7.49 O1 PEG B2003 coo 56.28 104.55 135.84 56.09 105.34 136.05 -17.99 -21.92 39.59 -17.39 -21.34 39.70 coo 58.46 103.90 139.48 57.57 102.00 139.16 -18.91 -18.64 42.47 -20.88 -19.31 42.77 coo 51.71 102.03 140.09 53.02 103.62 140.54 -24.41 -18.40 37.33 -24.92 -20.20 36.28 1dub_c14 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c14 naa= 3 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 1 3 # 1 D 141 GLY A 28 GLY~? 6.46 O1 PEG B2003 D 144 GLU A 26 GLU~? 10.48 O1 PEG B2003 D 164 GLU A 102 GLU.? 7.49 O1 PEG B2003 coo 86.19 80.64 132.77 86.38 79.85 132.93 -17.99 -21.92 39.59 -17.39 -21.34 39.70 coo 84.75 81.24 136.88 85.62 83.14 136.43 -18.91 -18.64 42.47 -20.88 -19.31 42.77 coo 91.47 83.05 136.24 90.35 81.38 136.84 -24.41 -18.40 37.33 -24.92 -20.20 36.28 1dub_c15 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c15 naa= 3 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 1 3 # 1 E 141 GLY A 28 GLY~? 6.46 O1 PEG B2003 E 144 GLU A 26 GLU~? 10.48 O1 PEG B2003 E 164 GLU A 102 GLU.? 7.49 O1 PEG B2003 coo 90.07 81.07 170.50 90.23 80.26 170.38 -17.99 -21.92 39.59 -17.39 -21.34 39.70 coo 87.05 81.30 167.53 86.38 82.74 168.94 -18.91 -18.64 42.47 -20.88 -19.31 42.77 coo 84.40 80.02 173.80 85.08 79.06 172.03 -24.41 -18.40 37.33 -24.92 -20.20 36.28 1dub_c16 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c16 naa= 3 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 1 3 # 1 F 141 GLY A 28 GLY~? 6.46 O1 PEG B2003 F 144 GLU A 26 GLU~? 10.48 O1 PEG B2003 F 164 GLU A 102 GLU.? 7.49 O1 PEG B2003 coo 57.12 70.68 155.10 57.52 69.95 155.02 -17.99 -21.92 39.59 -17.39 -21.34 39.70 coo 60.62 73.13 154.21 59.05 74.26 153.35 -18.91 -18.64 42.47 -20.88 -19.31 42.77 coo 56.75 71.71 148.46 58.44 71.01 149.54 -24.41 -18.40 37.33 -24.92 -20.20 36.28 1dub_c17 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c17 naa= 3 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 B 131 LYS B 10 LYS.? 28.13 CA CA B1002 B 215 LYS B 77 LYS.? 27.21 O4 PEG B2003 B 277 LYS B 81 LYS~? 24.83 O4 PEG B2003 coo 6.78 45.91 16.15 7.82 40.81 15.84 -1.99 -39.94 5.49 -0.05 -44.29 3.04 coo 17.88 38.77 19.81 16.38 34.23 17.24 -13.11 -36.51 7.32 -10.61 -42.26 6.72 coo 20.33 37.78 11.20 16.77 34.53 13.47 -13.27 -27.12 7.60 -17.56 -23.53 5.05 1e19_c01 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 1 hits 1e19_c01 naa= 3 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 66 TYR^? 22.56 C1 PEG B2003 A 40 ASP A 63 ASP.? 23.22 C1 PEG B2003 A 103 ASP A 60 ASP^? 23.70 C1 PEG B2003 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -10.60 -4.44 27.95 -11.26 -3.41 25.42 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -11.50 -2.39 37.13 -13.46 -2.26 37.99 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -5.40 -4.16 30.61 -7.36 -3.38 30.96 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR B 66 TYR^? 16.34 O4 PEG B2003 A 40 ASP B 63 ASP~? 19.91 O4 PEG B2003 A 103 ASP B 60 ASP^? 15.62 O4 PEG B2003 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -12.77 -43.45 27.28 -12.10 -44.44 24.75 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -11.65 -45.32 36.37 -13.02 -46.95 36.09 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -17.89 -43.42 30.19 -15.92 -44.27 30.31 1e3v_c02 source 1e3v STEROID DELTA-ISOMERASE : 2 hits 1e3v_c02 naa= 3 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 66 TYR^? 22.56 C1 PEG B2003 B 40 ASP A 63 ASP.? 23.22 C1 PEG B2003 B 103 ASP A 60 ASP^? 23.70 C1 PEG B2003 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -10.60 -4.44 27.95 -11.26 -3.41 25.42 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -11.50 -2.39 37.13 -13.46 -2.26 37.99 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -5.40 -4.16 30.61 -7.36 -3.38 30.96 1e3v_c03 source 1e3v STEROID DELTA-ISOMERASE : 1 hits 1e3v_c03 naa= 3 ULMN 3 1ef8_c00 METHYLMALONYL COA DECARBOXYLASE user 1 3 # 1 A 66 HIS A 21 HIS.? 16.23 C1 PEG B2003 A 110 GLY A 20 GLY.? 14.96 C1 PEG B2003 A 140 TYR A 66 TYR^? 22.56 C1 PEG B2003 coo 24.53 0.12 1.91 23.47 1.90 2.27 -9.66 -11.83 31.16 -7.90 -10.69 31.12 coo 22.96 1.26 5.85 23.32 1.32 6.60 -14.40 -9.93 33.49 -13.82 -10.08 32.97 coo 21.28 7.32 1.28 21.07 5.14 3.02 -10.60 -4.44 27.95 -11.26 -3.41 25.42 ULMN 3 1ef8_c00 METHYLMALONYL COA DECARBOXYLASE user 2 3 # 2 A 66 HIS A 21 HIS.? 16.23 C1 PEG B2003 A 110 GLY A 65 GLY.? 18.86 C1 PEG B2003 A 140 TYR A 66 TYR^? 22.56 C1 PEG B2003 coo 24.53 0.12 1.91 23.47 1.90 2.27 -9.66 -11.83 31.16 -7.90 -10.69 31.12 coo 22.96 1.26 5.85 23.32 1.32 6.60 -9.86 -7.46 33.11 -10.61 -7.04 33.04 coo 21.28 7.32 1.28 21.07 5.14 3.02 -10.60 -4.44 27.95 -11.26 -3.41 25.42 ULMN 3 1ef8_c00 METHYLMALONYL COA DECARBOXYLASE user 3 3 # 3 A 66 HIS B 21 HIS.? 9.56 O4 PEG B2003 A 110 GLY B 20 GLY.? 13.48 O4 PEG B2003 A 140 TYR B 66 TYR^? 16.34 O4 PEG B2003 coo 24.53 0.12 1.91 23.47 1.90 2.27 -11.59 -35.81 29.96 -12.58 -37.49 29.21 coo 22.96 1.26 5.85 23.32 1.32 6.60 -8.55 -38.17 33.00 -9.08 -37.90 32.50 coo 21.28 7.32 1.28 21.07 5.14 3.02 -12.77 -43.45 27.28 -12.10 -44.44 24.75 ULMN 3 1ef8_c00 METHYLMALONYL COA DECARBOXYLASE user 4 3 # 4 A 66 HIS B 21 HIS.? 9.56 O4 PEG B2003 A 110 GLY B 65 GLY.? 12.49 O4 PEG B2003 A 140 TYR B 66 TYR^? 16.34 O4 PEG B2003 coo 24.53 0.12 1.91 23.47 1.90 2.27 -11.59 -35.81 29.96 -12.58 -37.49 29.21 coo 22.96 1.26 5.85 23.32 1.32 6.60 -13.21 -40.11 32.31 -12.56 -40.63 32.31 coo 21.28 7.32 1.28 21.07 5.14 3.02 -12.77 -43.45 27.28 -12.10 -44.44 24.75 1ef8_c00 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 4 hits 1ef8_c00 naa= 3 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 1 3 # 1 B 66 HIS A 21 HIS.? 16.23 C1 PEG B2003 B 110 GLY A 20 GLY.? 14.96 C1 PEG B2003 B 140 TYR A 66 TYR^? 22.56 C1 PEG B2003 coo 15.25 42.02 9.50 15.08 40.17 8.54 -9.66 -11.83 31.16 -7.90 -10.69 31.12 coo 16.54 37.86 10.86 17.07 37.78 11.48 -14.40 -9.93 33.49 -13.82 -10.08 32.97 coo 8.70 35.97 10.91 11.44 36.02 10.35 -10.60 -4.44 27.95 -11.26 -3.41 25.42 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 2 3 # 2 B 66 HIS B 21 HIS.? 9.56 O4 PEG B2003 B 110 GLY B 20 GLY.? 13.48 O4 PEG B2003 B 140 TYR B 66 TYR^? 16.34 O4 PEG B2003 coo 15.25 42.02 9.50 15.08 40.17 8.54 -11.59 -35.81 29.96 -12.58 -37.49 29.21 coo 16.54 37.86 10.86 17.07 37.78 11.48 -8.55 -38.17 33.00 -9.08 -37.90 32.50 coo 8.70 35.97 10.91 11.44 36.02 10.35 -12.77 -43.45 27.28 -12.10 -44.44 24.75 1ef8_c01 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 2 hits 1ef8_c01 naa= 3 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 1 3 # 1 C 66 HIS A 21 HIS.? 16.23 C1 PEG B2003 C 110 GLY A 20 GLY.? 14.96 C1 PEG B2003 C 140 TYR A 66 TYR^? 22.56 C1 PEG B2003 coo -9.82 10.01 28.41 -9.17 11.02 26.71 -9.66 -11.83 31.16 -7.90 -10.69 31.12 coo -5.73 12.49 27.77 -5.15 12.61 28.37 -14.40 -9.93 33.49 -13.82 -10.08 32.97 coo -4.68 8.05 21.05 -4.91 10.19 22.84 -10.60 -4.44 27.95 -11.26 -3.41 25.42 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 2 3 # 2 C 66 HIS B 21 HIS.? 9.56 O4 PEG B2003 C 110 GLY B 20 GLY.? 13.48 O4 PEG B2003 C 140 TYR B 66 TYR^? 16.34 O4 PEG B2003 coo -9.82 10.01 28.41 -9.17 11.02 26.71 -11.59 -35.81 29.96 -12.58 -37.49 29.21 coo -5.73 12.49 27.77 -5.15 12.61 28.37 -8.55 -38.17 33.00 -9.08 -37.90 32.50 coo -4.68 8.05 21.05 -4.91 10.19 22.84 -12.77 -43.45 27.28 -12.10 -44.44 24.75 1ef8_c02 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 2 hits 1ef8_c02 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA A 34 ALA~? 7.46 O2 PEG B2003 A 257 ALA B 35 ALA~? 8.44 O2 PEG B2003 A 328 ASP B 30 ASP~? 11.37 C2 PEG B2003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -10.87 -20.87 32.55 -10.65 -22.13 33.42 coo 43.22 26.73 5.37 41.81 27.09 5.79 -9.96 -26.03 29.75 -8.50 -25.64 29.95 coo 38.17 34.10 6.67 37.72 32.06 6.84 -10.72 -29.17 38.90 -10.74 -31.13 39.77 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 2 3 # 2 A 229 ALA A 35 ALA~? 4.47 O2 PEG B2003 A 257 ALA A 34 ALA~? 7.46 O2 PEG B2003 A 328 ASP B 30 ASP~? 11.37 C2 PEG B2003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -13.26 -21.98 29.72 -14.71 -22.44 29.86 coo 43.22 26.73 5.37 41.81 27.09 5.79 -10.87 -20.87 32.55 -10.65 -22.13 33.42 coo 38.17 34.10 6.67 37.72 32.06 6.84 -10.72 -29.17 38.90 -10.74 -31.13 39.77 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 3 3 # 3 A 229 ALA A 35 ALA~? 4.47 O2 PEG B2003 A 257 ALA B 34 ALA~? 4.64 O2 PEG B2003 A 328 ASP A 30 ASP~? 11.64 C1 PEG B2003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -13.26 -21.98 29.72 -14.71 -22.44 29.86 coo 43.22 26.73 5.37 41.81 27.09 5.79 -12.29 -27.34 32.52 -12.53 -26.18 33.47 coo 38.17 34.10 6.67 37.72 32.06 6.84 -12.34 -20.31 39.33 -11.75 -18.93 40.82 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 4 3 # 4 A 229 ALA A 35 ALA~? 4.47 O2 PEG B2003 A 257 ALA B 35 ALA~? 8.44 O2 PEG B2003 A 328 ASP B 30 ASP~? 11.37 C2 PEG B2003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -13.26 -21.98 29.72 -14.71 -22.44 29.86 coo 43.22 26.73 5.37 41.81 27.09 5.79 -9.96 -26.03 29.75 -8.50 -25.64 29.95 coo 38.17 34.10 6.67 37.72 32.06 6.84 -10.72 -29.17 38.90 -10.74 -31.13 39.77 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 5 3 # 5 A 229 ALA B 34 ALA~? 4.64 O2 PEG B2003 A 257 ALA A 35 ALA~? 4.47 O2 PEG B2003 A 328 ASP A 30 ASP~? 11.64 C1 PEG B2003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -12.29 -27.34 32.52 -12.53 -26.18 33.47 coo 43.22 26.73 5.37 41.81 27.09 5.79 -13.26 -21.98 29.72 -14.71 -22.44 29.86 coo 38.17 34.10 6.67 37.72 32.06 6.84 -12.34 -20.31 39.33 -11.75 -18.93 40.82 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 6 3 # 6 A 229 ALA B 35 ALA~? 8.44 O2 PEG B2003 A 257 ALA A 34 ALA~? 7.46 O2 PEG B2003 A 328 ASP B 30 ASP~? 11.37 C2 PEG B2003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -9.96 -26.03 29.75 -8.50 -25.64 29.95 coo 43.22 26.73 5.37 41.81 27.09 5.79 -10.87 -20.87 32.55 -10.65 -22.13 33.42 coo 38.17 34.10 6.67 37.72 32.06 6.84 -10.72 -29.17 38.90 -10.74 -31.13 39.77 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 7 3 # 7 A 229 ALA B 35 ALA~? 8.44 O2 PEG B2003 A 257 ALA A 35 ALA~? 4.47 O2 PEG B2003 A 328 ASP A 30 ASP~? 11.64 C1 PEG B2003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -9.96 -26.03 29.75 -8.50 -25.64 29.95 coo 43.22 26.73 5.37 41.81 27.09 5.79 -13.26 -21.98 29.72 -14.71 -22.44 29.86 coo 38.17 34.10 6.67 37.72 32.06 6.84 -12.34 -20.31 39.33 -11.75 -18.93 40.82 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 8 3 # 8 A 229 ALA B 35 ALA~? 8.44 O2 PEG B2003 A 257 ALA B 34 ALA~? 4.64 O2 PEG B2003 A 328 ASP A 30 ASP~? 11.64 C1 PEG B2003 coo 39.84 24.12 8.44 38.50 24.23 9.11 -9.96 -26.03 29.75 -8.50 -25.64 29.95 coo 43.22 26.73 5.37 41.81 27.09 5.79 -12.29 -27.34 32.52 -12.53 -26.18 33.47 coo 38.17 34.10 6.67 37.72 32.06 6.84 -12.34 -20.31 39.33 -11.75 -18.93 40.82 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 8 hits 1eo7_c00 naa= 3 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 159 LYS A 77 LYS.? 28.85 O1 PEG A2001 A 193 GLU A 80 GLU~? 27.45 O4 PEG B2003 A 217 VAL A 82 VAL~? 24.54 C3 PEG B2003 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -10.44 -10.90 7.82 -13.04 -5.00 7.61 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -13.74 -20.99 4.34 -13.41 -22.52 2.91 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -10.40 -17.01 9.61 -9.44 -15.00 9.42 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 159 LYS B 77 LYS.? 27.21 O4 PEG B2003 A 193 GLU B 80 GLU~? 28.00 O4 PEG B2003 A 217 VAL B 82 VAL~? 20.52 O4 PEG B2003 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -13.11 -36.51 7.32 -10.61 -42.26 6.72 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -9.74 -26.27 4.08 -9.78 -24.63 2.72 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -13.22 -30.45 9.42 -14.18 -32.47 9.26 1et0_c00 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 2 hits 1et0_c00 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 54 THR.? 24.54 O1 PEG B2002 A 159 LYS A 77 LYS.? 28.85 O1 PEG A2001 A 193 GLU A 80 GLU~? 27.45 O4 PEG B2003 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -2.24 -11.47 12.22 -1.43 -9.50 11.62 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -10.44 -10.90 7.82 -13.04 -5.00 7.61 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -13.74 -20.99 4.34 -13.41 -22.52 2.91 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR A 54 THR.? 24.54 O1 PEG B2002 A 159 LYS A 77 LYS.? 28.85 O1 PEG A2001 A 193 GLU A 87 GLU~? 17.34 CA CA A1001 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -2.24 -11.47 12.22 -1.43 -9.50 11.62 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -10.44 -10.90 7.82 -13.04 -5.00 7.61 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -18.57 -18.33 12.01 -20.23 -17.06 12.53 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 38 THR A 94 THR~? 8.47 CA CA A1001 A 159 LYS A 107 LYS^? 14.69 O1 PEG A2001 A 193 GLU A 17 GLU^? 20.10 C1 PEG A2001 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -22.68 -18.69 23.14 -23.93 -18.18 21.39 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -24.09 -9.54 22.80 -23.65 -3.96 24.23 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -14.61 -5.23 24.51 -15.43 -3.28 24.45 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 38 THR A 110 THR^? 18.02 CA CA A1001 A 159 LYS A 107 LYS^? 14.69 O1 PEG A2001 A 193 GLU A 17 GLU^? 20.10 C1 PEG A2001 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -24.52 -6.43 13.42 -26.28 -7.43 12.69 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -24.09 -9.54 22.80 -23.65 -3.96 24.23 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -14.61 -5.23 24.51 -15.43 -3.28 24.45 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 5 3 # 5 A 38 THR B 54 THR.? 18.53 O4 PEG B2003 A 159 LYS B 77 LYS.? 27.21 O4 PEG B2003 A 193 GLU B 80 GLU~? 28.00 O4 PEG B2003 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -21.29 -35.65 12.60 -23.37 -35.92 13.29 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -13.11 -36.51 7.32 -10.61 -42.26 6.72 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -9.74 -26.27 4.08 -9.78 -24.63 2.72 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 6 3 # 6 A 38 THR B 54 THR.? 18.53 O4 PEG B2003 A 159 LYS B 77 LYS.? 27.21 O4 PEG B2003 A 193 GLU B 87 GLU~? 17.51 CA CA B1002 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -21.29 -35.65 12.60 -23.37 -35.92 13.29 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -13.11 -36.51 7.32 -10.61 -42.26 6.72 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -5.10 -29.50 11.76 -3.27 -30.54 11.89 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 7 3 # 7 A 38 THR B 94 THR~? 8.50 CA CA B1002 A 159 LYS B 107 LYS^? 14.71 O4 PEG B2002 A 193 GLU B 17 GLU^? 19.22 O4 PEG B2003 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -0.61 -29.12 22.75 0.55 -29.62 20.96 coo 2.10 10.68 61.44 -2.14 13.16 60.61 0.77 -38.34 22.11 0.18 -43.97 23.67 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -8.67 -42.47 23.80 -7.95 -44.48 23.69 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 8 3 # 8 A 38 THR B 110 THR^? 17.32 O4 PEG B2002 A 159 LYS B 107 LYS^? 14.71 O4 PEG B2002 A 193 GLU B 17 GLU^? 19.22 O4 PEG B2003 coo -2.58 16.31 54.79 -4.02 14.93 55.64 1.31 -40.85 12.60 2.83 -39.33 12.22 coo 2.10 10.68 61.44 -2.14 13.16 60.61 0.77 -38.34 22.11 0.18 -43.97 23.67 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -8.67 -42.47 23.80 -7.95 -44.48 23.69 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 8 hits 1et0_c02 naa= 3 ULMN 3 1euu_c00 SIALIDASE user 1 3 # 1 92 ASP A 70 ASP^? 25.92 O1 PEG A2001 260 GLU A 17 GLU^? 20.10 C1 PEG A2001 370 TYR A 66 TYR^? 22.56 C1 PEG B2003 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -9.86 -5.53 16.91 -10.88 -4.17 15.65 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -14.61 -5.23 24.51 -15.43 -3.28 24.45 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -10.60 -4.44 27.95 -11.26 -3.41 25.42 ULMN 3 1euu_c00 SIALIDASE user 2 3 # 2 92 ASP B 70 ASP^? 21.22 O4 PEG B2003 260 GLU B 17 GLU^? 19.22 O4 PEG B2003 370 TYR B 66 TYR^? 16.34 O4 PEG B2003 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -13.56 -42.18 16.17 -12.44 -43.52 14.94 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -8.67 -42.47 23.80 -7.95 -44.48 23.69 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -12.77 -43.45 27.28 -12.10 -44.44 24.75 1euu_c00 source 1euu SIALIDASE : 2 hits 1euu_c00 naa= 3 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 1 3 # 1 A 34 GLU A 17 GLU^? 20.10 C1 PEG A2001 A 260 ARG A 8 ARG^? 17.40 CA CA A1001 A 270 LYS A 107 LYS^? 14.69 O1 PEG A2001 coo 50.99 29.43 12.86 52.11 29.45 14.65 -14.61 -5.23 24.51 -15.43 -3.28 24.45 coo 39.80 27.50 22.98 42.20 26.56 21.34 -22.63 -11.55 11.44 -21.49 -14.30 12.11 coo 48.83 21.70 19.50 47.44 24.99 15.25 -24.09 -9.54 22.80 -23.65 -3.96 24.23 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 2 3 # 2 A 34 GLU A 80 GLU~? 27.45 O4 PEG B2003 A 260 ARG A 8 ARG^? 17.40 CA CA A1001 A 270 LYS A 77 LYS.? 28.85 O1 PEG A2001 coo 50.99 29.43 12.86 52.11 29.45 14.65 -13.74 -20.99 4.34 -13.41 -22.52 2.91 coo 39.80 27.50 22.98 42.20 26.56 21.34 -22.63 -11.55 11.44 -21.49 -14.30 12.11 coo 48.83 21.70 19.50 47.44 24.99 15.25 -10.44 -10.90 7.82 -13.04 -5.00 7.61 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 3 3 # 3 A 34 GLU A 87 GLU~? 17.34 CA CA A1001 A 260 ARG A 9 ARG^? 23.91 O1 PEG A2001 A 270 LYS A 77 LYS.? 28.85 O1 PEG A2001 coo 50.99 29.43 12.86 52.11 29.45 14.65 -18.57 -18.33 12.01 -20.23 -17.06 12.53 coo 39.80 27.50 22.98 42.20 26.56 21.34 -17.92 -3.27 10.91 -16.40 -3.09 13.61 coo 48.83 21.70 19.50 47.44 24.99 15.25 -10.44 -10.90 7.82 -13.04 -5.00 7.61 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 4 3 # 4 A 34 GLU A 98 GLU~? 2.29 CA CA A1001s A 260 ARG A 8 ARG^? 17.40 CA CA A1001 A 270 LYS A 107 LYS^? 14.69 O1 PEG A2001 coo 50.99 29.43 12.86 52.11 29.45 14.65 -27.16 -20.48 25.10 -28.97 -19.42 25.39 coo 39.80 27.50 22.98 42.20 26.56 21.34 -22.63 -11.55 11.44 -21.49 -14.30 12.11 coo 48.83 21.70 19.50 47.44 24.99 15.25 -24.09 -9.54 22.80 -23.65 -3.96 24.23 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 5 3 # 5 A 34 GLU B 17 GLU^? 19.22 O4 PEG B2003 A 260 ARG B 8 ARG^? 17.27 CA CA B1002 A 270 LYS B 107 LYS^? 14.71 O4 PEG B2002 coo 50.99 29.43 12.86 52.11 29.45 14.65 -8.67 -42.47 23.80 -7.95 -44.48 23.69 coo 39.80 27.50 22.98 42.20 26.56 21.34 -0.83 -35.82 10.68 -1.93 -33.11 11.68 coo 48.83 21.70 19.50 47.44 24.99 15.25 0.77 -38.34 22.11 0.18 -43.97 23.67 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 6 3 # 6 A 34 GLU B 80 GLU~? 28.00 O4 PEG B2003 A 260 ARG B 8 ARG^? 17.27 CA CA B1002 A 270 LYS B 77 LYS.? 27.21 O4 PEG B2003 coo 50.99 29.43 12.86 52.11 29.45 14.65 -9.74 -26.27 4.08 -9.78 -24.63 2.72 coo 39.80 27.50 22.98 42.20 26.56 21.34 -0.83 -35.82 10.68 -1.93 -33.11 11.68 coo 48.83 21.70 19.50 47.44 24.99 15.25 -13.11 -36.51 7.32 -10.61 -42.26 6.72 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 7 3 # 7 A 34 GLU B 87 GLU~? 17.51 CA CA B1002 A 260 ARG B 9 ARG^? 23.79 O4 PEG B2002 A 270 LYS B 77 LYS.? 27.21 O4 PEG B2003 coo 50.99 29.43 12.86 52.11 29.45 14.65 -5.10 -29.50 11.76 -3.27 -30.54 11.89 coo 39.80 27.50 22.98 42.20 26.56 21.34 -5.44 -44.19 10.09 -7.02 -44.36 12.75 coo 48.83 21.70 19.50 47.44 24.99 15.25 -13.11 -36.51 7.32 -10.61 -42.26 6.72 1euy_c00 source 1euy GLUTAMINYL-TRNA SYNTHETASE : 7 hits 1euy_c00 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 86 PHE~? 20.17 C3 PEG B2003 A 210 ASP A 79 ASP~? 30.35 CA CA B1002 A 244 LYS A 10 LYS.? 26.99 O1 PEG A2001 coo 9.23 46.77 25.11 11.48 48.39 24.76 -14.10 -14.46 14.77 -14.06 -12.14 16.40 coo 10.51 37.86 19.71 9.07 39.38 20.04 -9.53 -15.68 5.14 -8.10 -15.06 3.67 coo -1.20 42.34 17.67 3.19 45.13 19.06 -21.43 -7.28 6.26 -19.99 -2.17 7.33 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE A 86 PHE~? 20.17 C3 PEG B2003 A 210 ASP A 79 ASP~? 30.35 CA CA B1002 A 244 LYS B 81 LYS~? 24.83 O4 PEG B2003 coo 9.23 46.77 25.11 11.48 48.39 24.76 -14.10 -14.46 14.77 -14.06 -12.14 16.40 coo 10.51 37.86 19.71 9.07 39.38 20.04 -9.53 -15.68 5.14 -8.10 -15.06 3.67 coo -1.20 42.34 17.67 3.19 45.13 19.06 -13.27 -27.12 7.60 -17.56 -23.53 5.05 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 112 PHE B 86 PHE~? 17.32 O4 PEG B2003 A 210 ASP B 79 ASP~? 26.06 O4 PEG B2003 A 244 LYS A 81 LYS~? 24.71 CA CA B1002 coo 9.23 46.77 25.11 11.48 48.39 24.76 -9.38 -33.21 14.35 -9.40 -35.62 15.82 coo 10.51 37.86 19.71 9.07 39.38 20.04 -14.12 -31.44 4.95 -15.54 -32.00 3.54 coo -1.20 42.34 17.67 3.19 45.13 19.06 -10.43 -20.23 7.61 -6.19 -24.16 5.61 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 3 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 86 PHE~? 20.17 C3 PEG B2003 B 210 ASP A 79 ASP~? 30.35 CA CA B1002 B 244 LYS B 81 LYS~? 24.83 O4 PEG B2003 coo 8.76 47.85 34.91 11.08 46.36 35.41 -14.10 -14.46 14.77 -14.06 -12.14 16.40 coo 9.06 56.85 40.30 7.71 55.27 39.90 -9.53 -15.68 5.14 -8.10 -15.06 3.67 coo -2.38 51.82 41.62 2.07 49.19 40.42 -13.27 -27.12 7.60 -17.56 -23.53 5.05 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE B 86 PHE~? 17.32 O4 PEG B2003 B 210 ASP B 79 ASP~? 26.06 O4 PEG B2003 B 244 LYS A 81 LYS~? 24.71 CA CA B1002 coo 8.76 47.85 34.91 11.08 46.36 35.41 -9.38 -33.21 14.35 -9.40 -35.62 15.82 coo 9.06 56.85 40.30 7.71 55.27 39.90 -14.12 -31.44 4.95 -15.54 -32.00 3.54 coo -2.38 51.82 41.62 2.07 49.19 40.42 -10.43 -20.23 7.61 -6.19 -24.16 5.61 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 2 hits 1fc4_c03 naa= 3 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 47 SER A 37 SER~? 12.09 C1 PEG B2003 A 48 THR A 38 THR~? 9.35 O2 PEG B2003 A 165 LYS A 68 LYS^? 23.30 O1 PEG A2001 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -9.67 -17.81 28.57 -9.20 -16.58 30.64 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -8.95 -21.12 26.90 -8.78 -23.13 27.67 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -10.36 -7.13 22.60 -13.43 -2.53 19.68 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 47 SER B 37 SER~? -4.72 O4 PEG B2003s A 48 THR B 38 THR~? -4.31 C3 PEG B2003s A 165 LYS B 68 LYS^? 20.92 O4 PEG B2003 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -13.50 -30.16 28.32 -13.76 -31.55 30.19 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -14.33 -26.74 26.85 -14.43 -24.77 27.69 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -12.94 -40.63 21.91 -10.06 -45.25 18.80 1fdy_c04 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c04 naa= 3 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 47 SER A 37 SER~? 12.09 C1 PEG B2003 B 48 THR A 38 THR~? 9.35 O2 PEG B2003 B 165 LYS A 68 LYS^? 23.30 O1 PEG A2001 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -9.67 -17.81 28.57 -9.20 -16.58 30.64 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -8.95 -21.12 26.90 -8.78 -23.13 27.67 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -10.36 -7.13 22.60 -13.43 -2.53 19.68 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 47 SER B 37 SER~? -4.72 O4 PEG B2003s B 48 THR B 38 THR~? -4.31 C3 PEG B2003s B 165 LYS B 68 LYS^? 20.92 O4 PEG B2003 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -13.50 -30.16 28.32 -13.76 -31.55 30.19 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -14.33 -26.74 26.85 -14.43 -24.77 27.69 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -12.94 -40.63 21.91 -10.06 -45.25 18.80 1fdy_c05 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c05 naa= 3 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 47 SER A 37 SER~? 12.09 C1 PEG B2003 C 48 THR A 38 THR~? 9.35 O2 PEG B2003 C 165 LYS A 68 LYS^? 23.30 O1 PEG A2001 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -9.67 -17.81 28.57 -9.20 -16.58 30.64 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -8.95 -21.12 26.90 -8.78 -23.13 27.67 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -10.36 -7.13 22.60 -13.43 -2.53 19.68 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 47 SER B 37 SER~? -4.72 O4 PEG B2003s C 48 THR B 38 THR~? -4.31 C3 PEG B2003s C 165 LYS B 68 LYS^? 20.92 O4 PEG B2003 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -13.50 -30.16 28.32 -13.76 -31.55 30.19 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -14.33 -26.74 26.85 -14.43 -24.77 27.69 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -12.94 -40.63 21.91 -10.06 -45.25 18.80 1fdy_c06 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c06 naa= 3 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 47 SER A 37 SER~? 12.09 C1 PEG B2003 D 48 THR A 38 THR~? 9.35 O2 PEG B2003 D 165 LYS A 68 LYS^? 23.30 O1 PEG A2001 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -9.67 -17.81 28.57 -9.20 -16.58 30.64 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -8.95 -21.12 26.90 -8.78 -23.13 27.67 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -10.36 -7.13 22.60 -13.43 -2.53 19.68 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 47 SER B 37 SER~? -4.72 O4 PEG B2003s D 48 THR B 38 THR~? -4.31 C3 PEG B2003s D 165 LYS B 68 LYS^? 20.92 O4 PEG B2003 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -13.50 -30.16 28.32 -13.76 -31.55 30.19 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -14.33 -26.74 26.85 -14.43 -24.77 27.69 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -12.94 -40.63 21.91 -10.06 -45.25 18.80 1fdy_c07 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c07 naa= 3 ULMN 3 1fuq_c00 FUMARASE C user 1 3 # 1 A 324 LYS A 68 LYS^? 23.30 O1 PEG A2001 A 331 GLU A 61 GLU.? 19.08 C1 PEG B2003 B 188 HIS A 21 HIS.? 16.23 C1 PEG B2003 coo 130.22 155.23 83.49 125.21 153.71 84.04 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo 120.90 152.23 75.28 120.94 153.09 77.19 -3.95 -8.85 34.10 -5.28 -10.35 33.41 coo 122.04 152.80 81.06 120.71 154.37 81.46 -9.66 -11.83 31.16 -7.90 -10.69 31.12 1fuq_c00 source 1fuq FUMARASE C : 1 hits 1fuq_c00 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 86 PHE~? 20.17 C3 PEG B2003 A 298 ASP A 79 ASP~? 30.35 CA CA B1002 A 329 LYS B 81 LYS~? 24.83 O4 PEG B2003 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -14.10 -14.46 14.77 -14.06 -12.14 16.40 coo 2.59 0.29 25.55 4.65 0.18 25.07 -9.53 -15.68 5.14 -8.10 -15.06 3.67 coo 12.42 6.10 23.27 9.95 1.57 20.16 -13.27 -27.12 7.60 -17.56 -23.53 5.05 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 1 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 86 PHE~? 20.17 C3 PEG B2003 B 298 ASP A 79 ASP~? 30.35 CA CA B1002 B 329 LYS B 81 LYS~? 24.83 O4 PEG B2003 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -14.10 -14.46 14.77 -14.06 -12.14 16.40 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -9.53 -15.68 5.14 -8.10 -15.06 3.67 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -13.27 -27.12 7.60 -17.56 -23.53 5.05 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 1 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 86 PHE~? 20.17 C3 PEG B2003 C 298 ASP A 79 ASP~? 30.35 CA CA B1002 C 329 LYS B 81 LYS~? 24.83 O4 PEG B2003 coo 17.41 60.57 64.39 18.40 58.12 65.34 -14.10 -14.46 14.77 -14.06 -12.14 16.40 coo 24.10 66.43 63.33 24.18 64.30 63.40 -9.53 -15.68 5.14 -8.10 -15.06 3.67 coo 27.64 56.61 58.17 22.18 57.92 60.36 -13.27 -27.12 7.60 -17.56 -23.53 5.05 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 1 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 86 PHE~? 20.17 C3 PEG B2003 D 298 ASP A 79 ASP~? 30.35 CA CA B1002 D 329 LYS B 81 LYS~? 24.83 O4 PEG B2003 coo 35.44 53.35 83.81 35.65 54.53 81.28 -14.10 -14.46 14.77 -14.06 -12.14 16.40 coo 29.72 46.46 83.60 30.79 47.36 81.99 -9.53 -15.68 5.14 -8.10 -15.06 3.67 coo 36.89 44.91 74.55 37.33 48.94 79.01 -13.27 -27.12 7.60 -17.56 -23.53 5.05 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 1 hits 1gtx_c03 naa= 3 ULMN 3 1hy3_c01 ESTROGEN SULFOTRANSFERASE user 1 3 # 1 B 47 LYS B 68 LYS^? 20.92 O4 PEG B2003 B 107 HIS B 21 HIS.? 9.56 O4 PEG B2003 B 137 SER B 15 SER^? 20.57 O4 PEG B2003 coo -20.15 -16.49 60.11 -21.92 -14.52 56.18 -12.94 -40.63 21.91 -10.06 -45.25 18.80 coo -23.43 -14.78 66.71 -24.10 -15.65 64.93 -11.59 -35.81 29.96 -12.58 -37.49 29.21 coo -17.90 -14.30 55.11 -19.49 -15.96 55.90 -9.16 -39.49 15.93 -8.11 -41.66 16.33 1hy3_c01 source 1hy3 ESTROGEN SULFOTRANSFERASE : 1 hits 1hy3_c01 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 44 VAL~? 19.08 O1 PEG B2002 A 200 ASP A 79 ASP~? 30.35 CA CA B1002 A 226 LYS A 10 LYS.? 26.99 O1 PEG A2001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -5.74 -16.05 18.71 -5.04 -14.40 19.99 coo 24.51 43.28 11.18 25.17 44.50 9.58 -9.53 -15.68 5.14 -8.10 -15.06 3.67 coo 34.47 51.09 7.19 28.58 51.18 7.53 -21.43 -7.28 6.26 -19.99 -2.17 7.33 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL A 55 VAL.? 23.13 O1 PEG B2002 A 200 ASP A 52 ASP.? 24.46 O1 PEG B2002 A 226 LYS B 81 LYS~? 24.83 O4 PEG B2003 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -4.54 -10.46 15.10 -5.93 -11.56 16.48 coo 24.51 43.28 11.18 25.17 44.50 9.58 -2.05 -17.27 6.89 -0.38 -16.21 6.11 coo 34.47 51.09 7.19 28.58 51.18 7.53 -13.27 -27.12 7.60 -17.56 -23.53 5.05 ULMN 3 1i29_c03 CSDB user 3 3 # 3 A 128 VAL A 55 VAL.? 23.13 O1 PEG B2002 A 200 ASP A 79 ASP~? 30.35 CA CA B1002 A 226 LYS A 10 LYS.? 26.99 O1 PEG A2001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -4.54 -10.46 15.10 -5.93 -11.56 16.48 coo 24.51 43.28 11.18 25.17 44.50 9.58 -9.53 -15.68 5.14 -8.10 -15.06 3.67 coo 34.47 51.09 7.19 28.58 51.18 7.53 -21.43 -7.28 6.26 -19.99 -2.17 7.33 ULMN 3 1i29_c03 CSDB user 4 3 # 4 A 128 VAL A 55 VAL.? 23.13 O1 PEG B2002 A 200 ASP A 79 ASP~? 30.35 CA CA B1002 A 226 LYS B 81 LYS~? 24.83 O4 PEG B2003 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -4.54 -10.46 15.10 -5.93 -11.56 16.48 coo 24.51 43.28 11.18 25.17 44.50 9.58 -9.53 -15.68 5.14 -8.10 -15.06 3.67 coo 34.47 51.09 7.19 28.58 51.18 7.53 -13.27 -27.12 7.60 -17.56 -23.53 5.05 ULMN 3 1i29_c03 CSDB user 5 3 # 5 A 128 VAL B 44 VAL~? 10.79 O4 PEG B2003 A 200 ASP B 79 ASP~? 26.06 O4 PEG B2003 A 226 LYS B 10 LYS.? 28.13 CA CA B1002 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -17.69 -31.75 18.64 -18.37 -33.47 19.89 coo 24.51 43.28 11.18 25.17 44.50 9.58 -14.12 -31.44 4.95 -15.54 -32.00 3.54 coo 34.47 51.09 7.19 28.58 51.18 7.53 -1.99 -39.94 5.49 -0.05 -44.29 3.04 ULMN 3 1i29_c03 CSDB user 6 3 # 6 A 128 VAL B 55 VAL.? 16.29 O4 PEG B2003 A 200 ASP B 52 ASP.? 24.24 O4 PEG B2003 A 226 LYS A 81 LYS~? 24.71 CA CA B1002 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -18.65 -37.45 14.51 -17.60 -35.90 15.71 coo 24.51 43.28 11.18 25.17 44.50 9.58 -21.39 -30.03 6.82 -22.77 -31.26 5.81 coo 34.47 51.09 7.19 28.58 51.18 7.53 -10.43 -20.23 7.61 -6.19 -24.16 5.61 ULMN 3 1i29_c03 CSDB user 7 3 # 7 A 128 VAL B 55 VAL.? 16.29 O4 PEG B2003 A 200 ASP B 79 ASP~? 26.06 O4 PEG B2003 A 226 LYS A 81 LYS~? 24.71 CA CA B1002 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -18.65 -37.45 14.51 -17.60 -35.90 15.71 coo 24.51 43.28 11.18 25.17 44.50 9.58 -14.12 -31.44 4.95 -15.54 -32.00 3.54 coo 34.47 51.09 7.19 28.58 51.18 7.53 -10.43 -20.23 7.61 -6.19 -24.16 5.61 ULMN 3 1i29_c03 CSDB user 8 3 # 8 A 128 VAL B 55 VAL.? 16.29 O4 PEG B2003 A 200 ASP B 79 ASP~? 26.06 O4 PEG B2003 A 226 LYS B 10 LYS.? 28.13 CA CA B1002 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -18.65 -37.45 14.51 -17.60 -35.90 15.71 coo 24.51 43.28 11.18 25.17 44.50 9.58 -14.12 -31.44 4.95 -15.54 -32.00 3.54 coo 34.47 51.09 7.19 28.58 51.18 7.53 -1.99 -39.94 5.49 -0.05 -44.29 3.04 1i29_c03 source 1i29 CSDB : 8 hits 1i29_c03 naa= 3 ULMN 3 1ig8_c00 HEXOKINASE PII user 1 3 # 1 A 158 SER A 78 SER.? 29.96 CA CA A1001 A 173 ARG A 9 ARG^? 23.91 O1 PEG A2001 A 211 ASP A 79 ASP~? 30.35 CA CA B1002 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -13.07 -12.34 5.42 -12.90 -11.48 3.24 coo 18.77 77.82 11.69 20.55 80.22 10.73 -17.92 -3.27 10.91 -16.40 -3.09 13.61 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -9.53 -15.68 5.14 -8.10 -15.06 3.67 ULMN 3 1ig8_c00 HEXOKINASE PII user 2 3 # 2 A 158 SER B 78 SER.? 28.23 O4 PEG B2003 A 173 ARG B 9 ARG^? 23.79 O4 PEG B2002 A 211 ASP B 79 ASP~? 26.06 O4 PEG B2003 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -10.61 -34.92 4.88 -11.23 -35.54 2.64 coo 18.77 77.82 11.69 20.55 80.22 10.73 -5.44 -44.19 10.09 -7.02 -44.36 12.75 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -14.12 -31.44 4.95 -15.54 -32.00 3.54 1ig8_c00 source 1ig8 HEXOKINASE PII : 2 hits 1ig8_c00 naa= 3 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 3 # 1 54 ASP A 79 ASP~? 30.35 CA CA B1002 158 THR A 75 THR.? 31.76 O1 PEG B2002 317 ASP A 70 ASP^? 25.92 O1 PEG A2001 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -9.53 -15.68 5.14 -8.10 -15.06 3.67 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -6.45 -7.77 5.23 -4.76 -8.32 3.95 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -9.86 -5.53 16.91 -10.88 -4.17 15.65 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 3 # 2 54 ASP B 79 ASP~? 26.06 O4 PEG B2003 158 THR B 75 THR.? 28.73 O4 PEG B2003 317 ASP B 70 ASP^? 21.22 O4 PEG B2003 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -14.12 -31.44 4.95 -15.54 -32.00 3.54 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -16.62 -39.81 4.37 -18.18 -40.97 3.33 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -13.56 -42.18 16.17 -12.44 -43.52 14.94 1inp_c02 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 2 hits 1inp_c02 naa= 3 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 1 3 # 1 A 14 GLU A 61 GLU.? 19.08 C1 PEG B2003 A 61 GLU A 17 GLU^? 20.10 C1 PEG A2001 A 162 HIS A 21 HIS.? 16.23 C1 PEG B2003 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -3.95 -8.85 34.10 -5.28 -10.35 33.41 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -14.61 -5.23 24.51 -15.43 -3.28 24.45 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -9.66 -11.83 31.16 -7.90 -10.69 31.12 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 2 3 # 2 A 14 GLU B 61 GLU~? 8.88 O4 PEG B2003 A 61 GLU B 17 GLU^? 19.22 O4 PEG B2003 A 162 HIS B 21 HIS.? 9.56 O4 PEG B2003 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -19.12 -38.78 33.18 -18.13 -37.00 32.57 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -8.67 -42.47 23.80 -7.95 -44.48 23.69 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -11.59 -35.81 29.96 -12.58 -37.49 29.21 1j53_c00 source 1j53 DNA POLYMERASE III, EPSILON CHAIN : 2 hits 1j53_c00 naa= 3 ULMN 3 1kim_c00 THYMIDINE KINASE user 1 3 # 1 A 83 GLU B 14 GLU^? 25.81 O4 PEG B2002 A 163 ARG B 9 ARG^? 23.79 O4 PEG B2002 A 222 ARG B 8 ARG^? 17.27 CA CA B1002 coo 51.27 81.34 48.31 51.67 80.79 50.28 -7.72 -40.18 10.13 -8.30 -41.79 8.90 coo 48.06 78.22 50.94 48.51 78.27 53.98 -5.44 -44.19 10.09 -7.02 -44.36 12.75 coo 54.85 84.16 52.60 54.26 81.23 53.34 -0.83 -35.82 10.68 -1.93 -33.11 11.68 1kim_c00 source 1kim THYMIDINE KINASE : 1 hits 1kim_c00 naa= 3 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 1 3 # 1 A 123 LYS A 68 LYS^? 23.30 O1 PEG A2001 A 202 SER A 15 SER^? 21.14 O1 PEG A2001 A 226 SER A 72 SER.? 25.71 O1 PEG A2001 coo 1.62 6.10 69.30 3.81 1.25 65.91 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo 4.43 1.89 61.79 4.31 0.09 63.40 -14.21 -8.14 16.70 -15.25 -5.93 17.19 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -11.42 -4.87 11.47 -12.93 -4.20 13.23 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 2 3 # 2 A 123 LYS A 68 LYS^? 23.30 O1 PEG A2001 A 202 SER A 40 SER~? 13.43 O2 PEG B2003 A 226 SER A 37 SER~? 12.09 C1 PEG B2003 coo 1.62 6.10 69.30 3.81 1.25 65.91 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo 4.43 1.89 61.79 4.31 0.09 63.40 -10.00 -16.89 23.63 -11.41 -15.57 25.07 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -9.67 -17.81 28.57 -9.20 -16.58 30.64 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 3 3 # 3 A 123 LYS A 77 LYS.? 28.85 O1 PEG A2001 A 202 SER A 72 SER.? 25.71 O1 PEG A2001 A 226 SER A 15 SER^? 21.14 O1 PEG A2001 coo 1.62 6.10 69.30 3.81 1.25 65.91 -10.44 -10.90 7.82 -13.04 -5.00 7.61 coo 4.43 1.89 61.79 4.31 0.09 63.40 -11.42 -4.87 11.47 -12.93 -4.20 13.23 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -14.21 -8.14 16.70 -15.25 -5.93 17.19 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 4 3 # 4 A 123 LYS B 68 LYS^? 20.92 O4 PEG B2003 A 202 SER B 15 SER^? 20.57 O4 PEG B2003 A 226 SER B 72 SER.? 23.35 O4 PEG B2003 coo 1.62 6.10 69.30 3.81 1.25 65.91 -12.94 -40.63 21.91 -10.06 -45.25 18.80 coo 4.43 1.89 61.79 4.31 0.09 63.40 -9.16 -39.49 15.93 -8.11 -41.66 16.33 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -12.06 -42.72 10.71 -10.61 -43.41 12.48 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 5 3 # 5 A 123 LYS B 68 LYS^? 20.92 O4 PEG B2003 A 202 SER B 40 SER~? 8.16 O4 PEG B2003 A 226 SER B 37 SER~? -4.72 O4 PEG B2003s coo 1.62 6.10 69.30 3.81 1.25 65.91 -12.94 -40.63 21.91 -10.06 -45.25 18.80 coo 4.43 1.89 61.79 4.31 0.09 63.40 -13.24 -30.95 23.50 -11.93 -32.52 24.66 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -13.50 -30.16 28.32 -13.76 -31.55 30.19 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 6 3 # 6 A 123 LYS B 77 LYS.? 27.21 O4 PEG B2003 A 202 SER B 72 SER.? 23.35 O4 PEG B2003 A 226 SER B 15 SER^? 20.57 O4 PEG B2003 coo 1.62 6.10 69.30 3.81 1.25 65.91 -13.11 -36.51 7.32 -10.61 -42.26 6.72 coo 4.43 1.89 61.79 4.31 0.09 63.40 -12.06 -42.72 10.71 -10.61 -43.41 12.48 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -9.16 -39.49 15.93 -8.11 -41.66 16.33 1m21_c00 source 1m21 PEPTIDE AMIDASE : 6 hits 1m21_c00 naa= 3 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 1 3 # 1 B 123 LYS A 68 LYS^? 23.30 O1 PEG A2001 B 202 SER A 15 SER^? 21.14 O1 PEG A2001 B 226 SER A 72 SER.? 25.71 O1 PEG A2001 coo 35.67 -0.01 18.11 33.47 4.84 14.73 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo 32.81 4.27 10.70 32.87 6.07 12.31 -14.21 -8.14 16.70 -15.25 -5.93 17.19 coo 28.77 6.36 12.44 30.83 7.25 11.75 -11.42 -4.87 11.47 -12.93 -4.20 13.23 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 2 3 # 2 B 123 LYS A 68 LYS^? 23.30 O1 PEG A2001 B 202 SER A 40 SER~? 13.43 O2 PEG B2003 B 226 SER A 37 SER~? 12.09 C1 PEG B2003 coo 35.67 -0.01 18.11 33.47 4.84 14.73 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo 32.81 4.27 10.70 32.87 6.07 12.31 -10.00 -16.89 23.63 -11.41 -15.57 25.07 coo 28.77 6.36 12.44 30.83 7.25 11.75 -9.67 -17.81 28.57 -9.20 -16.58 30.64 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 3 3 # 3 B 123 LYS A 77 LYS.? 28.85 O1 PEG A2001 B 202 SER A 72 SER.? 25.71 O1 PEG A2001 B 226 SER A 15 SER^? 21.14 O1 PEG A2001 coo 35.67 -0.01 18.11 33.47 4.84 14.73 -10.44 -10.90 7.82 -13.04 -5.00 7.61 coo 32.81 4.27 10.70 32.87 6.07 12.31 -11.42 -4.87 11.47 -12.93 -4.20 13.23 coo 28.77 6.36 12.44 30.83 7.25 11.75 -14.21 -8.14 16.70 -15.25 -5.93 17.19 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 4 3 # 4 B 123 LYS B 68 LYS^? 20.92 O4 PEG B2003 B 202 SER B 15 SER^? 20.57 O4 PEG B2003 B 226 SER B 72 SER.? 23.35 O4 PEG B2003 coo 35.67 -0.01 18.11 33.47 4.84 14.73 -12.94 -40.63 21.91 -10.06 -45.25 18.80 coo 32.81 4.27 10.70 32.87 6.07 12.31 -9.16 -39.49 15.93 -8.11 -41.66 16.33 coo 28.77 6.36 12.44 30.83 7.25 11.75 -12.06 -42.72 10.71 -10.61 -43.41 12.48 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 5 3 # 5 B 123 LYS B 68 LYS^? 20.92 O4 PEG B2003 B 202 SER B 40 SER~? 8.16 O4 PEG B2003 B 226 SER B 37 SER~? -4.72 O4 PEG B2003s coo 35.67 -0.01 18.11 33.47 4.84 14.73 -12.94 -40.63 21.91 -10.06 -45.25 18.80 coo 32.81 4.27 10.70 32.87 6.07 12.31 -13.24 -30.95 23.50 -11.93 -32.52 24.66 coo 28.77 6.36 12.44 30.83 7.25 11.75 -13.50 -30.16 28.32 -13.76 -31.55 30.19 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 6 3 # 6 B 123 LYS B 77 LYS.? 27.21 O4 PEG B2003 B 202 SER B 72 SER.? 23.35 O4 PEG B2003 B 226 SER B 15 SER^? 20.57 O4 PEG B2003 coo 35.67 -0.01 18.11 33.47 4.84 14.73 -13.11 -36.51 7.32 -10.61 -42.26 6.72 coo 32.81 4.27 10.70 32.87 6.07 12.31 -12.06 -42.72 10.71 -10.61 -43.41 12.48 coo 28.77 6.36 12.44 30.83 7.25 11.75 -9.16 -39.49 15.93 -8.11 -41.66 16.33 1m21_c01 source 1m21 PEPTIDE AMIDASE : 6 hits 1m21_c01 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP B 30 ASP~? 11.37 C2 PEG B2003 A 279 GLU B 17 GLU^? 19.22 O4 PEG B2003 A 369 ASP A 30 ASP~? 11.64 C1 PEG B2003 coo 11.74 38.14 80.19 10.63 36.40 80.65 -10.72 -29.17 38.90 -10.74 -31.13 39.77 coo 16.54 46.37 63.94 14.77 45.79 62.95 -8.67 -42.47 23.80 -7.95 -44.48 23.69 coo 12.19 31.08 87.29 11.13 32.66 86.38 -12.34 -20.31 39.33 -11.75 -18.93 40.82 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 1 hits 1m53_c06 naa= 3 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 1 3 # 1 159 ARG A 9 ARG^? 23.91 O1 PEG A2001 229 SER A 15 SER^? 21.14 O1 PEG A2001 325 GLU A 14 GLU^? 25.75 O1 PEG A2001 coo 2.54 15.84 18.57 3.24 17.85 16.30 -17.92 -3.27 10.91 -16.40 -3.09 13.61 coo 10.17 13.48 15.92 9.61 15.76 15.27 -14.21 -8.14 16.70 -15.25 -5.93 17.19 coo 5.42 13.04 19.75 5.74 13.81 17.79 -15.45 -7.36 10.85 -15.33 -5.53 9.81 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 2 3 # 2 159 ARG A 9 ARG^? 23.91 O1 PEG A2001 229 SER A 72 SER.? 25.71 O1 PEG A2001 325 GLU A 14 GLU^? 25.75 O1 PEG A2001 coo 2.54 15.84 18.57 3.24 17.85 16.30 -17.92 -3.27 10.91 -16.40 -3.09 13.61 coo 10.17 13.48 15.92 9.61 15.76 15.27 -11.42 -4.87 11.47 -12.93 -4.20 13.23 coo 5.42 13.04 19.75 5.74 13.81 17.79 -15.45 -7.36 10.85 -15.33 -5.53 9.81 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 3 3 # 3 159 ARG B 9 ARG^? 23.79 O4 PEG B2002 229 SER B 15 SER^? 20.57 O4 PEG B2003 325 GLU B 14 GLU^? 25.81 O4 PEG B2002 coo 2.54 15.84 18.57 3.24 17.85 16.30 -5.44 -44.19 10.09 -7.02 -44.36 12.75 coo 10.17 13.48 15.92 9.61 15.76 15.27 -9.16 -39.49 15.93 -8.11 -41.66 16.33 coo 5.42 13.04 19.75 5.74 13.81 17.79 -7.72 -40.18 10.13 -8.30 -41.79 8.90 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 4 3 # 4 159 ARG B 9 ARG^? 23.79 O4 PEG B2002 229 SER B 72 SER.? 23.35 O4 PEG B2003 325 GLU B 14 GLU^? 25.81 O4 PEG B2002 coo 2.54 15.84 18.57 3.24 17.85 16.30 -5.44 -44.19 10.09 -7.02 -44.36 12.75 coo 10.17 13.48 15.92 9.61 15.76 15.27 -12.06 -42.72 10.71 -10.61 -43.41 12.48 coo 5.42 13.04 19.75 5.74 13.81 17.79 -7.72 -40.18 10.13 -8.30 -41.79 8.90 1mbb_c00 source 1mbb URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYLGLUCOSAMI: 4 hits 1mbb_c00 naa= 3 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 3 # 1 164 LYS A 81 LYS~? 24.71 CA CA B1002 166 LYS B 81 LYS~? 24.83 O4 PEG B2003 324 SER A 37 SER~? 12.09 C1 PEG B2003 coo 25.93 8.11 25.51 26.40 7.80 19.66 -10.43 -20.23 7.61 -6.19 -24.16 5.61 coo 27.27 1.43 25.09 29.18 5.25 22.89 -13.27 -27.12 7.60 -17.56 -23.53 5.05 coo 46.32 14.55 19.93 45.95 12.72 21.27 -9.67 -17.81 28.57 -9.20 -16.58 30.64 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 2 3 # 2 164 LYS B 81 LYS~? 24.83 O4 PEG B2003 166 LYS A 81 LYS~? 24.71 CA CA B1002 324 SER B 37 SER~? -4.72 O4 PEG B2003s coo 25.93 8.11 25.51 26.40 7.80 19.66 -13.27 -27.12 7.60 -17.56 -23.53 5.05 coo 27.27 1.43 25.09 29.18 5.25 22.89 -10.43 -20.23 7.61 -6.19 -24.16 5.61 coo 46.32 14.55 19.93 45.95 12.72 21.27 -13.50 -30.16 28.32 -13.76 -31.55 30.19 1mdr_c01 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 2 hits 1mdr_c01 naa= 3 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 3 # 1 A 50 ASP A 70 ASP^? 25.92 O1 PEG A2001 A 55 TYR A 73 TYR.? -31.47 O1 PEG A2001s A 84 LYS A 77 LYS.? 28.85 O1 PEG A2001 coo 11.09 42.89 24.44 11.32 42.06 22.49 -9.86 -5.53 16.91 -10.88 -4.17 15.65 coo 4.60 40.33 20.42 7.25 39.50 20.05 -8.12 -1.41 10.87 -9.66 0.82 11.59 coo 9.71 44.83 15.47 10.13 41.43 19.93 -10.44 -10.90 7.82 -13.04 -5.00 7.61 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 2 3 # 2 A 50 ASP B 70 ASP^? 21.22 O4 PEG B2003 A 55 TYR B 73 TYR.? -26.42 O4 PEG B2003s A 84 LYS B 77 LYS.? 27.21 O4 PEG B2003 coo 11.09 42.89 24.44 11.32 42.06 22.49 -13.56 -42.18 16.17 -12.44 -43.52 14.94 coo 4.60 40.33 20.42 7.25 39.50 20.05 -15.40 -46.09 10.22 -13.89 -48.32 11.05 coo 9.71 44.83 15.47 10.13 41.43 19.93 -13.11 -36.51 7.32 -10.61 -42.26 6.72 1mrq_c02 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 2 hits 1mrq_c02 naa= 3 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 A 142 LYS A 68 LYS^? 23.30 O1 PEG A2001 A 217 SER A 40 SER~? 13.43 O2 PEG B2003 A 241 SER A 37 SER~? 12.09 C1 PEG B2003 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -10.00 -16.89 23.63 -11.41 -15.57 25.07 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -9.67 -17.81 28.57 -9.20 -16.58 30.64 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 A 142 LYS B 68 LYS^? 20.92 O4 PEG B2003 A 217 SER B 40 SER~? 8.16 O4 PEG B2003 A 241 SER B 37 SER~? -4.72 O4 PEG B2003s coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -12.94 -40.63 21.91 -10.06 -45.25 18.80 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -13.24 -30.95 23.50 -11.93 -32.52 24.66 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -13.50 -30.16 28.32 -13.76 -31.55 30.19 1mt5_c00 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c00 naa= 3 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 B 142 LYS A 68 LYS^? 23.30 O1 PEG A2001 B 217 SER A 40 SER~? 13.43 O2 PEG B2003 B 241 SER A 37 SER~? 12.09 C1 PEG B2003 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -10.00 -16.89 23.63 -11.41 -15.57 25.07 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -9.67 -17.81 28.57 -9.20 -16.58 30.64 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 B 142 LYS B 68 LYS^? 20.92 O4 PEG B2003 B 217 SER B 40 SER~? 8.16 O4 PEG B2003 B 241 SER B 37 SER~? -4.72 O4 PEG B2003s coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -12.94 -40.63 21.91 -10.06 -45.25 18.80 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -13.24 -30.95 23.50 -11.93 -32.52 24.66 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -13.50 -30.16 28.32 -13.76 -31.55 30.19 1mt5_c01 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c01 naa= 3 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 C 142 LYS A 68 LYS^? 23.30 O1 PEG A2001 C 217 SER A 40 SER~? 13.43 O2 PEG B2003 C 241 SER A 37 SER~? 12.09 C1 PEG B2003 coo -12.07 2.83 63.52 -8.95 7.56 61.01 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -10.00 -16.89 23.63 -11.41 -15.57 25.07 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -9.67 -17.81 28.57 -9.20 -16.58 30.64 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 C 142 LYS B 68 LYS^? 20.92 O4 PEG B2003 C 217 SER B 40 SER~? 8.16 O4 PEG B2003 C 241 SER B 37 SER~? -4.72 O4 PEG B2003s coo -12.07 2.83 63.52 -8.95 7.56 61.01 -12.94 -40.63 21.91 -10.06 -45.25 18.80 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -13.24 -30.95 23.50 -11.93 -32.52 24.66 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -13.50 -30.16 28.32 -13.76 -31.55 30.19 1mt5_c02 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c02 naa= 3 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 D 142 LYS A 68 LYS^? 23.30 O1 PEG A2001 D 217 SER A 40 SER~? 13.43 O2 PEG B2003 D 241 SER A 37 SER~? 12.09 C1 PEG B2003 coo 32.93 17.78 71.88 30.89 13.50 67.83 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo 34.38 11.17 66.10 32.18 12.14 65.65 -10.00 -16.89 23.63 -11.41 -15.57 25.07 coo 31.34 7.96 67.74 31.44 9.08 65.62 -9.67 -17.81 28.57 -9.20 -16.58 30.64 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 D 142 LYS B 68 LYS^? 20.92 O4 PEG B2003 D 217 SER B 40 SER~? 8.16 O4 PEG B2003 D 241 SER B 37 SER~? -4.72 O4 PEG B2003s coo 32.93 17.78 71.88 30.89 13.50 67.83 -12.94 -40.63 21.91 -10.06 -45.25 18.80 coo 34.38 11.17 66.10 32.18 12.14 65.65 -13.24 -30.95 23.50 -11.93 -32.52 24.66 coo 31.34 7.96 67.74 31.44 9.08 65.62 -13.50 -30.16 28.32 -13.76 -31.55 30.19 1mt5_c03 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c03 naa= 3 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 E 142 LYS A 68 LYS^? 23.30 O1 PEG A2001 E 217 SER A 15 SER^? 21.14 O1 PEG A2001 E 241 SER A 72 SER.? 25.71 O1 PEG A2001 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -14.21 -8.14 16.70 -15.25 -5.93 17.19 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -11.42 -4.87 11.47 -12.93 -4.20 13.23 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 E 142 LYS A 68 LYS^? 23.30 O1 PEG A2001 E 217 SER A 40 SER~? 13.43 O2 PEG B2003 E 241 SER A 37 SER~? 12.09 C1 PEG B2003 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -10.00 -16.89 23.63 -11.41 -15.57 25.07 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -9.67 -17.81 28.57 -9.20 -16.58 30.64 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 E 142 LYS A 77 LYS.? 28.85 O1 PEG A2001 E 217 SER A 72 SER.? 25.71 O1 PEG A2001 E 241 SER A 15 SER^? 21.14 O1 PEG A2001 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -10.44 -10.90 7.82 -13.04 -5.00 7.61 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -11.42 -4.87 11.47 -12.93 -4.20 13.23 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -14.21 -8.14 16.70 -15.25 -5.93 17.19 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 E 142 LYS B 68 LYS^? 20.92 O4 PEG B2003 E 217 SER B 15 SER^? 20.57 O4 PEG B2003 E 241 SER B 72 SER.? 23.35 O4 PEG B2003 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -12.94 -40.63 21.91 -10.06 -45.25 18.80 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -9.16 -39.49 15.93 -8.11 -41.66 16.33 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -12.06 -42.72 10.71 -10.61 -43.41 12.48 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 E 142 LYS B 68 LYS^? 20.92 O4 PEG B2003 E 217 SER B 40 SER~? 8.16 O4 PEG B2003 E 241 SER B 37 SER~? -4.72 O4 PEG B2003s coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -12.94 -40.63 21.91 -10.06 -45.25 18.80 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -13.24 -30.95 23.50 -11.93 -32.52 24.66 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -13.50 -30.16 28.32 -13.76 -31.55 30.19 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 E 142 LYS B 77 LYS.? 27.21 O4 PEG B2003 E 217 SER B 72 SER.? 23.35 O4 PEG B2003 E 241 SER B 15 SER^? 20.57 O4 PEG B2003 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -13.11 -36.51 7.32 -10.61 -42.26 6.72 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -12.06 -42.72 10.71 -10.61 -43.41 12.48 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -9.16 -39.49 15.93 -8.11 -41.66 16.33 1mt5_c04 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 6 hits 1mt5_c04 naa= 3 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 F 142 LYS A 68 LYS^? 23.30 O1 PEG A2001 F 217 SER A 15 SER^? 21.14 O1 PEG A2001 F 241 SER A 72 SER.? 25.71 O1 PEG A2001 coo 85.78 13.19 64.96 85.47 13.47 58.63 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo 87.43 17.13 57.15 85.84 15.39 56.76 -14.21 -8.14 16.70 -15.25 -5.93 17.19 coo 89.69 13.60 54.86 87.60 14.67 54.46 -11.42 -4.87 11.47 -12.93 -4.20 13.23 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 F 142 LYS A 68 LYS^? 23.30 O1 PEG A2001 F 217 SER A 40 SER~? 13.43 O2 PEG B2003 F 241 SER A 37 SER~? 12.09 C1 PEG B2003 coo 85.78 13.19 64.96 85.47 13.47 58.63 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo 87.43 17.13 57.15 85.84 15.39 56.76 -10.00 -16.89 23.63 -11.41 -15.57 25.07 coo 89.69 13.60 54.86 87.60 14.67 54.46 -9.67 -17.81 28.57 -9.20 -16.58 30.64 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 F 142 LYS A 77 LYS.? 28.85 O1 PEG A2001 F 217 SER A 72 SER.? 25.71 O1 PEG A2001 F 241 SER A 15 SER^? 21.14 O1 PEG A2001 coo 85.78 13.19 64.96 85.47 13.47 58.63 -10.44 -10.90 7.82 -13.04 -5.00 7.61 coo 87.43 17.13 57.15 85.84 15.39 56.76 -11.42 -4.87 11.47 -12.93 -4.20 13.23 coo 89.69 13.60 54.86 87.60 14.67 54.46 -14.21 -8.14 16.70 -15.25 -5.93 17.19 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 F 142 LYS B 68 LYS^? 20.92 O4 PEG B2003 F 217 SER B 15 SER^? 20.57 O4 PEG B2003 F 241 SER B 72 SER.? 23.35 O4 PEG B2003 coo 85.78 13.19 64.96 85.47 13.47 58.63 -12.94 -40.63 21.91 -10.06 -45.25 18.80 coo 87.43 17.13 57.15 85.84 15.39 56.76 -9.16 -39.49 15.93 -8.11 -41.66 16.33 coo 89.69 13.60 54.86 87.60 14.67 54.46 -12.06 -42.72 10.71 -10.61 -43.41 12.48 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 F 142 LYS B 68 LYS^? 20.92 O4 PEG B2003 F 217 SER B 40 SER~? 8.16 O4 PEG B2003 F 241 SER B 37 SER~? -4.72 O4 PEG B2003s coo 85.78 13.19 64.96 85.47 13.47 58.63 -12.94 -40.63 21.91 -10.06 -45.25 18.80 coo 87.43 17.13 57.15 85.84 15.39 56.76 -13.24 -30.95 23.50 -11.93 -32.52 24.66 coo 89.69 13.60 54.86 87.60 14.67 54.46 -13.50 -30.16 28.32 -13.76 -31.55 30.19 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 F 142 LYS B 77 LYS.? 27.21 O4 PEG B2003 F 217 SER B 72 SER.? 23.35 O4 PEG B2003 F 241 SER B 15 SER^? 20.57 O4 PEG B2003 coo 85.78 13.19 64.96 85.47 13.47 58.63 -13.11 -36.51 7.32 -10.61 -42.26 6.72 coo 87.43 17.13 57.15 85.84 15.39 56.76 -12.06 -42.72 10.71 -10.61 -43.41 12.48 coo 89.69 13.60 54.86 87.60 14.67 54.46 -9.16 -39.49 15.93 -8.11 -41.66 16.33 1mt5_c05 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 6 hits 1mt5_c05 naa= 3 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 G 142 LYS A 68 LYS^? 23.30 O1 PEG A2001 G 217 SER A 40 SER~? 13.43 O2 PEG B2003 G 241 SER A 37 SER~? 12.09 C1 PEG B2003 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -10.00 -16.89 23.63 -11.41 -15.57 25.07 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -9.67 -17.81 28.57 -9.20 -16.58 30.64 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 G 142 LYS B 68 LYS^? 20.92 O4 PEG B2003 G 217 SER B 40 SER~? 8.16 O4 PEG B2003 G 241 SER B 37 SER~? -4.72 O4 PEG B2003s coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -12.94 -40.63 21.91 -10.06 -45.25 18.80 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -13.24 -30.95 23.50 -11.93 -32.52 24.66 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -13.50 -30.16 28.32 -13.76 -31.55 30.19 1mt5_c06 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c06 naa= 3 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 H 142 LYS A 68 LYS^? 23.30 O1 PEG A2001 H 217 SER A 15 SER^? 21.14 O1 PEG A2001 H 241 SER A 72 SER.? 25.71 O1 PEG A2001 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -14.21 -8.14 16.70 -15.25 -5.93 17.19 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -11.42 -4.87 11.47 -12.93 -4.20 13.23 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 H 142 LYS A 68 LYS^? 23.30 O1 PEG A2001 H 217 SER A 40 SER~? 13.43 O2 PEG B2003 H 241 SER A 37 SER~? 12.09 C1 PEG B2003 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -10.00 -16.89 23.63 -11.41 -15.57 25.07 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -9.67 -17.81 28.57 -9.20 -16.58 30.64 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 H 142 LYS A 77 LYS.? 28.85 O1 PEG A2001 H 217 SER A 72 SER.? 25.71 O1 PEG A2001 H 241 SER A 15 SER^? 21.14 O1 PEG A2001 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -10.44 -10.90 7.82 -13.04 -5.00 7.61 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -11.42 -4.87 11.47 -12.93 -4.20 13.23 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -14.21 -8.14 16.70 -15.25 -5.93 17.19 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 H 142 LYS B 68 LYS^? 20.92 O4 PEG B2003 H 217 SER B 15 SER^? 20.57 O4 PEG B2003 H 241 SER B 72 SER.? 23.35 O4 PEG B2003 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -12.94 -40.63 21.91 -10.06 -45.25 18.80 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -9.16 -39.49 15.93 -8.11 -41.66 16.33 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -12.06 -42.72 10.71 -10.61 -43.41 12.48 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 H 142 LYS B 68 LYS^? 20.92 O4 PEG B2003 H 217 SER B 40 SER~? 8.16 O4 PEG B2003 H 241 SER B 37 SER~? -4.72 O4 PEG B2003s coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -12.94 -40.63 21.91 -10.06 -45.25 18.80 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -13.24 -30.95 23.50 -11.93 -32.52 24.66 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -13.50 -30.16 28.32 -13.76 -31.55 30.19 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 H 142 LYS B 77 LYS.? 27.21 O4 PEG B2003 H 217 SER B 72 SER.? 23.35 O4 PEG B2003 H 241 SER B 15 SER^? 20.57 O4 PEG B2003 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -13.11 -36.51 7.32 -10.61 -42.26 6.72 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -12.06 -42.72 10.71 -10.61 -43.41 12.48 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -9.16 -39.49 15.93 -8.11 -41.66 16.33 1mt5_c07 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 6 hits 1mt5_c07 naa= 3 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 I 142 LYS A 68 LYS^? 23.30 O1 PEG A2001 I 217 SER A 15 SER^? 21.14 O1 PEG A2001 I 241 SER A 72 SER.? 25.71 O1 PEG A2001 coo -5.05 91.11 27.04 -1.24 87.39 30.21 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo 2.83 88.63 29.54 1.30 86.82 30.03 -14.21 -8.14 16.70 -15.25 -5.93 17.19 coo 2.37 88.32 34.25 2.82 86.58 32.61 -11.42 -4.87 11.47 -12.93 -4.20 13.23 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 I 142 LYS A 68 LYS^? 23.30 O1 PEG A2001 I 217 SER A 40 SER~? 13.43 O2 PEG B2003 I 241 SER A 37 SER~? 12.09 C1 PEG B2003 coo -5.05 91.11 27.04 -1.24 87.39 30.21 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo 2.83 88.63 29.54 1.30 86.82 30.03 -10.00 -16.89 23.63 -11.41 -15.57 25.07 coo 2.37 88.32 34.25 2.82 86.58 32.61 -9.67 -17.81 28.57 -9.20 -16.58 30.64 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 I 142 LYS A 77 LYS.? 28.85 O1 PEG A2001 I 217 SER A 72 SER.? 25.71 O1 PEG A2001 I 241 SER A 15 SER^? 21.14 O1 PEG A2001 coo -5.05 91.11 27.04 -1.24 87.39 30.21 -10.44 -10.90 7.82 -13.04 -5.00 7.61 coo 2.83 88.63 29.54 1.30 86.82 30.03 -11.42 -4.87 11.47 -12.93 -4.20 13.23 coo 2.37 88.32 34.25 2.82 86.58 32.61 -14.21 -8.14 16.70 -15.25 -5.93 17.19 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 I 142 LYS B 68 LYS^? 20.92 O4 PEG B2003 I 217 SER B 15 SER^? 20.57 O4 PEG B2003 I 241 SER B 72 SER.? 23.35 O4 PEG B2003 coo -5.05 91.11 27.04 -1.24 87.39 30.21 -12.94 -40.63 21.91 -10.06 -45.25 18.80 coo 2.83 88.63 29.54 1.30 86.82 30.03 -9.16 -39.49 15.93 -8.11 -41.66 16.33 coo 2.37 88.32 34.25 2.82 86.58 32.61 -12.06 -42.72 10.71 -10.61 -43.41 12.48 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 I 142 LYS B 68 LYS^? 20.92 O4 PEG B2003 I 217 SER B 40 SER~? 8.16 O4 PEG B2003 I 241 SER B 37 SER~? -4.72 O4 PEG B2003s coo -5.05 91.11 27.04 -1.24 87.39 30.21 -12.94 -40.63 21.91 -10.06 -45.25 18.80 coo 2.83 88.63 29.54 1.30 86.82 30.03 -13.24 -30.95 23.50 -11.93 -32.52 24.66 coo 2.37 88.32 34.25 2.82 86.58 32.61 -13.50 -30.16 28.32 -13.76 -31.55 30.19 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 I 142 LYS B 77 LYS.? 27.21 O4 PEG B2003 I 217 SER B 72 SER.? 23.35 O4 PEG B2003 I 241 SER B 15 SER^? 20.57 O4 PEG B2003 coo -5.05 91.11 27.04 -1.24 87.39 30.21 -13.11 -36.51 7.32 -10.61 -42.26 6.72 coo 2.83 88.63 29.54 1.30 86.82 30.03 -12.06 -42.72 10.71 -10.61 -43.41 12.48 coo 2.37 88.32 34.25 2.82 86.58 32.61 -9.16 -39.49 15.93 -8.11 -41.66 16.33 1mt5_c08 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 6 hits 1mt5_c08 naa= 3 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 J 142 LYS A 68 LYS^? 23.30 O1 PEG A2001 J 217 SER A 40 SER~? 13.43 O2 PEG B2003 J 241 SER A 37 SER~? 12.09 C1 PEG B2003 coo -16.11 59.78 61.53 -15.92 58.68 55.43 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -10.00 -16.89 23.63 -11.41 -15.57 25.07 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -9.67 -17.81 28.57 -9.20 -16.58 30.64 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 J 142 LYS B 68 LYS^? 20.92 O4 PEG B2003 J 217 SER B 40 SER~? 8.16 O4 PEG B2003 J 241 SER B 37 SER~? -4.72 O4 PEG B2003s coo -16.11 59.78 61.53 -15.92 58.68 55.43 -12.94 -40.63 21.91 -10.06 -45.25 18.80 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -13.24 -30.95 23.50 -11.93 -32.52 24.66 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -13.50 -30.16 28.32 -13.76 -31.55 30.19 1mt5_c09 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c09 naa= 3 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 K 142 LYS A 68 LYS^? 23.30 O1 PEG A2001 K 217 SER A 15 SER^? 21.14 O1 PEG A2001 K 241 SER A 72 SER.? 25.71 O1 PEG A2001 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -14.21 -8.14 16.70 -15.25 -5.93 17.19 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -11.42 -4.87 11.47 -12.93 -4.20 13.23 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 K 142 LYS A 68 LYS^? 23.30 O1 PEG A2001 K 217 SER A 40 SER~? 13.43 O2 PEG B2003 K 241 SER A 37 SER~? 12.09 C1 PEG B2003 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -10.00 -16.89 23.63 -11.41 -15.57 25.07 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -9.67 -17.81 28.57 -9.20 -16.58 30.64 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 K 142 LYS A 77 LYS.? 28.85 O1 PEG A2001 K 217 SER A 72 SER.? 25.71 O1 PEG A2001 K 241 SER A 15 SER^? 21.14 O1 PEG A2001 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -10.44 -10.90 7.82 -13.04 -5.00 7.61 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -11.42 -4.87 11.47 -12.93 -4.20 13.23 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -14.21 -8.14 16.70 -15.25 -5.93 17.19 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 K 142 LYS B 68 LYS^? 20.92 O4 PEG B2003 K 217 SER B 15 SER^? 20.57 O4 PEG B2003 K 241 SER B 72 SER.? 23.35 O4 PEG B2003 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -12.94 -40.63 21.91 -10.06 -45.25 18.80 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -9.16 -39.49 15.93 -8.11 -41.66 16.33 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -12.06 -42.72 10.71 -10.61 -43.41 12.48 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 K 142 LYS B 68 LYS^? 20.92 O4 PEG B2003 K 217 SER B 40 SER~? 8.16 O4 PEG B2003 K 241 SER B 37 SER~? -4.72 O4 PEG B2003s coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -12.94 -40.63 21.91 -10.06 -45.25 18.80 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -13.24 -30.95 23.50 -11.93 -32.52 24.66 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -13.50 -30.16 28.32 -13.76 -31.55 30.19 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 K 142 LYS B 77 LYS.? 27.21 O4 PEG B2003 K 217 SER B 72 SER.? 23.35 O4 PEG B2003 K 241 SER B 15 SER^? 20.57 O4 PEG B2003 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -13.11 -36.51 7.32 -10.61 -42.26 6.72 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -12.06 -42.72 10.71 -10.61 -43.41 12.48 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -9.16 -39.49 15.93 -8.11 -41.66 16.33 1mt5_c10 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 6 hits 1mt5_c10 naa= 3 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 L 142 LYS A 68 LYS^? 23.30 O1 PEG A2001 L 217 SER A 15 SER^? 21.14 O1 PEG A2001 L 241 SER A 72 SER.? 25.71 O1 PEG A2001 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -14.21 -8.14 16.70 -15.25 -5.93 17.19 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -11.42 -4.87 11.47 -12.93 -4.20 13.23 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 L 142 LYS A 68 LYS^? 23.30 O1 PEG A2001 L 217 SER A 40 SER~? 13.43 O2 PEG B2003 L 241 SER A 37 SER~? 12.09 C1 PEG B2003 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -10.00 -16.89 23.63 -11.41 -15.57 25.07 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -9.67 -17.81 28.57 -9.20 -16.58 30.64 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 L 142 LYS A 77 LYS.? 28.85 O1 PEG A2001 L 217 SER A 72 SER.? 25.71 O1 PEG A2001 L 241 SER A 15 SER^? 21.14 O1 PEG A2001 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -10.44 -10.90 7.82 -13.04 -5.00 7.61 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -11.42 -4.87 11.47 -12.93 -4.20 13.23 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -14.21 -8.14 16.70 -15.25 -5.93 17.19 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 L 142 LYS B 68 LYS^? 20.92 O4 PEG B2003 L 217 SER B 15 SER^? 20.57 O4 PEG B2003 L 241 SER B 72 SER.? 23.35 O4 PEG B2003 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -12.94 -40.63 21.91 -10.06 -45.25 18.80 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -9.16 -39.49 15.93 -8.11 -41.66 16.33 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -12.06 -42.72 10.71 -10.61 -43.41 12.48 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 L 142 LYS B 68 LYS^? 20.92 O4 PEG B2003 L 217 SER B 40 SER~? 8.16 O4 PEG B2003 L 241 SER B 37 SER~? -4.72 O4 PEG B2003s coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -12.94 -40.63 21.91 -10.06 -45.25 18.80 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -13.24 -30.95 23.50 -11.93 -32.52 24.66 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -13.50 -30.16 28.32 -13.76 -31.55 30.19 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 L 142 LYS B 77 LYS.? 27.21 O4 PEG B2003 L 217 SER B 72 SER.? 23.35 O4 PEG B2003 L 241 SER B 15 SER^? 20.57 O4 PEG B2003 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -13.11 -36.51 7.32 -10.61 -42.26 6.72 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -12.06 -42.72 10.71 -10.61 -43.41 12.48 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -9.16 -39.49 15.93 -8.11 -41.66 16.33 1mt5_c11 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 6 hits 1mt5_c11 naa= 3 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 M 142 LYS A 68 LYS^? 23.30 O1 PEG A2001 M 217 SER A 40 SER~? 13.43 O2 PEG B2003 M 241 SER A 37 SER~? 12.09 C1 PEG B2003 coo 57.83 99.61 24.25 54.90 95.14 20.60 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo 51.07 94.66 21.52 53.18 93.49 22.20 -10.00 -16.89 23.63 -11.41 -15.57 25.07 coo 51.67 94.23 16.93 51.60 92.47 18.57 -9.67 -17.81 28.57 -9.20 -16.58 30.64 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 M 142 LYS B 68 LYS^? 20.92 O4 PEG B2003 M 217 SER B 40 SER~? 8.16 O4 PEG B2003 M 241 SER B 37 SER~? -4.72 O4 PEG B2003s coo 57.83 99.61 24.25 54.90 95.14 20.60 -12.94 -40.63 21.91 -10.06 -45.25 18.80 coo 51.07 94.66 21.52 53.18 93.49 22.20 -13.24 -30.95 23.50 -11.93 -32.52 24.66 coo 51.67 94.23 16.93 51.60 92.47 18.57 -13.50 -30.16 28.32 -13.76 -31.55 30.19 1mt5_c12 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c12 naa= 3 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 N 142 LYS A 68 LYS^? 23.30 O1 PEG A2001 N 217 SER A 40 SER~? 13.43 O2 PEG B2003 N 241 SER A 37 SER~? 12.09 C1 PEG B2003 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -10.00 -16.89 23.63 -11.41 -15.57 25.07 coo 82.47 71.15 2.07 80.82 69.44 2.28 -9.67 -17.81 28.57 -9.20 -16.58 30.64 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 N 142 LYS B 68 LYS^? 20.92 O4 PEG B2003 N 217 SER B 40 SER~? 8.16 O4 PEG B2003 N 241 SER B 37 SER~? -4.72 O4 PEG B2003s coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -12.94 -40.63 21.91 -10.06 -45.25 18.80 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -13.24 -30.95 23.50 -11.93 -32.52 24.66 coo 82.47 71.15 2.07 80.82 69.44 2.28 -13.50 -30.16 28.32 -13.76 -31.55 30.19 1mt5_c13 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c13 naa= 3 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 O 142 LYS A 68 LYS^? 23.30 O1 PEG A2001 O 217 SER A 15 SER^? 21.14 O1 PEG A2001 O 241 SER A 72 SER.? 25.71 O1 PEG A2001 coo 81.67 70.12 58.71 78.82 64.87 57.22 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo 81.62 62.23 55.05 79.32 62.93 55.20 -14.21 -8.14 16.70 -15.25 -5.93 17.19 coo 79.39 59.54 58.42 78.72 60.00 56.11 -11.42 -4.87 11.47 -12.93 -4.20 13.23 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 O 142 LYS A 68 LYS^? 23.30 O1 PEG A2001 O 217 SER A 40 SER~? 13.43 O2 PEG B2003 O 241 SER A 37 SER~? 12.09 C1 PEG B2003 coo 81.67 70.12 58.71 78.82 64.87 57.22 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo 81.62 62.23 55.05 79.32 62.93 55.20 -10.00 -16.89 23.63 -11.41 -15.57 25.07 coo 79.39 59.54 58.42 78.72 60.00 56.11 -9.67 -17.81 28.57 -9.20 -16.58 30.64 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 O 142 LYS A 77 LYS.? 28.85 O1 PEG A2001 O 217 SER A 72 SER.? 25.71 O1 PEG A2001 O 241 SER A 15 SER^? 21.14 O1 PEG A2001 coo 81.67 70.12 58.71 78.82 64.87 57.22 -10.44 -10.90 7.82 -13.04 -5.00 7.61 coo 81.62 62.23 55.05 79.32 62.93 55.20 -11.42 -4.87 11.47 -12.93 -4.20 13.23 coo 79.39 59.54 58.42 78.72 60.00 56.11 -14.21 -8.14 16.70 -15.25 -5.93 17.19 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 O 142 LYS B 68 LYS^? 20.92 O4 PEG B2003 O 217 SER B 15 SER^? 20.57 O4 PEG B2003 O 241 SER B 72 SER.? 23.35 O4 PEG B2003 coo 81.67 70.12 58.71 78.82 64.87 57.22 -12.94 -40.63 21.91 -10.06 -45.25 18.80 coo 81.62 62.23 55.05 79.32 62.93 55.20 -9.16 -39.49 15.93 -8.11 -41.66 16.33 coo 79.39 59.54 58.42 78.72 60.00 56.11 -12.06 -42.72 10.71 -10.61 -43.41 12.48 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 O 142 LYS B 68 LYS^? 20.92 O4 PEG B2003 O 217 SER B 40 SER~? 8.16 O4 PEG B2003 O 241 SER B 37 SER~? -4.72 O4 PEG B2003s coo 81.67 70.12 58.71 78.82 64.87 57.22 -12.94 -40.63 21.91 -10.06 -45.25 18.80 coo 81.62 62.23 55.05 79.32 62.93 55.20 -13.24 -30.95 23.50 -11.93 -32.52 24.66 coo 79.39 59.54 58.42 78.72 60.00 56.11 -13.50 -30.16 28.32 -13.76 -31.55 30.19 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 O 142 LYS B 77 LYS.? 27.21 O4 PEG B2003 O 217 SER B 72 SER.? 23.35 O4 PEG B2003 O 241 SER B 15 SER^? 20.57 O4 PEG B2003 coo 81.67 70.12 58.71 78.82 64.87 57.22 -13.11 -36.51 7.32 -10.61 -42.26 6.72 coo 81.62 62.23 55.05 79.32 62.93 55.20 -12.06 -42.72 10.71 -10.61 -43.41 12.48 coo 79.39 59.54 58.42 78.72 60.00 56.11 -9.16 -39.49 15.93 -8.11 -41.66 16.33 1mt5_c14 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 6 hits 1mt5_c14 naa= 3 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 P 142 LYS A 68 LYS^? 23.30 O1 PEG A2001 P 217 SER A 40 SER~? 13.43 O2 PEG B2003 P 241 SER A 37 SER~? 12.09 C1 PEG B2003 coo 37.29 55.72 69.54 38.73 59.85 65.07 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo 35.55 61.40 62.96 37.72 60.41 62.66 -10.00 -16.89 23.63 -11.41 -15.57 25.07 coo 38.60 64.77 64.10 38.63 63.28 62.26 -9.67 -17.81 28.57 -9.20 -16.58 30.64 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 P 142 LYS B 68 LYS^? 20.92 O4 PEG B2003 P 217 SER B 40 SER~? 8.16 O4 PEG B2003 P 241 SER B 37 SER~? -4.72 O4 PEG B2003s coo 37.29 55.72 69.54 38.73 59.85 65.07 -12.94 -40.63 21.91 -10.06 -45.25 18.80 coo 35.55 61.40 62.96 37.72 60.41 62.66 -13.24 -30.95 23.50 -11.93 -32.52 24.66 coo 38.60 64.77 64.10 38.63 63.28 62.26 -13.50 -30.16 28.32 -13.76 -31.55 30.19 1mt5_c15 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c15 naa= 3 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 1 3 # 1 A 167 LYS A 81 LYS~? 24.71 CA CA B1002 A 169 LYS B 81 LYS~? 24.83 O4 PEG B2003 A 327 GLU A 87 GLU~? 17.34 CA CA A1001 coo 20.73 15.53 25.54 22.09 15.64 19.40 -10.43 -20.23 7.61 -6.19 -24.16 5.61 coo 24.31 10.25 23.71 29.02 12.05 20.75 -13.27 -27.12 7.60 -17.56 -23.53 5.05 coo 21.86 20.40 18.59 22.12 18.33 18.33 -18.57 -18.33 12.01 -20.23 -17.06 12.53 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 2 3 # 2 A 167 LYS B 81 LYS~? 24.83 O4 PEG B2003 A 169 LYS A 81 LYS~? 24.71 CA CA B1002 A 327 GLU B 87 GLU~? 17.51 CA CA B1002 coo 20.73 15.53 25.54 22.09 15.64 19.40 -13.27 -27.12 7.60 -17.56 -23.53 5.05 coo 24.31 10.25 23.71 29.02 12.05 20.75 -10.43 -20.23 7.61 -6.19 -24.16 5.61 coo 21.86 20.40 18.59 22.12 18.33 18.33 -5.10 -29.50 11.76 -3.27 -30.54 11.89 1muc_c00 source 1muc MUCONATE LACTONIZING ENZYME : 2 hits 1muc_c00 naa= 3 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 1 3 # 1 B 167 LYS A 81 LYS~? 24.71 CA CA B1002 B 169 LYS B 81 LYS~? 24.83 O4 PEG B2003 B 327 GLU A 87 GLU~? 17.34 CA CA A1001 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -10.43 -20.23 7.61 -6.19 -24.16 5.61 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -13.27 -27.12 7.60 -17.56 -23.53 5.05 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -18.57 -18.33 12.01 -20.23 -17.06 12.53 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 2 3 # 2 B 167 LYS B 81 LYS~? 24.83 O4 PEG B2003 B 169 LYS A 81 LYS~? 24.71 CA CA B1002 B 327 GLU B 87 GLU~? 17.51 CA CA B1002 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -13.27 -27.12 7.60 -17.56 -23.53 5.05 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -10.43 -20.23 7.61 -6.19 -24.16 5.61 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -5.10 -29.50 11.76 -3.27 -30.54 11.89 1muc_c01 source 1muc MUCONATE LACTONIZING ENZYME : 2 hits 1muc_c01 naa= 3 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 1 3 # 1 549 LYS A 81 LYS~? 24.71 CA CA B1002 631 LYS B 10 LYS.? 28.13 CA CA B1002 708 LYS A 77 LYS.? 28.85 O1 PEG A2001 coo 8.61 33.06 11.15 10.12 29.19 8.82 -10.43 -20.23 7.61 -6.19 -24.16 5.61 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -1.99 -39.94 5.49 -0.05 -44.29 3.04 coo 18.16 32.86 9.85 16.06 28.20 13.56 -10.44 -10.90 7.82 -13.04 -5.00 7.61 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 2 3 # 2 549 LYS B 81 LYS~? 24.83 O4 PEG B2003 631 LYS A 10 LYS.? 26.99 O1 PEG A2001 708 LYS B 77 LYS.? 27.21 O4 PEG B2003 coo 8.61 33.06 11.15 10.12 29.19 8.82 -13.27 -27.12 7.60 -17.56 -23.53 5.05 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -21.43 -7.28 6.26 -19.99 -2.17 7.33 coo 18.16 32.86 9.85 16.06 28.20 13.56 -13.11 -36.51 7.32 -10.61 -42.26 6.72 1nsf_c00 source 1nsf N-ETHYLMALEIMIDE SENSITIVE FACTOR : 2 hits 1nsf_c00 naa= 3 ULMN 3 1nw9_c02 CASPASE 9, APOPTOSIS-RELATED CYSTEINuser 1 3 # 1 B 237 HIS B 21 HIS.? 9.56 O4 PEG B2003 B 238 GLY B 23 GLY.? 10.56 C4 PEG B2003 B 287 CYH B 33 CYH~? 9.84 C4 PEG B2003 coo 51.19 11.65 88.44 53.07 12.52 88.13 -11.59 -35.81 29.96 -12.58 -37.49 29.21 coo 45.40 11.66 89.13 45.79 11.98 88.49 -11.52 -34.07 37.14 -11.49 -34.90 37.06 coo 48.33 16.15 90.44 50.61 16.80 91.98 -9.83 -30.15 33.15 -9.47 -32.30 34.84 1nw9_c02 source 1nw9 CASPASE 9, APOPTOSIS-RELATED CYSTEINE PROTEASE: 1 hits 1nw9_c02 naa= 3 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 A 175 LYS A 10 LYS.? 26.99 O1 PEG A2001 A 208 GLN A 83 GLN~? 23.05 CA CA A1001 A 209 LYS A 81 LYS~? 24.71 CA CA B1002 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -21.43 -7.28 6.26 -19.99 -2.17 7.33 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -14.86 -14.93 8.21 -15.33 -13.67 9.86 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -10.43 -20.23 7.61 -6.19 -24.16 5.61 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 A 175 LYS A 81 LYS~? 24.71 CA CA B1002 A 208 GLN B 83 GLN~? 22.59 O4 PEG B2003 A 209 LYS B 77 LYS.? 27.21 O4 PEG B2003 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -10.43 -20.23 7.61 -6.19 -24.16 5.61 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -8.60 -32.34 7.87 -8.11 -33.73 9.38 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -13.11 -36.51 7.32 -10.61 -42.26 6.72 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 3 # 3 A 175 LYS B 10 LYS.? 28.13 CA CA B1002 A 208 GLN B 83 GLN~? 22.59 O4 PEG B2003 A 209 LYS B 81 LYS~? 24.83 O4 PEG B2003 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -1.99 -39.94 5.49 -0.05 -44.29 3.04 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -8.60 -32.34 7.87 -8.11 -33.73 9.38 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -13.27 -27.12 7.60 -17.56 -23.53 5.05 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 4 3 # 4 A 175 LYS B 81 LYS~? 24.83 O4 PEG B2003 A 208 GLN A 83 GLN~? 23.05 CA CA A1001 A 209 LYS A 77 LYS.? 28.85 O1 PEG A2001 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -13.27 -27.12 7.60 -17.56 -23.53 5.05 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -14.86 -14.93 8.21 -15.33 -13.67 9.86 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -10.44 -10.90 7.82 -13.04 -5.00 7.61 1ohh_c06 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 4 hits 1ohh_c06 naa= 3 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 B 175 LYS A 10 LYS.? 26.99 O1 PEG A2001 B 208 GLN A 83 GLN~? 23.05 CA CA A1001 B 209 LYS A 81 LYS~? 24.71 CA CA B1002 coo 105.03 46.01 19.55 106.59 42.35 15.55 -21.43 -7.28 6.26 -19.99 -2.17 7.33 coo 113.93 46.99 13.56 113.37 48.52 14.95 -14.86 -14.93 8.21 -15.33 -13.67 9.86 coo 115.66 49.12 8.60 111.19 49.52 4.73 -10.43 -20.23 7.61 -6.19 -24.16 5.61 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 B 175 LYS A 81 LYS~? 24.71 CA CA B1002 B 208 GLN B 83 GLN~? 22.59 O4 PEG B2003 B 209 LYS B 77 LYS.? 27.21 O4 PEG B2003 coo 105.03 46.01 19.55 106.59 42.35 15.55 -10.43 -20.23 7.61 -6.19 -24.16 5.61 coo 113.93 46.99 13.56 113.37 48.52 14.95 -8.60 -32.34 7.87 -8.11 -33.73 9.38 coo 115.66 49.12 8.60 111.19 49.52 4.73 -13.11 -36.51 7.32 -10.61 -42.26 6.72 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 3 # 3 B 175 LYS B 10 LYS.? 28.13 CA CA B1002 B 208 GLN B 83 GLN~? 22.59 O4 PEG B2003 B 209 LYS B 81 LYS~? 24.83 O4 PEG B2003 coo 105.03 46.01 19.55 106.59 42.35 15.55 -1.99 -39.94 5.49 -0.05 -44.29 3.04 coo 113.93 46.99 13.56 113.37 48.52 14.95 -8.60 -32.34 7.87 -8.11 -33.73 9.38 coo 115.66 49.12 8.60 111.19 49.52 4.73 -13.27 -27.12 7.60 -17.56 -23.53 5.05 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 4 3 # 4 B 175 LYS B 81 LYS~? 24.83 O4 PEG B2003 B 208 GLN A 83 GLN~? 23.05 CA CA A1001 B 209 LYS A 77 LYS.? 28.85 O1 PEG A2001 coo 105.03 46.01 19.55 106.59 42.35 15.55 -13.27 -27.12 7.60 -17.56 -23.53 5.05 coo 113.93 46.99 13.56 113.37 48.52 14.95 -14.86 -14.93 8.21 -15.33 -13.67 9.86 coo 115.66 49.12 8.60 111.19 49.52 4.73 -10.44 -10.90 7.82 -13.04 -5.00 7.61 1ohh_c07 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 4 hits 1ohh_c07 naa= 3 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 C 175 LYS A 81 LYS~? 24.71 CA CA B1002 C 208 GLN B 83 GLN~? 22.59 O4 PEG B2003 C 209 LYS B 77 LYS.? 27.21 O4 PEG B2003 coo 100.54 -2.78 25.52 103.29 2.02 24.05 -10.43 -20.23 7.61 -6.19 -24.16 5.61 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 -8.60 -32.34 7.87 -8.11 -33.73 9.38 coo 113.62 1.19 33.65 109.52 3.92 36.47 -13.11 -36.51 7.32 -10.61 -42.26 6.72 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 C 175 LYS B 81 LYS~? 24.83 O4 PEG B2003 C 208 GLN A 83 GLN~? 23.05 CA CA A1001 C 209 LYS A 77 LYS.? 28.85 O1 PEG A2001 coo 100.54 -2.78 25.52 103.29 2.02 24.05 -13.27 -27.12 7.60 -17.56 -23.53 5.05 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 -14.86 -14.93 8.21 -15.33 -13.67 9.86 coo 113.62 1.19 33.65 109.52 3.92 36.47 -10.44 -10.90 7.82 -13.04 -5.00 7.61 1ohh_c08 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 2 hits 1ohh_c08 naa= 3 ULMN 3 1onr_c00 TRANSALDOLASE B user 1 3 # 1 A 17 ASP A 52 ASP.? 24.46 O1 PEG B2002 A 96 GLU B 80 GLU~? 28.00 O4 PEG B2003 A 132 LYS B 81 LYS~? 24.83 O4 PEG B2003 coo 31.23 12.29 16.44 30.82 11.56 18.39 -2.05 -17.27 6.89 -0.38 -16.21 6.11 coo 26.82 3.20 24.36 27.99 4.86 24.98 -9.74 -26.27 4.08 -9.78 -24.63 2.72 coo 29.99 0.62 22.18 30.38 6.69 20.81 -13.27 -27.12 7.60 -17.56 -23.53 5.05 ULMN 3 1onr_c00 TRANSALDOLASE B user 2 3 # 2 A 17 ASP B 52 ASP.? 24.24 O4 PEG B2003 A 96 GLU A 80 GLU~? 27.45 O4 PEG B2003 A 132 LYS A 81 LYS~? 24.71 CA CA B1002 coo 31.23 12.29 16.44 30.82 11.56 18.39 -21.39 -30.03 6.82 -22.77 -31.26 5.81 coo 26.82 3.20 24.36 27.99 4.86 24.98 -13.74 -20.99 4.34 -13.41 -22.52 2.91 coo 29.99 0.62 22.18 30.38 6.69 20.81 -10.43 -20.23 7.61 -6.19 -24.16 5.61 1onr_c00 source 1onr TRANSALDOLASE B : 2 hits 1onr_c00 naa= 3 ULMN 3 1onr_c01 TRANSALDOLASE B user 1 3 # 1 B 17 ASP A 52 ASP.? 24.46 O1 PEG B2002 B 96 GLU B 80 GLU~? 28.00 O4 PEG B2003 B 132 LYS B 81 LYS~? 24.83 O4 PEG B2003 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -2.05 -17.27 6.89 -0.38 -16.21 6.11 coo 26.69 48.45 7.18 27.85 50.13 7.74 -9.74 -26.27 4.08 -9.78 -24.63 2.72 coo 29.82 45.80 5.07 30.26 51.81 3.56 -13.27 -27.12 7.60 -17.56 -23.53 5.05 ULMN 3 1onr_c01 TRANSALDOLASE B user 2 3 # 2 B 17 ASP B 52 ASP.? 24.24 O4 PEG B2003 B 96 GLU A 80 GLU~? 27.45 O4 PEG B2003 B 132 LYS A 81 LYS~? 24.71 CA CA B1002 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -21.39 -30.03 6.82 -22.77 -31.26 5.81 coo 26.69 48.45 7.18 27.85 50.13 7.74 -13.74 -20.99 4.34 -13.41 -22.52 2.91 coo 29.82 45.80 5.07 30.26 51.81 3.56 -10.43 -20.23 7.61 -6.19 -24.16 5.61 1onr_c01 source 1onr TRANSALDOLASE B : 2 hits 1onr_c01 naa= 3 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 1 3 # 1 A 170 SER A 40 SER~? 13.43 O2 PEG B2003 A 239 VAL A 44 VAL~? 19.08 O1 PEG B2002 A 413 ASN A 42 ASN~? 14.52 C3 PEG B2003 coo 80.14 40.76 52.28 77.73 40.59 51.94 -10.00 -16.89 23.63 -11.41 -15.57 25.07 coo 75.67 35.37 52.30 76.00 35.96 50.23 -5.74 -16.05 18.71 -5.04 -14.40 19.99 coo 81.75 35.21 52.13 80.92 37.12 51.69 -7.85 -22.02 21.46 -7.56 -23.56 20.01 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 2 3 # 2 A 170 SER A 78 SER.? 29.96 CA CA A1001 A 239 VAL A 82 VAL~? 24.54 C3 PEG B2003 A 413 ASN A 76 ASN.? 27.74 O1 PEG B2002 coo 80.14 40.76 52.28 77.73 40.59 51.94 -13.07 -12.34 5.42 -12.90 -11.48 3.24 coo 75.67 35.37 52.30 76.00 35.96 50.23 -10.40 -17.01 9.61 -9.44 -15.00 9.42 coo 81.75 35.21 52.13 80.92 37.12 51.69 -6.69 -12.45 4.90 -5.54 -13.05 6.59 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 3 3 # 3 A 170 SER B 40 SER~? 8.16 O4 PEG B2003 A 239 VAL B 44 VAL~? 10.79 O4 PEG B2003 A 413 ASN B 42 ASN~? 10.30 O4 PEG B2003 coo 80.14 40.76 52.28 77.73 40.59 51.94 -13.24 -30.95 23.50 -11.93 -32.52 24.66 coo 75.67 35.37 52.30 76.00 35.96 50.23 -17.69 -31.75 18.64 -18.37 -33.47 19.89 coo 81.75 35.21 52.13 80.92 37.12 51.69 -15.54 -25.88 21.48 -16.00 -24.28 20.16 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 4 3 # 4 A 170 SER B 78 SER.? 28.23 O4 PEG B2003 A 239 VAL B 82 VAL~? 20.52 O4 PEG B2003 A 413 ASN B 76 ASN.? 23.89 O4 PEG B2003 coo 80.14 40.76 52.28 77.73 40.59 51.94 -10.61 -34.92 4.88 -11.23 -35.54 2.64 coo 75.67 35.37 52.30 76.00 35.96 50.23 -13.22 -30.45 9.42 -14.18 -32.47 9.26 coo 81.75 35.21 52.13 80.92 37.12 51.69 -16.90 -35.01 4.40 -18.02 -34.43 6.12 1oqz_c00 source 1oqz GLUTARYL ACYLASE : 4 hits 1oqz_c00 naa= 3 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 1 3 # 1 B 170 SER A 40 SER~? 13.43 O2 PEG B2003 B 239 VAL A 44 VAL~? 19.08 O1 PEG B2002 B 413 ASN A 42 ASN~? 14.52 C3 PEG B2003 coo 25.22 6.41 2.90 27.67 6.33 3.11 -10.00 -16.89 23.63 -11.41 -15.57 25.07 coo 29.71 1.00 2.66 29.43 1.57 4.74 -5.74 -16.05 18.71 -5.04 -14.40 19.99 coo 23.72 0.88 2.95 24.56 2.79 3.34 -7.85 -22.02 21.46 -7.56 -23.56 20.01 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 2 3 # 2 B 170 SER A 78 SER.? 29.96 CA CA A1001 B 239 VAL A 82 VAL~? 24.54 C3 PEG B2003 B 413 ASN A 76 ASN.? 27.74 O1 PEG B2002 coo 25.22 6.41 2.90 27.67 6.33 3.11 -13.07 -12.34 5.42 -12.90 -11.48 3.24 coo 29.71 1.00 2.66 29.43 1.57 4.74 -10.40 -17.01 9.61 -9.44 -15.00 9.42 coo 23.72 0.88 2.95 24.56 2.79 3.34 -6.69 -12.45 4.90 -5.54 -13.05 6.59 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 3 3 # 3 B 170 SER B 40 SER~? 8.16 O4 PEG B2003 B 239 VAL B 44 VAL~? 10.79 O4 PEG B2003 B 413 ASN B 42 ASN~? 10.30 O4 PEG B2003 coo 25.22 6.41 2.90 27.67 6.33 3.11 -13.24 -30.95 23.50 -11.93 -32.52 24.66 coo 29.71 1.00 2.66 29.43 1.57 4.74 -17.69 -31.75 18.64 -18.37 -33.47 19.89 coo 23.72 0.88 2.95 24.56 2.79 3.34 -15.54 -25.88 21.48 -16.00 -24.28 20.16 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 4 3 # 4 B 170 SER B 78 SER.? 28.23 O4 PEG B2003 B 239 VAL B 82 VAL~? 20.52 O4 PEG B2003 B 413 ASN B 76 ASN.? 23.89 O4 PEG B2003 coo 25.22 6.41 2.90 27.67 6.33 3.11 -10.61 -34.92 4.88 -11.23 -35.54 2.64 coo 29.71 1.00 2.66 29.43 1.57 4.74 -13.22 -30.45 9.42 -14.18 -32.47 9.26 coo 23.72 0.88 2.95 24.56 2.79 3.34 -16.90 -35.01 4.40 -18.02 -34.43 6.12 1oqz_c01 source 1oqz GLUTARYL ACYLASE : 4 hits 1oqz_c01 naa= 3 ULMN 3 1oyg_c00 LEVANSUCRASE user 1 3 # 1 A 86 ASP A 63 ASP.? 23.22 C1 PEG B2003 A 247 ASP A 60 ASP^? 23.70 C1 PEG B2003 A 342 GLU A 61 GLU.? 19.08 C1 PEG B2003 coo 44.36 35.68 9.71 43.29 36.20 11.51 -11.50 -2.39 37.13 -13.46 -2.26 37.99 coo 41.40 28.81 12.91 40.82 30.90 12.97 -5.40 -4.16 30.61 -7.36 -3.38 30.96 coo 40.37 33.11 18.06 39.99 34.93 17.06 -3.95 -8.85 34.10 -5.28 -10.35 33.41 ULMN 3 1oyg_c00 LEVANSUCRASE user 2 3 # 2 A 86 ASP B 63 ASP~? 19.91 O4 PEG B2003 A 247 ASP B 60 ASP^? 15.62 O4 PEG B2003 A 342 GLU B 61 GLU~? 8.88 O4 PEG B2003 coo 44.36 35.68 9.71 43.29 36.20 11.51 -11.65 -45.32 36.37 -13.02 -46.95 36.09 coo 41.40 28.81 12.91 40.82 30.90 12.97 -17.89 -43.42 30.19 -15.92 -44.27 30.31 coo 40.37 33.11 18.06 39.99 34.93 17.06 -19.12 -38.78 33.18 -18.13 -37.00 32.57 1oyg_c00 source 1oyg LEVANSUCRASE : 2 hits 1oyg_c00 naa= 3 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 A 630 SER A 37 SER~? 12.09 C1 PEG B2003 A 709 ASP A 60 ASP^? 23.70 C1 PEG B2003 A 740 HIS A 21 HIS.? 16.23 C1 PEG B2003 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -9.67 -17.81 28.57 -9.20 -16.58 30.64 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 -5.40 -4.16 30.61 -7.36 -3.38 30.96 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -9.66 -11.83 31.16 -7.90 -10.69 31.12 1pfq_c02 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 1 hits 1pfq_c02 naa= 3 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 B 630 SER A 37 SER~? 12.09 C1 PEG B2003 B 709 ASP A 60 ASP^? 23.70 C1 PEG B2003 B 740 HIS A 21 HIS.? 16.23 C1 PEG B2003 coo 4.44 13.29 37.64 6.01 11.66 38.49 -9.67 -17.81 28.57 -9.20 -16.58 30.64 coo 10.26 2.81 31.69 11.64 4.30 32.43 -5.40 -4.16 30.61 -7.36 -3.38 30.96 coo 8.57 10.09 34.47 7.10 10.73 35.82 -9.66 -11.83 31.16 -7.90 -10.69 31.12 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 B 630 SER B 37 SER~? -4.72 O4 PEG B2003s B 709 ASP B 60 ASP^? 15.62 O4 PEG B2003 B 740 HIS B 21 HIS.? 9.56 O4 PEG B2003 coo 4.44 13.29 37.64 6.01 11.66 38.49 -13.50 -30.16 28.32 -13.76 -31.55 30.19 coo 10.26 2.81 31.69 11.64 4.30 32.43 -17.89 -43.42 30.19 -15.92 -44.27 30.31 coo 8.57 10.09 34.47 7.10 10.73 35.82 -11.59 -35.81 29.96 -12.58 -37.49 29.21 1pfq_c03 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 2 hits 1pfq_c03 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 46 ALA~? 18.56 C3 PEG B2003 A 126 LEU A 50 LEU~? 18.52 CA CA B1002 A 158 GLU B 87 GLU~? 17.51 CA CA B1002 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -5.29 -20.84 15.78 -6.67 -21.55 16.01 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -4.54 -23.04 11.81 -4.06 -24.91 12.83 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -5.10 -29.50 11.76 -3.27 -30.54 11.89 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA A 46 ALA~? 18.56 C3 PEG B2003 A 126 LEU B 91 LEU~? 13.60 CA CA B1002 A 158 GLU B 87 GLU~? 17.51 CA CA B1002 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -5.29 -20.84 15.78 -6.67 -21.55 16.01 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -3.37 -25.59 17.96 -1.95 -23.93 17.71 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -5.10 -29.50 11.76 -3.27 -30.54 11.89 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 A 70 ALA A 51 ALA~? 23.59 CA CA B1002 A 126 LEU A 50 LEU~? 18.52 CA CA B1002 A 158 GLU B 87 GLU~? 17.51 CA CA B1002 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -5.26 -19.32 9.24 -6.62 -18.85 9.77 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -4.54 -23.04 11.81 -4.06 -24.91 12.83 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -5.10 -29.50 11.76 -3.27 -30.54 11.89 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 A 70 ALA A 51 ALA~? 23.59 CA CA B1002 A 126 LEU B 84 LEU~? 21.47 O4 PEG B2003 A 158 GLU B 80 GLU~? 28.00 O4 PEG B2003 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -5.26 -19.32 9.24 -6.62 -18.85 9.77 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -9.60 -25.70 9.76 -8.83 -23.67 10.10 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -9.74 -26.27 4.08 -9.78 -24.63 2.72 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 A 70 ALA A 51 ALA~? 23.59 CA CA B1002 A 126 LEU B 84 LEU~? 21.47 O4 PEG B2003 A 158 GLU B 87 GLU~? 17.51 CA CA B1002 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -5.26 -19.32 9.24 -6.62 -18.85 9.77 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -9.60 -25.70 9.76 -8.83 -23.67 10.10 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -5.10 -29.50 11.76 -3.27 -30.54 11.89 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 A 70 ALA B 46 ALA~? 13.59 O4 PEG B2003 A 126 LEU A 91 LEU~? 12.97 O4 PEG B2003 A 158 GLU A 87 GLU~? 17.34 CA CA A1001 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -18.26 -26.86 15.83 -16.87 -26.16 16.00 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -20.01 -22.15 18.35 -21.38 -23.83 17.98 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -18.57 -18.33 12.01 -20.23 -17.06 12.53 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 A 70 ALA B 46 ALA~? 13.59 O4 PEG B2003 A 126 LEU B 50 LEU~? 17.69 O4 PEG B2003 A 158 GLU A 87 GLU~? 17.34 CA CA A1001 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -18.26 -26.86 15.83 -16.87 -26.16 16.00 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -19.02 -24.53 11.89 -19.33 -22.74 13.06 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -18.57 -18.33 12.01 -20.23 -17.06 12.53 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 A 70 ALA B 51 ALA~? 19.49 O4 PEG B2003 A 126 LEU A 84 LEU~? 20.51 O4 PEG B2003 A 158 GLU A 80 GLU~? 27.45 O4 PEG B2003 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -18.29 -28.17 9.22 -17.00 -28.75 9.84 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -13.95 -21.75 9.86 -14.60 -23.80 10.09 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -13.74 -20.99 4.34 -13.41 -22.52 2.91 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 A 70 ALA B 51 ALA~? 19.49 O4 PEG B2003 A 126 LEU A 84 LEU~? 20.51 O4 PEG B2003 A 158 GLU A 87 GLU~? 17.34 CA CA A1001 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -18.29 -28.17 9.22 -17.00 -28.75 9.84 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -13.95 -21.75 9.86 -14.60 -23.80 10.09 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -18.57 -18.33 12.01 -20.23 -17.06 12.53 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 A 70 ALA B 51 ALA~? 19.49 O4 PEG B2003 A 126 LEU B 50 LEU~? 17.69 O4 PEG B2003 A 158 GLU A 87 GLU~? 17.34 CA CA A1001 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -18.29 -28.17 9.22 -17.00 -28.75 9.84 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -19.02 -24.53 11.89 -19.33 -22.74 13.06 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -18.57 -18.33 12.01 -20.23 -17.06 12.53 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 10 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 46 ALA~? 18.56 C3 PEG B2003 B 126 LEU A 50 LEU~? 18.52 CA CA B1002 B 158 GLU B 87 GLU~? 17.51 CA CA B1002 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -5.29 -20.84 15.78 -6.67 -21.55 16.01 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -4.54 -23.04 11.81 -4.06 -24.91 12.83 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -5.10 -29.50 11.76 -3.27 -30.54 11.89 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA A 46 ALA~? 18.56 C3 PEG B2003 B 126 LEU B 91 LEU~? 13.60 CA CA B1002 B 158 GLU B 87 GLU~? 17.51 CA CA B1002 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -5.29 -20.84 15.78 -6.67 -21.55 16.01 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -3.37 -25.59 17.96 -1.95 -23.93 17.71 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -5.10 -29.50 11.76 -3.27 -30.54 11.89 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 B 70 ALA A 51 ALA~? 23.59 CA CA B1002 B 126 LEU A 50 LEU~? 18.52 CA CA B1002 B 158 GLU B 87 GLU~? 17.51 CA CA B1002 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -5.26 -19.32 9.24 -6.62 -18.85 9.77 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -4.54 -23.04 11.81 -4.06 -24.91 12.83 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -5.10 -29.50 11.76 -3.27 -30.54 11.89 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 B 70 ALA A 51 ALA~? 23.59 CA CA B1002 B 126 LEU B 84 LEU~? 21.47 O4 PEG B2003 B 158 GLU B 80 GLU~? 28.00 O4 PEG B2003 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -5.26 -19.32 9.24 -6.62 -18.85 9.77 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -9.60 -25.70 9.76 -8.83 -23.67 10.10 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -9.74 -26.27 4.08 -9.78 -24.63 2.72 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 B 70 ALA A 51 ALA~? 23.59 CA CA B1002 B 126 LEU B 84 LEU~? 21.47 O4 PEG B2003 B 158 GLU B 87 GLU~? 17.51 CA CA B1002 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -5.26 -19.32 9.24 -6.62 -18.85 9.77 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -9.60 -25.70 9.76 -8.83 -23.67 10.10 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -5.10 -29.50 11.76 -3.27 -30.54 11.89 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 B 70 ALA B 46 ALA~? 13.59 O4 PEG B2003 B 126 LEU A 91 LEU~? 12.97 O4 PEG B2003 B 158 GLU A 87 GLU~? 17.34 CA CA A1001 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -18.26 -26.86 15.83 -16.87 -26.16 16.00 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -20.01 -22.15 18.35 -21.38 -23.83 17.98 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -18.57 -18.33 12.01 -20.23 -17.06 12.53 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 B 70 ALA B 46 ALA~? 13.59 O4 PEG B2003 B 126 LEU B 50 LEU~? 17.69 O4 PEG B2003 B 158 GLU A 87 GLU~? 17.34 CA CA A1001 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -18.26 -26.86 15.83 -16.87 -26.16 16.00 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -19.02 -24.53 11.89 -19.33 -22.74 13.06 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -18.57 -18.33 12.01 -20.23 -17.06 12.53 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 B 70 ALA B 51 ALA~? 19.49 O4 PEG B2003 B 126 LEU A 84 LEU~? 20.51 O4 PEG B2003 B 158 GLU A 80 GLU~? 27.45 O4 PEG B2003 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -18.29 -28.17 9.22 -17.00 -28.75 9.84 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -13.95 -21.75 9.86 -14.60 -23.80 10.09 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -13.74 -20.99 4.34 -13.41 -22.52 2.91 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 B 70 ALA B 51 ALA~? 19.49 O4 PEG B2003 B 126 LEU A 84 LEU~? 20.51 O4 PEG B2003 B 158 GLU A 87 GLU~? 17.34 CA CA A1001 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -18.29 -28.17 9.22 -17.00 -28.75 9.84 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -13.95 -21.75 9.86 -14.60 -23.80 10.09 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -18.57 -18.33 12.01 -20.23 -17.06 12.53 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 B 70 ALA B 51 ALA~? 19.49 O4 PEG B2003 B 126 LEU B 50 LEU~? 17.69 O4 PEG B2003 B 158 GLU A 87 GLU~? 17.34 CA CA A1001 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -18.29 -28.17 9.22 -17.00 -28.75 9.84 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -19.02 -24.53 11.89 -19.33 -22.74 13.06 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -18.57 -18.33 12.01 -20.23 -17.06 12.53 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 10 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 46 ALA~? 18.56 C3 PEG B2003 C 126 LEU A 50 LEU~? 18.52 CA CA B1002 C 158 GLU B 87 GLU~? 17.51 CA CA B1002 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -5.29 -20.84 15.78 -6.67 -21.55 16.01 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -4.54 -23.04 11.81 -4.06 -24.91 12.83 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -5.10 -29.50 11.76 -3.27 -30.54 11.89 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA A 46 ALA~? 18.56 C3 PEG B2003 C 126 LEU B 91 LEU~? 13.60 CA CA B1002 C 158 GLU B 87 GLU~? 17.51 CA CA B1002 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -5.29 -20.84 15.78 -6.67 -21.55 16.01 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -3.37 -25.59 17.96 -1.95 -23.93 17.71 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -5.10 -29.50 11.76 -3.27 -30.54 11.89 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 C 70 ALA A 51 ALA~? 23.59 CA CA B1002 C 126 LEU A 50 LEU~? 18.52 CA CA B1002 C 158 GLU B 87 GLU~? 17.51 CA CA B1002 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -5.26 -19.32 9.24 -6.62 -18.85 9.77 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -4.54 -23.04 11.81 -4.06 -24.91 12.83 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -5.10 -29.50 11.76 -3.27 -30.54 11.89 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 C 70 ALA A 51 ALA~? 23.59 CA CA B1002 C 126 LEU B 84 LEU~? 21.47 O4 PEG B2003 C 158 GLU B 80 GLU~? 28.00 O4 PEG B2003 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -5.26 -19.32 9.24 -6.62 -18.85 9.77 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -9.60 -25.70 9.76 -8.83 -23.67 10.10 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -9.74 -26.27 4.08 -9.78 -24.63 2.72 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 C 70 ALA A 51 ALA~? 23.59 CA CA B1002 C 126 LEU B 84 LEU~? 21.47 O4 PEG B2003 C 158 GLU B 87 GLU~? 17.51 CA CA B1002 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -5.26 -19.32 9.24 -6.62 -18.85 9.77 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -9.60 -25.70 9.76 -8.83 -23.67 10.10 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -5.10 -29.50 11.76 -3.27 -30.54 11.89 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 C 70 ALA B 46 ALA~? 13.59 O4 PEG B2003 C 126 LEU A 91 LEU~? 12.97 O4 PEG B2003 C 158 GLU A 87 GLU~? 17.34 CA CA A1001 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -18.26 -26.86 15.83 -16.87 -26.16 16.00 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -20.01 -22.15 18.35 -21.38 -23.83 17.98 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -18.57 -18.33 12.01 -20.23 -17.06 12.53 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 C 70 ALA B 46 ALA~? 13.59 O4 PEG B2003 C 126 LEU B 50 LEU~? 17.69 O4 PEG B2003 C 158 GLU A 87 GLU~? 17.34 CA CA A1001 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -18.26 -26.86 15.83 -16.87 -26.16 16.00 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -19.02 -24.53 11.89 -19.33 -22.74 13.06 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -18.57 -18.33 12.01 -20.23 -17.06 12.53 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 C 70 ALA B 51 ALA~? 19.49 O4 PEG B2003 C 126 LEU A 84 LEU~? 20.51 O4 PEG B2003 C 158 GLU A 80 GLU~? 27.45 O4 PEG B2003 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -18.29 -28.17 9.22 -17.00 -28.75 9.84 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -13.95 -21.75 9.86 -14.60 -23.80 10.09 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -13.74 -20.99 4.34 -13.41 -22.52 2.91 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 C 70 ALA B 51 ALA~? 19.49 O4 PEG B2003 C 126 LEU A 84 LEU~? 20.51 O4 PEG B2003 C 158 GLU A 87 GLU~? 17.34 CA CA A1001 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -18.29 -28.17 9.22 -17.00 -28.75 9.84 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -13.95 -21.75 9.86 -14.60 -23.80 10.09 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -18.57 -18.33 12.01 -20.23 -17.06 12.53 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 C 70 ALA B 51 ALA~? 19.49 O4 PEG B2003 C 126 LEU B 50 LEU~? 17.69 O4 PEG B2003 C 158 GLU A 87 GLU~? 17.34 CA CA A1001 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -18.29 -28.17 9.22 -17.00 -28.75 9.84 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -19.02 -24.53 11.89 -19.33 -22.74 13.06 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -18.57 -18.33 12.01 -20.23 -17.06 12.53 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 10 hits 1pjh_c02 naa= 3 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 1 3 # 1 A 248 ASP A 60 ASP^? 23.70 C1 PEG B2003 A 270 LYS A 68 LYS^? 23.30 O1 PEG A2001 A 382 MET A 1 MET?? 9.97 C1 PEG A2001 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -5.40 -4.16 30.61 -7.36 -3.38 30.96 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -19.49 -11.55 35.40 -22.42 -11.87 33.53 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 2 3 # 2 A 248 ASP A 70 ASP^? 25.92 O1 PEG A2001 A 270 LYS A 77 LYS.? 28.85 O1 PEG A2001 A 382 MET A 41 MET?? 17.11 O1 PEG B2002 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -9.86 -5.53 16.91 -10.88 -4.17 15.65 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -10.44 -10.90 7.82 -13.04 -5.00 7.61 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -6.39 -17.87 23.59 -4.63 -15.26 24.93 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 3 3 # 3 A 248 ASP A 70 ASP^? 25.92 O1 PEG A2001 A 270 LYS A 77 LYS.? 28.85 O1 PEG A2001 A 382 MET A 109 MET?? 16.34 O1 PEG A2001 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -9.86 -5.53 16.91 -10.88 -4.17 15.65 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -10.44 -10.90 7.82 -13.04 -5.00 7.61 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -24.23 -6.83 17.16 -23.32 -3.96 20.03 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 4 3 # 4 A 248 ASP B 60 ASP^? 15.62 O4 PEG B2003 A 270 LYS B 68 LYS^? 20.92 O4 PEG B2003 A 382 MET B 1 MET?? 9.59 C4 PEG B2002 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -17.89 -43.42 30.19 -15.92 -44.27 30.31 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -12.94 -40.63 21.91 -10.06 -45.25 18.80 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -3.33 -36.60 34.65 -0.64 -35.99 32.77 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 5 3 # 5 A 248 ASP B 70 ASP^? 21.22 O4 PEG B2003 A 270 LYS B 77 LYS.? 27.21 O4 PEG B2003 A 382 MET B 41 MET?? 6.13 O4 PEG B2003 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -13.56 -42.18 16.17 -12.44 -43.52 14.94 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -13.11 -36.51 7.32 -10.61 -42.26 6.72 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -16.88 -30.11 23.44 -18.60 -32.62 24.71 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 6 3 # 6 A 248 ASP B 70 ASP^? 21.22 O4 PEG B2003 A 270 LYS B 77 LYS.? 27.21 O4 PEG B2003 A 382 MET B 109 MET?? 15.83 O4 PEG B2002 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -13.56 -42.18 16.17 -12.44 -43.52 14.94 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -13.11 -36.51 7.32 -10.61 -42.26 6.72 coo -23.75 127.89 58.42 -26.02 128.79 55.12 0.80 -40.79 16.33 0.09 -43.36 19.32 1pjq_c02 source 1pjq SIROHEME SYNTHASE : 6 hits 1pjq_c02 naa= 3 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 1 3 # 1 B 248 ASP A 70 ASP^? 25.92 O1 PEG A2001 B 270 LYS A 68 LYS^? 23.30 O1 PEG A2001 B 382 MET A 109 MET?? 16.34 O1 PEG A2001 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -9.86 -5.53 16.91 -10.88 -4.17 15.65 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -10.36 -7.13 22.60 -13.43 -2.53 19.68 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -24.23 -6.83 17.16 -23.32 -3.96 20.03 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 2 3 # 2 B 248 ASP B 70 ASP^? 21.22 O4 PEG B2003 B 270 LYS B 68 LYS^? 20.92 O4 PEG B2003 B 382 MET B 109 MET?? 15.83 O4 PEG B2002 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -13.56 -42.18 16.17 -12.44 -43.52 14.94 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -12.94 -40.63 21.91 -10.06 -45.25 18.80 coo -2.79 145.52 50.38 -5.75 148.14 51.66 0.80 -40.79 16.33 0.09 -43.36 19.32 1pjq_c03 source 1pjq SIROHEME SYNTHASE : 2 hits 1pjq_c03 naa= 3 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 1 3 # 1 B 1 SER A 100 SER~? 3.90 O1 PEG B2003 B 69 ALA A 97 ALA~? -5.56 C1 PEG A2001s B 241 ASN A 99 ASN~? 7.66 O1 PEG B2003 coo 13.24 41.94 33.13 13.08 39.54 33.17 -23.99 -20.35 32.61 -22.13 -21.83 33.13 coo 9.15 37.89 36.69 10.55 37.76 37.22 -23.82 -17.88 27.92 -23.98 -16.88 26.75 coo 10.91 43.03 38.47 11.81 41.82 36.93 -24.23 -23.83 29.86 -24.62 -25.28 28.37 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 2 3 # 2 B 1 SER B 100 SER~? 9.30 C3 PEG B2002 B 69 ALA B 97 ALA~? -5.38 C4 PEG B2002s B 241 ASN B 99 ASN~? 7.82 C2 PEG B2002 coo 13.24 41.94 33.13 13.08 39.54 33.17 0.85 -27.49 32.31 -1.03 -26.05 32.94 coo 9.15 37.89 36.69 10.55 37.76 37.22 0.58 -29.83 27.51 0.73 -30.90 26.42 coo 10.91 43.03 38.47 11.81 41.82 36.93 0.85 -23.90 29.59 1.20 -22.57 27.92 1pnl_c00 source 1pnl PENICILLIN AMIDOHYDROLASE : 2 hits 1pnl_c00 naa= 3 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 3 # 1 A 67 ASP A 52 ASP.? 24.46 O1 PEG B2002 A 68 ALA A 51 ALA~? 23.59 CA CA B1002 A 72 LEU A 47 LEU~? 21.88 C3 PEG B2003 coo 46.76 7.59 18.65 45.27 6.01 18.52 -2.05 -17.27 6.89 -0.38 -16.21 6.11 coo 48.88 4.35 16.59 48.73 5.09 15.20 -5.26 -19.32 9.24 -6.62 -18.85 9.77 coo 53.89 6.25 15.09 52.88 7.92 14.14 -6.29 -16.25 14.17 -8.39 -15.72 13.89 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 3 # 2 A 67 ASP A 52 ASP.? 24.46 O1 PEG B2002 A 68 ALA A 51 ALA~? 23.59 CA CA B1002 A 72 LEU A 50 LEU~? 18.52 CA CA B1002 coo 46.76 7.59 18.65 45.27 6.01 18.52 -2.05 -17.27 6.89 -0.38 -16.21 6.11 coo 48.88 4.35 16.59 48.73 5.09 15.20 -5.26 -19.32 9.24 -6.62 -18.85 9.77 coo 53.89 6.25 15.09 52.88 7.92 14.14 -4.54 -23.04 11.81 -4.06 -24.91 12.83 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 3 3 # 3 A 67 ASP B 52 ASP.? 24.24 O4 PEG B2003 A 68 ALA B 51 ALA~? 19.49 O4 PEG B2003 A 72 LEU B 47 LEU~? 15.81 O4 PEG B2003 coo 46.76 7.59 18.65 45.27 6.01 18.52 -21.39 -30.03 6.82 -22.77 -31.26 5.81 coo 48.88 4.35 16.59 48.73 5.09 15.20 -18.29 -28.17 9.22 -17.00 -28.75 9.84 coo 53.89 6.25 15.09 52.88 7.92 14.14 -17.26 -31.34 14.01 -15.18 -31.90 13.66 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 4 3 # 4 A 67 ASP B 52 ASP.? 24.24 O4 PEG B2003 A 68 ALA B 51 ALA~? 19.49 O4 PEG B2003 A 72 LEU B 50 LEU~? 17.69 O4 PEG B2003 coo 46.76 7.59 18.65 45.27 6.01 18.52 -21.39 -30.03 6.82 -22.77 -31.26 5.81 coo 48.88 4.35 16.59 48.73 5.09 15.20 -18.29 -28.17 9.22 -17.00 -28.75 9.84 coo 53.89 6.25 15.09 52.88 7.92 14.14 -19.02 -24.53 11.89 -19.33 -22.74 13.06 1q6l_c05 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 4 hits 1q6l_c05 naa= 3 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 1 3 # 1 A 86 GLU A 61 GLU.? 19.08 C1 PEG B2003 A 143 HIS A 21 HIS.? 16.23 C1 PEG B2003 A 170 LYS A 68 LYS^? 23.30 O1 PEG A2001 coo -2.40 27.37 52.92 -1.22 29.09 52.71 -3.95 -8.85 34.10 -5.28 -10.35 33.41 coo 1.36 26.79 49.43 3.17 26.89 50.50 -9.66 -11.83 31.16 -7.90 -10.69 31.12 coo 7.24 31.80 48.14 6.27 25.92 49.70 -10.36 -7.13 22.60 -13.43 -2.53 19.68 1qfe_c00 source 1qfe 3-DEHYDROQUINATE DEHYDRATASE : 1 hits 1qfe_c00 naa= 3 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 1 3 # 1 B 86 GLU A 61 GLU.? 19.08 C1 PEG B2003 B 143 HIS A 21 HIS.? 16.23 C1 PEG B2003 B 170 LYS A 68 LYS^? 23.30 O1 PEG A2001 coo 13.90 37.16 5.96 12.00 36.26 6.12 -3.95 -8.85 34.10 -5.28 -10.35 33.41 coo 13.52 33.69 9.79 13.20 31.83 8.88 -9.66 -11.83 31.16 -7.90 -10.69 31.12 coo 7.52 28.83 11.02 13.59 28.74 9.95 -10.36 -7.13 22.60 -13.43 -2.53 19.68 1qfe_c01 source 1qfe 3-DEHYDROQUINATE DEHYDRATASE : 1 hits 1qfe_c01 naa= 3 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 73 TYR.? -31.47 O1 PEG A2001s A 236 ASP A 70 ASP^? 25.92 O1 PEG A2001 A 261 LYS A 77 LYS.? 28.85 O1 PEG A2001 coo 55.48 26.51 40.65 55.39 23.99 39.43 -8.12 -1.41 10.87 -9.66 0.82 11.59 coo 48.87 29.19 44.63 49.10 27.34 43.63 -9.86 -5.53 16.91 -10.88 -4.17 15.65 coo 47.58 17.35 41.83 51.40 20.85 40.83 -10.44 -10.90 7.82 -13.04 -5.00 7.61 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR B 73 TYR.? -26.42 O4 PEG B2003s A 236 ASP B 70 ASP^? 21.22 O4 PEG B2003 A 261 LYS B 77 LYS.? 27.21 O4 PEG B2003 coo 55.48 26.51 40.65 55.39 23.99 39.43 -15.40 -46.09 10.22 -13.89 -48.32 11.05 coo 48.87 29.19 44.63 49.10 27.34 43.63 -13.56 -42.18 16.17 -12.44 -43.52 14.94 coo 47.58 17.35 41.83 51.40 20.85 40.83 -13.11 -36.51 7.32 -10.61 -42.26 6.72 1qgn_c08 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c08 naa= 3 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 73 TYR.? -31.47 O1 PEG A2001s B 236 ASP A 70 ASP^? 25.92 O1 PEG A2001 B 261 LYS A 77 LYS.? 28.85 O1 PEG A2001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -8.12 -1.41 10.87 -9.66 0.82 11.59 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -9.86 -5.53 16.91 -10.88 -4.17 15.65 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -10.44 -10.90 7.82 -13.04 -5.00 7.61 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR B 73 TYR.? -26.42 O4 PEG B2003s B 236 ASP B 70 ASP^? 21.22 O4 PEG B2003 B 261 LYS B 77 LYS.? 27.21 O4 PEG B2003 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -15.40 -46.09 10.22 -13.89 -48.32 11.05 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -13.56 -42.18 16.17 -12.44 -43.52 14.94 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -13.11 -36.51 7.32 -10.61 -42.26 6.72 1qgn_c09 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c09 naa= 3 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 163 TYR A 73 TYR.? -31.47 O1 PEG A2001s C 236 ASP A 70 ASP^? 25.92 O1 PEG A2001 C 261 LYS A 77 LYS.? 28.85 O1 PEG A2001 coo 39.51 34.34 13.63 37.63 32.61 14.79 -8.12 -1.41 10.87 -9.66 0.82 11.59 coo 45.78 31.11 9.51 44.25 30.06 10.53 -9.86 -5.53 16.91 -10.88 -4.17 15.65 coo 37.54 22.37 12.10 37.83 27.55 13.24 -10.44 -10.90 7.82 -13.04 -5.00 7.61 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 163 TYR B 73 TYR.? -26.42 O4 PEG B2003s C 236 ASP B 70 ASP^? 21.22 O4 PEG B2003 C 261 LYS B 77 LYS.? 27.21 O4 PEG B2003 coo 39.51 34.34 13.63 37.63 32.61 14.79 -15.40 -46.09 10.22 -13.89 -48.32 11.05 coo 45.78 31.11 9.51 44.25 30.06 10.53 -13.56 -42.18 16.17 -12.44 -43.52 14.94 coo 37.54 22.37 12.10 37.83 27.55 13.24 -13.11 -36.51 7.32 -10.61 -42.26 6.72 1qgn_c10 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c10 naa= 3 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 163 TYR A 73 TYR.? -31.47 O1 PEG A2001s D 236 ASP A 70 ASP^? 25.92 O1 PEG A2001 D 261 LYS A 77 LYS.? 28.85 O1 PEG A2001 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -8.12 -1.41 10.87 -9.66 0.82 11.59 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -9.86 -5.53 16.91 -10.88 -4.17 15.65 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -10.44 -10.90 7.82 -13.04 -5.00 7.61 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 163 TYR B 73 TYR.? -26.42 O4 PEG B2003s D 236 ASP B 70 ASP^? 21.22 O4 PEG B2003 D 261 LYS B 77 LYS.? 27.21 O4 PEG B2003 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -15.40 -46.09 10.22 -13.89 -48.32 11.05 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -13.56 -42.18 16.17 -12.44 -43.52 14.94 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -13.11 -36.51 7.32 -10.61 -42.26 6.72 1qgn_c11 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c11 naa= 3 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 73 TYR.? -31.47 O1 PEG A2001s E 236 ASP A 70 ASP^? 25.92 O1 PEG A2001 E 261 LYS A 77 LYS.? 28.85 O1 PEG A2001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -8.12 -1.41 10.87 -9.66 0.82 11.59 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -9.86 -5.53 16.91 -10.88 -4.17 15.65 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -10.44 -10.90 7.82 -13.04 -5.00 7.61 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR B 73 TYR.? -26.42 O4 PEG B2003s E 236 ASP B 70 ASP^? 21.22 O4 PEG B2003 E 261 LYS B 77 LYS.? 27.21 O4 PEG B2003 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -15.40 -46.09 10.22 -13.89 -48.32 11.05 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -13.56 -42.18 16.17 -12.44 -43.52 14.94 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -13.11 -36.51 7.32 -10.61 -42.26 6.72 1qgn_c12 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c12 naa= 3 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 73 TYR.? -31.47 O1 PEG A2001s F 236 ASP A 70 ASP^? 25.92 O1 PEG A2001 F 261 LYS A 77 LYS.? 28.85 O1 PEG A2001 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -8.12 -1.41 10.87 -9.66 0.82 11.59 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -9.86 -5.53 16.91 -10.88 -4.17 15.65 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -10.44 -10.90 7.82 -13.04 -5.00 7.61 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR B 73 TYR.? -26.42 O4 PEG B2003s F 236 ASP B 70 ASP^? 21.22 O4 PEG B2003 F 261 LYS B 77 LYS.? 27.21 O4 PEG B2003 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -15.40 -46.09 10.22 -13.89 -48.32 11.05 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -13.56 -42.18 16.17 -12.44 -43.52 14.94 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -13.11 -36.51 7.32 -10.61 -42.26 6.72 1qgn_c13 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c13 naa= 3 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 163 TYR A 73 TYR.? -31.47 O1 PEG A2001s G 236 ASP A 70 ASP^? 25.92 O1 PEG A2001 G 261 LYS A 77 LYS.? 28.85 O1 PEG A2001 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -8.12 -1.41 10.87 -9.66 0.82 11.59 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -9.86 -5.53 16.91 -10.88 -4.17 15.65 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -10.44 -10.90 7.82 -13.04 -5.00 7.61 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 163 TYR B 73 TYR.? -26.42 O4 PEG B2003s G 236 ASP B 70 ASP^? 21.22 O4 PEG B2003 G 261 LYS B 77 LYS.? 27.21 O4 PEG B2003 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -15.40 -46.09 10.22 -13.89 -48.32 11.05 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -13.56 -42.18 16.17 -12.44 -43.52 14.94 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -13.11 -36.51 7.32 -10.61 -42.26 6.72 1qgn_c14 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c14 naa= 3 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 163 TYR A 73 TYR.? -31.47 O1 PEG A2001s H 236 ASP A 70 ASP^? 25.92 O1 PEG A2001 H 261 LYS A 77 LYS.? 28.85 O1 PEG A2001 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -8.12 -1.41 10.87 -9.66 0.82 11.59 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -9.86 -5.53 16.91 -10.88 -4.17 15.65 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -10.44 -10.90 7.82 -13.04 -5.00 7.61 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 163 TYR B 73 TYR.? -26.42 O4 PEG B2003s H 236 ASP B 70 ASP^? 21.22 O4 PEG B2003 H 261 LYS B 77 LYS.? 27.21 O4 PEG B2003 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -15.40 -46.09 10.22 -13.89 -48.32 11.05 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -13.56 -42.18 16.17 -12.44 -43.52 14.94 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -13.11 -36.51 7.32 -10.61 -42.26 6.72 1qgn_c15 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c15 naa= 3 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 1 3 # 1 A 49 ASP A 79 ASP~? 30.35 CA CA B1002 A 147 THR A 75 THR.? 31.76 O1 PEG B2002 A 294 ASP A 70 ASP^? 25.92 O1 PEG A2001 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -9.53 -15.68 5.14 -8.10 -15.06 3.67 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -6.45 -7.77 5.23 -4.76 -8.32 3.95 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -9.86 -5.53 16.91 -10.88 -4.17 15.65 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 2 3 # 2 A 49 ASP B 79 ASP~? 26.06 O4 PEG B2003 A 147 THR B 75 THR.? 28.73 O4 PEG B2003 A 294 ASP B 70 ASP^? 21.22 O4 PEG B2003 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -14.12 -31.44 4.95 -15.54 -32.00 3.54 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -16.62 -39.81 4.37 -18.18 -40.97 3.33 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -13.56 -42.18 16.17 -12.44 -43.52 14.94 1qgx_c02 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 2 hits 1qgx_c02 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 63 ASP.? 23.22 C1 PEG B2003 A 261 ASP A 70 ASP^? 25.92 O1 PEG A2001 A 329 ASP A 60 ASP^? 23.70 C1 PEG B2003 coo 28.46 69.88 26.74 30.40 70.70 26.53 -11.50 -2.39 37.13 -13.46 -2.26 37.99 coo 34.02 79.89 42.60 34.73 78.01 41.86 -9.86 -5.53 16.91 -10.88 -4.17 15.65 coo 37.87 70.12 31.80 36.61 69.74 30.15 -5.40 -4.16 30.61 -7.36 -3.38 30.96 ULMN 3 1qho_c05 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP B 60 ASP^? 15.62 O4 PEG B2003 A 261 ASP B 30 ASP~? 11.37 C2 PEG B2003 A 329 ASP B 63 ASP~? 19.91 O4 PEG B2003 coo 28.46 69.88 26.74 30.40 70.70 26.53 -17.89 -43.42 30.19 -15.92 -44.27 30.31 coo 34.02 79.89 42.60 34.73 78.01 41.86 -10.72 -29.17 38.90 -10.74 -31.13 39.77 coo 37.87 70.12 31.80 36.61 69.74 30.15 -11.65 -45.32 36.37 -13.02 -46.95 36.09 ULMN 3 1qho_c05 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP B 63 ASP~? 19.91 O4 PEG B2003 A 261 ASP B 70 ASP^? 21.22 O4 PEG B2003 A 329 ASP B 60 ASP^? 15.62 O4 PEG B2003 coo 28.46 69.88 26.74 30.40 70.70 26.53 -11.65 -45.32 36.37 -13.02 -46.95 36.09 coo 34.02 79.89 42.60 34.73 78.01 41.86 -13.56 -42.18 16.17 -12.44 -43.52 14.94 coo 37.87 70.12 31.80 36.61 69.74 30.15 -17.89 -43.42 30.19 -15.92 -44.27 30.31 1qho_c05 source 1qho ALPHA-AMYLASE : 3 hits 1qho_c05 naa= 3 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 A 51 ALA A 22 ALA.? 17.13 C1 PEG B2003 A 148 HIS A 21 HIS.? 16.23 C1 PEG B2003 A 163 ASP A 60 ASP^? 23.70 C1 PEG B2003 coo 1.42 19.18 21.84 1.11 19.57 23.28 -9.61 -11.57 35.52 -8.52 -10.48 35.41 coo 0.71 19.67 27.92 2.43 19.16 26.83 -9.66 -11.83 31.16 -7.90 -10.69 31.12 coo 7.15 16.22 27.50 6.15 18.00 27.94 -5.40 -4.16 30.61 -7.36 -3.38 30.96 1qol_c00 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 1 hits 1qol_c00 naa= 3 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 B 51 ALA A 22 ALA.? 17.13 C1 PEG B2003 B 148 HIS A 21 HIS.? 16.23 C1 PEG B2003 B 163 ASP A 60 ASP^? 23.70 C1 PEG B2003 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -9.61 -11.57 35.52 -8.52 -10.48 35.41 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -9.66 -11.83 31.16 -7.90 -10.69 31.12 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -5.40 -4.16 30.61 -7.36 -3.38 30.96 1qol_c01 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 1 hits 1qol_c01 naa= 3 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 C 51 ALA A 22 ALA.? 17.13 C1 PEG B2003 C 148 HIS A 21 HIS.? 16.23 C1 PEG B2003 C 163 ASP A 60 ASP^? 23.70 C1 PEG B2003 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -9.61 -11.57 35.52 -8.52 -10.48 35.41 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -9.66 -11.83 31.16 -7.90 -10.69 31.12 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -5.40 -4.16 30.61 -7.36 -3.38 30.96 1qol_c02 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 1 hits 1qol_c02 naa= 3 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 D 51 ALA A 22 ALA.? 17.13 C1 PEG B2003 D 148 HIS A 21 HIS.? 16.23 C1 PEG B2003 D 163 ASP A 60 ASP^? 23.70 C1 PEG B2003 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -9.61 -11.57 35.52 -8.52 -10.48 35.41 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -9.66 -11.83 31.16 -7.90 -10.69 31.12 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -5.40 -4.16 30.61 -7.36 -3.38 30.96 1qol_c03 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 1 hits 1qol_c03 naa= 3 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 E 51 ALA A 22 ALA.? 17.13 C1 PEG B2003 E 148 HIS A 21 HIS.? 16.23 C1 PEG B2003 E 163 ASP A 60 ASP^? 23.70 C1 PEG B2003 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -9.61 -11.57 35.52 -8.52 -10.48 35.41 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -9.66 -11.83 31.16 -7.90 -10.69 31.12 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -5.40 -4.16 30.61 -7.36 -3.38 30.96 1qol_c04 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 1 hits 1qol_c04 naa= 3 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 F 51 ALA A 22 ALA.? 17.13 C1 PEG B2003 F 148 HIS A 21 HIS.? 16.23 C1 PEG B2003 F 163 ASP A 60 ASP^? 23.70 C1 PEG B2003 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -9.61 -11.57 35.52 -8.52 -10.48 35.41 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -9.66 -11.83 31.16 -7.90 -10.69 31.12 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -5.40 -4.16 30.61 -7.36 -3.38 30.96 1qol_c05 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 1 hits 1qol_c05 naa= 3 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 G 51 ALA A 22 ALA.? 17.13 C1 PEG B2003 G 148 HIS A 21 HIS.? 16.23 C1 PEG B2003 G 163 ASP A 60 ASP^? 23.70 C1 PEG B2003 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -9.61 -11.57 35.52 -8.52 -10.48 35.41 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -9.66 -11.83 31.16 -7.90 -10.69 31.12 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -5.40 -4.16 30.61 -7.36 -3.38 30.96 1qol_c06 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 1 hits 1qol_c06 naa= 3 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 H 51 ALA A 22 ALA.? 17.13 C1 PEG B2003 H 148 HIS A 21 HIS.? 16.23 C1 PEG B2003 H 163 ASP A 60 ASP^? 23.70 C1 PEG B2003 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -9.61 -11.57 35.52 -8.52 -10.48 35.41 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -9.66 -11.83 31.16 -7.90 -10.69 31.12 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -5.40 -4.16 30.61 -7.36 -3.38 30.96 1qol_c07 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 1 hits 1qol_c07 naa= 3 ULMN 3 1qrz_c20 PLASMINOGEN user 1 3 # 1 A 603 HIS B 21 HIS.? 9.56 O4 PEG B2003 A 646 ASP B 60 ASP^? 15.62 O4 PEG B2003 A 739 GLY B 25 GLY.? 14.27 C2 PEG B2003 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -11.59 -35.81 29.96 -12.58 -37.49 29.21 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -17.89 -43.42 30.19 -15.92 -44.27 30.31 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -11.01 -32.87 42.99 -10.28 -32.75 42.62 1qrz_c20 source 1qrz PLASMINOGEN : 1 hits 1qrz_c20 naa= 3 ULMN 3 1qrz_c21 PLASMINOGEN user 1 3 # 1 B 603 HIS B 21 HIS.? 9.56 O4 PEG B2003 B 646 ASP B 60 ASP^? 15.62 O4 PEG B2003 B 739 GLY B 25 GLY.? 14.27 C2 PEG B2003 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -11.59 -35.81 29.96 -12.58 -37.49 29.21 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -17.89 -43.42 30.19 -15.92 -44.27 30.31 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -11.01 -32.87 42.99 -10.28 -32.75 42.62 1qrz_c21 source 1qrz PLASMINOGEN : 1 hits 1qrz_c21 naa= 3 ULMN 3 1qrz_c22 PLASMINOGEN user 1 3 # 1 C 603 HIS B 21 HIS.? 9.56 O4 PEG B2003 C 646 ASP B 60 ASP^? 15.62 O4 PEG B2003 C 739 GLY B 25 GLY.? 14.27 C2 PEG B2003 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -11.59 -35.81 29.96 -12.58 -37.49 29.21 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -17.89 -43.42 30.19 -15.92 -44.27 30.31 coo 7.82 1.25 3.03 7.30 1.31 3.65 -11.01 -32.87 42.99 -10.28 -32.75 42.62 1qrz_c22 source 1qrz PLASMINOGEN : 1 hits 1qrz_c22 naa= 3 ULMN 3 1qrz_c23 PLASMINOGEN user 1 3 # 1 D 603 HIS B 21 HIS.? 9.56 O4 PEG B2003 D 646 ASP B 60 ASP^? 15.62 O4 PEG B2003 D 739 GLY B 25 GLY.? 14.27 C2 PEG B2003 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -11.59 -35.81 29.96 -12.58 -37.49 29.21 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -17.89 -43.42 30.19 -15.92 -44.27 30.31 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -11.01 -32.87 42.99 -10.28 -32.75 42.62 1qrz_c23 source 1qrz PLASMINOGEN : 1 hits 1qrz_c23 naa= 3 ULMN 3 1qtn_c02 ACETYL-ILE-GLU-THR-ASP-ALDEHYDE user 1 3 # 1 A 317 HIS B 21 HIS.? 9.56 O4 PEG B2003 A 318 GLY B 23 GLY.? 10.56 C4 PEG B2003 A 360 CYH B 33 CYH~? 9.84 C4 PEG B2003 coo -8.43 39.80 36.26 -8.18 39.59 38.31 -11.59 -35.81 29.96 -12.58 -37.49 29.21 coo -11.14 38.10 31.61 -11.46 38.10 32.37 -11.52 -34.07 37.14 -11.49 -34.90 37.06 coo -11.95 34.09 34.07 -11.89 34.73 36.80 -9.83 -30.15 33.15 -9.47 -32.30 34.84 1qtn_c02 source 1qtn ACETYL-ILE-GLU-THR-ASP-ALDEHYDE : 1 hits 1qtn_c02 naa= 3 ULMN 3 1qx3_c00 APOPAIN user 1 3 # 1 A 121 HIS B 21 HIS.? 9.56 O4 PEG B2003 A 122 GLY B 23 GLY.? 10.56 C4 PEG B2003 A 163 CYH B 33 CYH~? 9.84 C4 PEG B2003 coo 2.23 29.11 15.20 1.24 27.27 15.13 -11.59 -35.81 29.96 -12.58 -37.49 29.21 coo 2.54 34.86 14.60 1.83 34.53 14.82 -11.52 -34.07 37.14 -11.49 -34.90 37.06 coo -1.20 35.13 11.95 -2.11 32.67 12.98 -9.83 -30.15 33.15 -9.47 -32.30 34.84 1qx3_c00 source 1qx3 APOPAIN : 1 hits 1qx3_c00 naa= 3 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 A 137 GLU A 26 GLU~? 10.48 O1 PEG B2003 A 288 HIS B 21 HIS.? 9.56 O4 PEG B2003 A 329 LYS B 68 LYS^? 20.92 O4 PEG B2003 coo 29.27 18.78 14.99 27.16 18.62 14.76 -18.91 -18.64 42.47 -20.88 -19.31 42.77 coo 49.52 10.06 10.36 50.99 9.65 8.92 -11.59 -35.81 29.96 -12.58 -37.49 29.21 coo 57.80 12.92 13.83 53.77 8.42 12.15 -12.94 -40.63 21.91 -10.06 -45.25 18.80 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 A 137 GLU A 102 GLU.? 7.49 O1 PEG B2003 A 288 HIS B 21 HIS.? 9.56 O4 PEG B2003 A 329 LYS B 68 LYS^? 20.92 O4 PEG B2003 coo 29.27 18.78 14.99 27.16 18.62 14.76 -24.41 -18.40 37.33 -24.92 -20.20 36.28 coo 49.52 10.06 10.36 50.99 9.65 8.92 -11.59 -35.81 29.96 -12.58 -37.49 29.21 coo 57.80 12.92 13.83 53.77 8.42 12.15 -12.94 -40.63 21.91 -10.06 -45.25 18.80 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 A 137 GLU B 102 GLU.? 8.57 C3 PEG B2002 A 288 HIS A 21 HIS.? 16.23 C1 PEG B2003 A 329 LYS A 68 LYS^? 23.30 O1 PEG A2001 coo 29.27 18.78 14.99 27.16 18.62 14.76 1.59 -29.80 36.90 1.85 -28.01 35.77 coo 49.52 10.06 10.36 50.99 9.65 8.92 -9.66 -11.83 31.16 -7.90 -10.69 31.12 coo 57.80 12.92 13.83 53.77 8.42 12.15 -10.36 -7.13 22.60 -13.43 -2.53 19.68 1roz_c00 source 1roz DEOXYHYPUSINE SYNTHASE : 3 hits 1roz_c00 naa= 3 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 B 137 GLU A 26 GLU~? 10.48 O1 PEG B2003 B 288 HIS B 21 HIS.? 9.56 O4 PEG B2003 B 329 LYS B 68 LYS^? 20.92 O4 PEG B2003 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -18.91 -18.64 42.47 -20.88 -19.31 42.77 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -11.59 -35.81 29.96 -12.58 -37.49 29.21 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -12.94 -40.63 21.91 -10.06 -45.25 18.80 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 B 137 GLU A 102 GLU.? 7.49 O1 PEG B2003 B 288 HIS B 21 HIS.? 9.56 O4 PEG B2003 B 329 LYS B 68 LYS^? 20.92 O4 PEG B2003 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -24.41 -18.40 37.33 -24.92 -20.20 36.28 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -11.59 -35.81 29.96 -12.58 -37.49 29.21 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -12.94 -40.63 21.91 -10.06 -45.25 18.80 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 B 137 GLU B 102 GLU.? 8.57 C3 PEG B2002 B 288 HIS A 21 HIS.? 16.23 C1 PEG B2003 B 329 LYS A 68 LYS^? 23.30 O1 PEG A2001 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 1.59 -29.80 36.90 1.85 -28.01 35.77 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -9.66 -11.83 31.16 -7.90 -10.69 31.12 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -10.36 -7.13 22.60 -13.43 -2.53 19.68 1roz_c01 source 1roz DEOXYHYPUSINE SYNTHASE : 3 hits 1roz_c01 naa= 3 ULMN 3 1sll_c00 SIALIDASE L user 1 3 # 1 318 ASP B 70 ASP^? 21.22 O4 PEG B2003 595 GLU B 17 GLU^? 19.22 O4 PEG B2003 713 TYR B 66 TYR^? 16.34 O4 PEG B2003 coo 5.64 2.82 38.49 4.59 4.19 37.25 -13.56 -42.18 16.17 -12.44 -43.52 14.94 coo 4.35 13.73 37.63 3.39 12.18 36.55 -8.67 -42.47 23.80 -7.95 -44.48 23.69 coo 3.76 10.25 31.38 3.16 9.87 34.10 -12.77 -43.45 27.28 -12.10 -44.44 24.75 1sll_c00 source 1sll SIALIDASE L : 1 hits 1sll_c00 naa= 3 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP A 79 ASP~? 30.35 CA CA B1002 E 168 LYS A 77 LYS.? 28.85 O1 PEG A2001 E 171 ASN A 76 ASN.? 27.74 O1 PEG B2002 coo 5.36 16.20 22.10 3.88 17.00 23.31 -9.53 -15.68 5.14 -8.10 -15.06 3.67 coo 5.06 22.32 18.11 1.02 22.08 22.74 -10.44 -10.90 7.82 -13.04 -5.00 7.61 coo 6.68 21.78 22.39 5.28 20.74 23.60 -6.69 -12.45 4.90 -5.54 -13.05 6.59 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 2 3 # 2 E 166 ASP B 79 ASP~? 26.06 O4 PEG B2003 E 168 LYS B 77 LYS.? 27.21 O4 PEG B2003 E 171 ASN B 76 ASN.? 23.89 O4 PEG B2003 coo 5.36 16.20 22.10 3.88 17.00 23.31 -14.12 -31.44 4.95 -15.54 -32.00 3.54 coo 5.06 22.32 18.11 1.02 22.08 22.74 -13.11 -36.51 7.32 -10.61 -42.26 6.72 coo 6.68 21.78 22.39 5.28 20.74 23.60 -16.90 -35.01 4.40 -18.02 -34.43 6.12 1stc_c03 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 2 hits 1stc_c03 naa= 3 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 1 3 # 1 A 88 SER A 15 SER^? 21.14 O1 PEG A2001 A 90 SER A 72 SER.? 25.71 O1 PEG A2001 A 145 LYS A 77 LYS.? 28.85 O1 PEG A2001 coo -3.31 40.95 15.56 -0.94 40.79 14.97 -14.21 -8.14 16.70 -15.25 -5.93 17.19 coo 1.47 40.03 18.48 2.45 41.37 16.68 -11.42 -4.87 11.47 -12.93 -4.20 13.23 coo 7.35 44.71 16.29 4.71 40.98 14.52 -10.44 -10.90 7.82 -13.04 -5.00 7.61 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 2 3 # 2 A 88 SER A 72 SER.? 25.71 O1 PEG A2001 A 90 SER A 15 SER^? 21.14 O1 PEG A2001 A 145 LYS A 68 LYS^? 23.30 O1 PEG A2001 coo -3.31 40.95 15.56 -0.94 40.79 14.97 -11.42 -4.87 11.47 -12.93 -4.20 13.23 coo 1.47 40.03 18.48 2.45 41.37 16.68 -14.21 -8.14 16.70 -15.25 -5.93 17.19 coo 7.35 44.71 16.29 4.71 40.98 14.52 -10.36 -7.13 22.60 -13.43 -2.53 19.68 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 3 3 # 3 A 88 SER B 15 SER^? 20.57 O4 PEG B2003 A 90 SER B 72 SER.? 23.35 O4 PEG B2003 A 145 LYS B 77 LYS.? 27.21 O4 PEG B2003 coo -3.31 40.95 15.56 -0.94 40.79 14.97 -9.16 -39.49 15.93 -8.11 -41.66 16.33 coo 1.47 40.03 18.48 2.45 41.37 16.68 -12.06 -42.72 10.71 -10.61 -43.41 12.48 coo 7.35 44.71 16.29 4.71 40.98 14.52 -13.11 -36.51 7.32 -10.61 -42.26 6.72 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 4 3 # 4 A 88 SER B 72 SER.? 23.35 O4 PEG B2003 A 90 SER B 15 SER^? 20.57 O4 PEG B2003 A 145 LYS B 68 LYS^? 20.92 O4 PEG B2003 coo -3.31 40.95 15.56 -0.94 40.79 14.97 -12.06 -42.72 10.71 -10.61 -43.41 12.48 coo 1.47 40.03 18.48 2.45 41.37 16.68 -9.16 -39.49 15.93 -8.11 -41.66 16.33 coo 7.35 44.71 16.29 4.71 40.98 14.52 -12.94 -40.63 21.91 -10.06 -45.25 18.80 1t7d_c00 source 1t7d SIGNAL PEPTIDASE I : 4 hits 1t7d_c00 naa= 3 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 1 3 # 1 B 88 SER A 15 SER^? 21.14 O1 PEG A2001 B 90 SER A 72 SER.? 25.71 O1 PEG A2001 B 145 LYS A 77 LYS.? 28.85 O1 PEG A2001 coo 61.01 10.03 12.97 58.78 10.97 12.69 -14.21 -8.14 16.70 -15.25 -5.93 17.19 coo 56.85 12.22 16.37 55.62 11.34 14.45 -11.42 -4.87 11.47 -12.93 -4.20 13.23 coo 49.80 9.51 14.88 53.14 11.99 12.77 -10.44 -10.90 7.82 -13.04 -5.00 7.61 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 2 3 # 2 B 88 SER A 72 SER.? 25.71 O1 PEG A2001 B 90 SER A 15 SER^? 21.14 O1 PEG A2001 B 145 LYS A 68 LYS^? 23.30 O1 PEG A2001 coo 61.01 10.03 12.97 58.78 10.97 12.69 -11.42 -4.87 11.47 -12.93 -4.20 13.23 coo 56.85 12.22 16.37 55.62 11.34 14.45 -14.21 -8.14 16.70 -15.25 -5.93 17.19 coo 49.80 9.51 14.88 53.14 11.99 12.77 -10.36 -7.13 22.60 -13.43 -2.53 19.68 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 3 3 # 3 B 88 SER B 15 SER^? 20.57 O4 PEG B2003 B 90 SER B 72 SER.? 23.35 O4 PEG B2003 B 145 LYS B 77 LYS.? 27.21 O4 PEG B2003 coo 61.01 10.03 12.97 58.78 10.97 12.69 -9.16 -39.49 15.93 -8.11 -41.66 16.33 coo 56.85 12.22 16.37 55.62 11.34 14.45 -12.06 -42.72 10.71 -10.61 -43.41 12.48 coo 49.80 9.51 14.88 53.14 11.99 12.77 -13.11 -36.51 7.32 -10.61 -42.26 6.72 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 4 3 # 4 B 88 SER B 72 SER.? 23.35 O4 PEG B2003 B 90 SER B 15 SER^? 20.57 O4 PEG B2003 B 145 LYS B 68 LYS^? 20.92 O4 PEG B2003 coo 61.01 10.03 12.97 58.78 10.97 12.69 -12.06 -42.72 10.71 -10.61 -43.41 12.48 coo 56.85 12.22 16.37 55.62 11.34 14.45 -9.16 -39.49 15.93 -8.11 -41.66 16.33 coo 49.80 9.51 14.88 53.14 11.99 12.77 -12.94 -40.63 21.91 -10.06 -45.25 18.80 1t7d_c01 source 1t7d SIGNAL PEPTIDASE I : 4 hits 1t7d_c01 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 63 ASP.? 23.22 C1 PEG B2003 218 GLU A 87 GLU~? 17.34 CA CA A1001 329 ASP A 60 ASP^? 23.70 C1 PEG B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 -11.50 -2.39 37.13 -13.46 -2.26 37.99 coo 70.09 11.71 8.46 70.56 12.89 6.77 -18.57 -18.33 12.01 -20.23 -17.06 12.53 coo 59.16 37.82 13.95 57.63 37.03 15.12 -5.40 -4.16 30.61 -7.36 -3.38 30.96 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 63 ASP.? 23.22 C1 PEG B2003 218 GLU B 102 GLU.? 8.57 C3 PEG B2002 329 ASP A 60 ASP^? 23.70 C1 PEG B2003 coo 49.16 35.16 15.19 51.08 34.43 15.65 -11.50 -2.39 37.13 -13.46 -2.26 37.99 coo 70.09 11.71 8.46 70.56 12.89 6.77 1.59 -29.80 36.90 1.85 -28.01 35.77 coo 59.16 37.82 13.95 57.63 37.03 15.12 -5.40 -4.16 30.61 -7.36 -3.38 30.96 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 2 hits 1uok_c04 naa= 3 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 1 3 # 1 A 105 HIS A 21 HIS.? 16.23 C1 PEG B2003 A 169 ASP A 30 ASP~? 11.64 C1 PEG B2003 A 288 GLU A 26 GLU~? 10.48 O1 PEG B2003 coo 67.72 35.99 30.87 69.77 36.13 31.33 -9.66 -11.83 31.16 -7.90 -10.69 31.12 coo 73.17 30.66 22.56 72.87 30.30 20.46 -12.34 -20.31 39.33 -11.75 -18.93 40.82 coo 74.06 28.51 15.92 73.77 29.56 17.73 -18.91 -18.64 42.47 -20.88 -19.31 42.77 1w1o_c00 source 1w1o CYTOKININ DEHYDROGENASE 1 : 1 hits 1w1o_c00 naa= 3 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 183 GLY A 20 GLY.? 14.96 C1 PEG B2003 B 419 GLY A 64 GLY.? 18.50 C1 PEG B2003 B 420 ALA A 22 ALA.? 17.13 C1 PEG B2003 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -14.40 -9.93 33.49 -13.82 -10.08 32.97 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -12.15 -7.23 36.15 -11.45 -6.96 35.85 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -9.61 -11.57 35.52 -8.52 -10.48 35.41 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 183 GLY A 20 GLY.? 14.96 C1 PEG B2003 B 419 GLY A 65 GLY.? 18.86 C1 PEG B2003 B 420 ALA A 22 ALA.? 17.13 C1 PEG B2003 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -14.40 -9.93 33.49 -13.82 -10.08 32.97 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -9.86 -7.46 33.11 -10.61 -7.04 33.04 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -9.61 -11.57 35.52 -8.52 -10.48 35.41 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 3 3 # 3 A 183 GLY B 20 GLY.? 13.48 O4 PEG B2003 B 419 GLY B 64 GLY~? 14.60 C4 PEG B2003 B 420 ALA B 22 ALA.? 10.36 C4 PEG B2003 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -8.55 -38.17 33.00 -9.08 -37.90 32.50 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -11.18 -40.43 35.51 -11.83 -40.72 35.13 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -13.45 -35.76 34.31 -14.03 -37.13 34.56 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 4 3 # 4 A 183 GLY B 20 GLY.? 13.48 O4 PEG B2003 B 419 GLY B 65 GLY.? 12.49 O4 PEG B2003 B 420 ALA B 22 ALA.? 10.36 C4 PEG B2003 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -8.55 -38.17 33.00 -9.08 -37.90 32.50 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -13.21 -40.11 32.31 -12.56 -40.63 32.31 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -13.45 -35.76 34.31 -14.03 -37.13 34.56 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 5 3 # 5 A 183 GLY B 64 GLY~? 14.60 C4 PEG B2003 B 419 GLY B 20 GLY.? 13.48 O4 PEG B2003 B 420 ALA B 22 ALA.? 10.36 C4 PEG B2003 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -11.18 -40.43 35.51 -11.83 -40.72 35.13 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -8.55 -38.17 33.00 -9.08 -37.90 32.50 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -13.45 -35.76 34.31 -14.03 -37.13 34.56 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 6 3 # 6 A 183 GLY B 64 GLY~? 14.60 C4 PEG B2003 B 419 GLY B 65 GLY.? 12.49 O4 PEG B2003 B 420 ALA B 22 ALA.? 10.36 C4 PEG B2003 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -11.18 -40.43 35.51 -11.83 -40.72 35.13 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -13.21 -40.11 32.31 -12.56 -40.63 32.31 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -13.45 -35.76 34.31 -14.03 -37.13 34.56 1xny_c00 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 6 hits 1xny_c00 naa= 3 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 1 3 # 1 A 243 THR A 19 THR^? 17.40 C1 PEG A2001 A 345 PHE A 29 PHE~? 10.36 O1 PEG B2003 A 352 CYH A 33 CYH~? 10.72 C1 PEG B2003 coo 9.58 21.79 21.50 11.25 23.03 20.90 -14.60 -7.97 30.22 -15.86 -6.22 29.97 coo 19.40 19.75 18.58 17.39 17.81 18.80 -16.52 -16.10 37.98 -15.88 -14.02 36.22 coo 21.57 22.52 22.79 19.20 21.13 23.26 -13.26 -18.01 33.48 -11.40 -16.21 34.23 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 2 3 # 2 A 243 THR A 105 THR^? 7.70 C1 PEG A2001 A 345 PHE A 29 PHE~? 10.36 O1 PEG B2003 A 352 CYH A 33 CYH~? 10.72 C1 PEG B2003 coo 9.58 21.79 21.50 11.25 23.03 20.90 -23.59 -12.52 29.06 -24.89 -11.07 29.94 coo 19.40 19.75 18.58 17.39 17.81 18.80 -16.52 -16.10 37.98 -15.88 -14.02 36.22 coo 21.57 22.52 22.79 19.20 21.13 23.26 -13.26 -18.01 33.48 -11.40 -16.21 34.23 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 3 3 # 3 A 243 THR B 19 THR^? 16.39 O4 PEG B2003 A 345 PHE B 29 PHE~? 13.33 C4 PEG B2003 A 352 CYH B 33 CYH~? 9.84 C4 PEG B2003 coo 9.58 21.79 21.50 11.25 23.03 20.90 -8.63 -39.92 29.57 -7.43 -41.72 29.21 coo 19.40 19.75 18.58 17.39 17.81 18.80 -6.26 -32.33 37.47 -7.01 -34.41 35.76 coo 21.57 22.52 22.79 19.20 21.13 23.26 -9.83 -30.15 33.15 -9.47 -32.30 34.84 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 4 3 # 4 A 243 THR B 105 THR^? 7.36 C4 PEG B2002 A 345 PHE B 29 PHE~? 13.33 C4 PEG B2003 A 352 CYH B 33 CYH~? 9.84 C4 PEG B2003 coo 9.58 21.79 21.50 11.25 23.03 20.90 0.42 -35.31 28.37 1.77 -36.76 29.26 coo 19.40 19.75 18.58 17.39 17.81 18.80 -6.26 -32.33 37.47 -7.01 -34.41 35.76 coo 21.57 22.52 22.79 19.20 21.13 23.26 -9.83 -30.15 33.15 -9.47 -32.30 34.84 1xqd_c02 source 1xqd CYTOCHROME P450 55A1 : 4 hits 1xqd_c02 naa= 3 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP A 79 ASP~? 30.35 CA CA B1002 A 371 LYS A 77 LYS.? 28.85 O1 PEG A2001 A 407 THR A 75 THR.? 31.76 O1 PEG B2002 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -9.53 -15.68 5.14 -8.10 -15.06 3.67 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -10.44 -10.90 7.82 -13.04 -5.00 7.61 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -6.45 -7.77 5.23 -4.76 -8.32 3.95 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 2 3 # 2 A 369 ASP B 79 ASP~? 26.06 O4 PEG B2003 A 371 LYS B 77 LYS.? 27.21 O4 PEG B2003 A 407 THR B 75 THR.? 28.73 O4 PEG B2003 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -14.12 -31.44 4.95 -15.54 -32.00 3.54 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -13.11 -36.51 7.32 -10.61 -42.26 6.72 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -16.62 -39.81 4.37 -18.18 -40.97 3.33 1zrz_c02 source 1zrz PROTEIN KINASE C, IOTA : 2 hits 1zrz_c02 naa= 3 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP A 79 ASP~? 30.35 CA CA B1002 A 371 LYS A 77 LYS.? 28.85 O1 PEG A2001 A 374 ASN A 76 ASN.? 27.74 O1 PEG B2002 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -9.53 -15.68 5.14 -8.10 -15.06 3.67 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -10.44 -10.90 7.82 -13.04 -5.00 7.61 coo -4.84 27.04 20.49 -6.40 27.76 19.26 -6.69 -12.45 4.90 -5.54 -13.05 6.59 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 2 3 # 2 A 369 ASP B 79 ASP~? 26.06 O4 PEG B2003 A 371 LYS B 77 LYS.? 27.21 O4 PEG B2003 A 374 ASN B 76 ASN.? 23.89 O4 PEG B2003 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -14.12 -31.44 4.95 -15.54 -32.00 3.54 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -13.11 -36.51 7.32 -10.61 -42.26 6.72 coo -4.84 27.04 20.49 -6.40 27.76 19.26 -16.90 -35.01 4.40 -18.02 -34.43 6.12 1zrz_c03 source 1zrz PROTEIN KINASE C, IOTA : 2 hits 1zrz_c03 naa= 3 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 1 3 # 1 A 43 ASP A 60 ASP^? 23.70 C1 PEG B2003 A 48 HIS A 21 HIS.? 16.23 C1 PEG B2003 A 77 LYS A 68 LYS^? 23.30 O1 PEG A2001 coo 13.04 30.41 72.50 12.95 30.65 70.36 -5.40 -4.16 30.61 -7.36 -3.38 30.96 coo 12.77 23.50 68.33 13.58 25.42 68.49 -9.66 -11.83 31.16 -7.90 -10.69 31.12 coo 7.53 29.84 65.06 12.29 29.41 67.79 -10.36 -7.13 22.60 -13.43 -2.53 19.68 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 2 3 # 2 A 43 ASP B 60 ASP^? 15.62 O4 PEG B2003 A 48 HIS B 21 HIS.? 9.56 O4 PEG B2003 A 77 LYS B 68 LYS^? 20.92 O4 PEG B2003 coo 13.04 30.41 72.50 12.95 30.65 70.36 -17.89 -43.42 30.19 -15.92 -44.27 30.31 coo 12.77 23.50 68.33 13.58 25.42 68.49 -11.59 -35.81 29.96 -12.58 -37.49 29.21 coo 7.53 29.84 65.06 12.29 29.41 67.79 -12.94 -40.63 21.91 -10.06 -45.25 18.80 2acu_c01 source 2acu ALDOSE REDUCTASE (E.C.1.1.1.21) MUTANT WITH TY: 2 hits 2acu_c01 naa= 3 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 1 3 # 1 B 46 HIS A 21 HIS.? 16.23 C1 PEG B2003 B 163 ALA A 34 ALA~? 7.46 O2 PEG B2003 B 182 SER A 37 SER~? 12.09 C1 PEG B2003 coo 30.42 1.98 4.36 29.07 0.41 4.68 -9.66 -11.83 31.16 -7.90 -10.69 31.12 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -10.87 -20.87 32.55 -10.65 -22.13 33.42 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -9.67 -17.81 28.57 -9.20 -16.58 30.64 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 2 3 # 2 B 46 HIS B 21 HIS.? 9.56 O4 PEG B2003 B 163 ALA B 34 ALA~? 4.64 O2 PEG B2003 B 182 SER B 37 SER~? -4.72 O4 PEG B2003s coo 30.42 1.98 4.36 29.07 0.41 4.68 -11.59 -35.81 29.96 -12.58 -37.49 29.21 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -12.29 -27.34 32.52 -12.53 -26.18 33.47 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -13.50 -30.16 28.32 -13.76 -31.55 30.19 2bhg_c02 source 2bhg FOOT-AND-MOUTH DISEASE VIRUS 3C PROTEASE : 2 hits 2bhg_c02 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU A 14 GLU^? 25.75 O1 PEG A2001 A 156 GLU A 87 GLU~? 17.34 CA CA A1001 A 194 ASN A 76 ASN.? 27.74 O1 PEG B2002 coo 74.14 15.91 8.55 72.08 15.36 8.63 -15.45 -7.36 10.85 -15.33 -5.53 9.81 coo 67.47 20.07 1.34 65.99 20.06 2.88 -18.57 -18.33 12.01 -20.23 -17.06 12.53 coo 67.44 25.26 13.91 67.54 23.65 15.28 -6.69 -12.45 4.90 -5.54 -13.05 6.59 ULMN 3 2dbt_c00 CHITINASE C user 2 3 # 2 A 147 GLU A 80 GLU~? 27.45 O4 PEG B2003 A 156 GLU A 87 GLU~? 17.34 CA CA A1001 A 194 ASN A 76 ASN.? 27.74 O1 PEG B2002 coo 74.14 15.91 8.55 72.08 15.36 8.63 -13.74 -20.99 4.34 -13.41 -22.52 2.91 coo 67.47 20.07 1.34 65.99 20.06 2.88 -18.57 -18.33 12.01 -20.23 -17.06 12.53 coo 67.44 25.26 13.91 67.54 23.65 15.28 -6.69 -12.45 4.90 -5.54 -13.05 6.59 ULMN 3 2dbt_c00 CHITINASE C user 3 3 # 3 A 147 GLU B 14 GLU^? 25.81 O4 PEG B2002 A 156 GLU B 87 GLU~? 17.51 CA CA B1002 A 194 ASN B 76 ASN.? 23.89 O4 PEG B2003 coo 74.14 15.91 8.55 72.08 15.36 8.63 -7.72 -40.18 10.13 -8.30 -41.79 8.90 coo 67.47 20.07 1.34 65.99 20.06 2.88 -5.10 -29.50 11.76 -3.27 -30.54 11.89 coo 67.44 25.26 13.91 67.54 23.65 15.28 -16.90 -35.01 4.40 -18.02 -34.43 6.12 ULMN 3 2dbt_c00 CHITINASE C user 4 3 # 4 A 147 GLU B 80 GLU~? 28.00 O4 PEG B2003 A 156 GLU B 87 GLU~? 17.51 CA CA B1002 A 194 ASN B 76 ASN.? 23.89 O4 PEG B2003 coo 74.14 15.91 8.55 72.08 15.36 8.63 -9.74 -26.27 4.08 -9.78 -24.63 2.72 coo 67.47 20.07 1.34 65.99 20.06 2.88 -5.10 -29.50 11.76 -3.27 -30.54 11.89 coo 67.44 25.26 13.91 67.54 23.65 15.28 -16.90 -35.01 4.40 -18.02 -34.43 6.12 2dbt_c00 source 2dbt CHITINASE C : 4 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c01 CHITINASE C user 1 3 # 1 B 147 GLU A 14 GLU^? 25.75 O1 PEG A2001 B 156 GLU A 87 GLU~? 17.34 CA CA A1001 B 194 ASN A 76 ASN.? 27.74 O1 PEG B2002 coo 45.64 63.11 17.20 47.48 62.43 16.45 -15.45 -7.36 10.85 -15.33 -5.53 9.81 coo 54.43 67.89 19.82 55.62 67.90 18.07 -18.57 -18.33 12.01 -20.23 -17.06 12.53 coo 49.79 70.75 7.78 50.10 68.90 6.86 -6.69 -12.45 4.90 -5.54 -13.05 6.59 ULMN 3 2dbt_c01 CHITINASE C user 2 3 # 2 B 147 GLU A 80 GLU~? 27.45 O4 PEG B2003 B 156 GLU A 87 GLU~? 17.34 CA CA A1001 B 194 ASN A 76 ASN.? 27.74 O1 PEG B2002 coo 45.64 63.11 17.20 47.48 62.43 16.45 -13.74 -20.99 4.34 -13.41 -22.52 2.91 coo 54.43 67.89 19.82 55.62 67.90 18.07 -18.57 -18.33 12.01 -20.23 -17.06 12.53 coo 49.79 70.75 7.78 50.10 68.90 6.86 -6.69 -12.45 4.90 -5.54 -13.05 6.59 ULMN 3 2dbt_c01 CHITINASE C user 3 3 # 3 B 147 GLU B 14 GLU^? 25.81 O4 PEG B2002 B 156 GLU B 87 GLU~? 17.51 CA CA B1002 B 194 ASN B 76 ASN.? 23.89 O4 PEG B2003 coo 45.64 63.11 17.20 47.48 62.43 16.45 -7.72 -40.18 10.13 -8.30 -41.79 8.90 coo 54.43 67.89 19.82 55.62 67.90 18.07 -5.10 -29.50 11.76 -3.27 -30.54 11.89 coo 49.79 70.75 7.78 50.10 68.90 6.86 -16.90 -35.01 4.40 -18.02 -34.43 6.12 ULMN 3 2dbt_c01 CHITINASE C user 4 3 # 4 B 147 GLU B 80 GLU~? 28.00 O4 PEG B2003 B 156 GLU B 87 GLU~? 17.51 CA CA B1002 B 194 ASN B 76 ASN.? 23.89 O4 PEG B2003 coo 45.64 63.11 17.20 47.48 62.43 16.45 -9.74 -26.27 4.08 -9.78 -24.63 2.72 coo 54.43 67.89 19.82 55.62 67.90 18.07 -5.10 -29.50 11.76 -3.27 -30.54 11.89 coo 49.79 70.75 7.78 50.10 68.90 6.86 -16.90 -35.01 4.40 -18.02 -34.43 6.12 2dbt_c01 source 2dbt CHITINASE C : 4 hits 2dbt_c01 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU A 14 GLU^? 25.75 O1 PEG A2001 C 156 GLU A 87 GLU~? 17.34 CA CA A1001 C 194 ASN A 76 ASN.? 27.74 O1 PEG B2002 coo 41.23 29.31 13.28 43.03 29.85 12.29 -15.45 -7.36 10.85 -15.33 -5.53 9.81 coo 44.75 23.09 5.51 46.77 22.91 6.12 -18.57 -18.33 12.01 -20.23 -17.06 12.53 coo 49.75 21.00 18.12 50.45 23.02 18.26 -6.69 -12.45 4.90 -5.54 -13.05 6.59 ULMN 3 2dbt_c02 CHITINASE C user 2 3 # 2 C 147 GLU A 80 GLU~? 27.45 O4 PEG B2003 C 156 GLU A 87 GLU~? 17.34 CA CA A1001 C 194 ASN A 76 ASN.? 27.74 O1 PEG B2002 coo 41.23 29.31 13.28 43.03 29.85 12.29 -13.74 -20.99 4.34 -13.41 -22.52 2.91 coo 44.75 23.09 5.51 46.77 22.91 6.12 -18.57 -18.33 12.01 -20.23 -17.06 12.53 coo 49.75 21.00 18.12 50.45 23.02 18.26 -6.69 -12.45 4.90 -5.54 -13.05 6.59 ULMN 3 2dbt_c02 CHITINASE C user 3 3 # 3 C 147 GLU B 14 GLU^? 25.81 O4 PEG B2002 C 156 GLU B 87 GLU~? 17.51 CA CA B1002 C 194 ASN B 76 ASN.? 23.89 O4 PEG B2003 coo 41.23 29.31 13.28 43.03 29.85 12.29 -7.72 -40.18 10.13 -8.30 -41.79 8.90 coo 44.75 23.09 5.51 46.77 22.91 6.12 -5.10 -29.50 11.76 -3.27 -30.54 11.89 coo 49.75 21.00 18.12 50.45 23.02 18.26 -16.90 -35.01 4.40 -18.02 -34.43 6.12 ULMN 3 2dbt_c02 CHITINASE C user 4 3 # 4 C 147 GLU B 80 GLU~? 28.00 O4 PEG B2003 C 156 GLU B 87 GLU~? 17.51 CA CA B1002 C 194 ASN B 76 ASN.? 23.89 O4 PEG B2003 coo 41.23 29.31 13.28 43.03 29.85 12.29 -9.74 -26.27 4.08 -9.78 -24.63 2.72 coo 44.75 23.09 5.51 46.77 22.91 6.12 -5.10 -29.50 11.76 -3.27 -30.54 11.89 coo 49.75 21.00 18.12 50.45 23.02 18.26 -16.90 -35.01 4.40 -18.02 -34.43 6.12 2dbt_c02 source 2dbt CHITINASE C : 4 hits 2dbt_c02 naa= 3 ULMN 3 2esd_c00 1.02.01.0009 user 1 3 # 1 A 154 ASN A 76 ASN.? 27.74 O1 PEG B2002 A 250 ALA A 46 ALA~? 18.56 C3 PEG B2003 A 284 CYH A 53 CYH.? 25.46 O1 PEG B2002 coo -98.31 19.25 26.95 -99.27 21.10 26.57 -6.69 -12.45 4.90 -5.54 -13.05 6.59 coo -102.90 29.72 23.02 -103.69 28.50 23.43 -5.29 -20.84 15.78 -6.67 -21.55 16.01 coo -98.59 26.45 29.50 -99.24 25.73 26.84 -3.99 -14.24 10.25 -6.51 -13.04 10.75 2esd_c00 source 2esd 1.02.01.0009 : 1 hits 2esd_c00 naa= 3 ULMN 3 2esd_c01 1.02.01.0009 user 1 3 # 1 B 154 ASN A 76 ASN.? 27.74 O1 PEG B2002 B 250 ALA A 46 ALA~? 18.56 C3 PEG B2003 B 284 CYH A 53 CYH.? 25.46 O1 PEG B2002 coo -116.62 58.12 2.11 -116.17 56.24 3.01 -6.69 -12.45 4.90 -5.54 -13.05 6.59 coo -114.20 47.61 7.65 -114.88 48.80 8.33 -5.29 -20.84 15.78 -6.67 -21.55 16.01 coo -118.73 50.90 1.30 -116.61 51.76 2.87 -3.99 -14.24 10.25 -6.51 -13.04 10.75 2esd_c01 source 2esd 1.02.01.0009 : 1 hits 2esd_c01 naa= 3 ULMN 3 2esd_c02 1.02.01.0009 user 1 3 # 1 C 154 ASN A 76 ASN.? 27.74 O1 PEG B2002 C 250 ALA A 46 ALA~? 18.56 C3 PEG B2003 C 284 CYH A 53 CYH.? 25.46 O1 PEG B2002 coo -155.36 18.42 28.93 -154.49 20.30 29.39 -6.69 -12.45 4.90 -5.54 -13.05 6.59 coo -150.95 29.02 32.87 -150.10 27.86 32.40 -5.29 -20.84 15.78 -6.67 -21.55 16.01 coo -155.22 25.64 26.33 -154.78 25.20 29.09 -3.99 -14.24 10.25 -6.51 -13.04 10.75 2esd_c02 source 2esd 1.02.01.0009 : 1 hits 2esd_c02 naa= 3 ULMN 3 2esd_c03 1.02.01.0009 user 1 3 # 1 D 154 ASN A 76 ASN.? 27.74 O1 PEG B2002 D 250 ALA A 46 ALA~? 18.56 C3 PEG B2003 D 284 CYH A 53 CYH.? 25.46 O1 PEG B2002 coo -138.05 57.23 54.59 -137.96 55.47 53.43 -6.69 -12.45 4.90 -5.54 -13.05 6.59 coo -139.97 46.71 48.80 -139.25 47.90 48.19 -5.29 -20.84 15.78 -6.67 -21.55 16.01 coo -135.22 50.13 55.22 -137.25 50.94 53.65 -3.99 -14.24 10.25 -6.51 -13.04 10.75 ULMN 3 2esd_c03 1.02.01.0009 user 2 3 # 2 D 154 ASN B 76 ASN.? 23.89 O4 PEG B2003 D 250 ALA B 46 ALA~? 13.59 O4 PEG B2003 D 284 CYH B 53 CYH.? 19.65 O4 PEG B2003 coo -138.05 57.23 54.59 -137.96 55.47 53.43 -16.90 -35.01 4.40 -18.02 -34.43 6.12 coo -139.97 46.71 48.80 -139.25 47.90 48.19 -18.26 -26.86 15.83 -16.87 -26.16 16.00 coo -135.22 50.13 55.22 -137.25 50.94 53.65 -19.64 -33.35 10.08 -17.03 -34.49 10.54 2esd_c03 source 2esd 1.02.01.0009 : 2 hits 2esd_c03 naa= 3 ULMN 3 2f9z_c00 PROTEIN (CHEMOTAXIS METHYLATION PROTuser 1 3 # 1 C 21 THR A 19 THR^? 17.40 C1 PEG A2001 C 27 CYH A 33 CYH~? 10.72 C1 PEG B2003 C 44 HIS A 21 HIS.? 16.23 C1 PEG B2003 coo 31.18 22.40 -15.93 30.94 20.86 -14.44 -14.60 -7.97 30.22 -15.86 -6.22 29.97 coo 33.52 13.02 -11.58 35.31 14.81 -10.35 -13.26 -18.01 33.48 -11.40 -16.21 34.23 coo 32.65 18.86 -10.97 34.16 18.23 -12.28 -9.66 -11.83 31.16 -7.90 -10.69 31.12 ULMN 3 2f9z_c00 PROTEIN (CHEMOTAXIS METHYLATION PROTuser 2 3 # 2 C 21 THR B 19 THR^? 16.39 O4 PEG B2003 C 27 CYH B 33 CYH~? 9.84 C4 PEG B2003 C 44 HIS B 21 HIS.? 9.56 O4 PEG B2003 coo 31.18 22.40 -15.93 30.94 20.86 -14.44 -8.63 -39.92 29.57 -7.43 -41.72 29.21 coo 33.52 13.02 -11.58 35.31 14.81 -10.35 -9.83 -30.15 33.15 -9.47 -32.30 34.84 coo 32.65 18.86 -10.97 34.16 18.23 -12.28 -11.59 -35.81 29.96 -12.58 -37.49 29.21 2f9z_c00 source 2f9z PROTEIN (CHEMOTAXIS METHYLATION PROTEIN) : 2 hits 2f9z_c00 naa= 3 ULMN 3 2f9z_c01 PROTEIN (CHEMOTAXIS METHYLATION PROTuser 1 3 # 1 D 21 THR A 19 THR^? 17.40 C1 PEG A2001 D 27 CYH A 33 CYH~? 10.72 C1 PEG B2003 D 44 HIS A 21 HIS.? 16.23 C1 PEG B2003 coo 8.10 8.69 -37.60 9.58 7.79 -38.92 -14.60 -7.97 30.22 -15.86 -6.22 29.97 coo 15.06 1.75 -41.51 12.66 0.75 -42.59 -13.26 -18.01 33.48 -11.40 -16.21 34.23 coo 10.53 5.51 -42.28 10.30 3.78 -41.11 -9.66 -11.83 31.16 -7.90 -10.69 31.12 ULMN 3 2f9z_c01 PROTEIN (CHEMOTAXIS METHYLATION PROTuser 2 3 # 2 D 21 THR B 19 THR^? 16.39 O4 PEG B2003 D 27 CYH B 33 CYH~? 9.84 C4 PEG B2003 D 44 HIS B 21 HIS.? 9.56 O4 PEG B2003 coo 8.10 8.69 -37.60 9.58 7.79 -38.92 -8.63 -39.92 29.57 -7.43 -41.72 29.21 coo 15.06 1.75 -41.51 12.66 0.75 -42.59 -9.83 -30.15 33.15 -9.47 -32.30 34.84 coo 10.53 5.51 -42.28 10.30 3.78 -41.11 -11.59 -35.81 29.96 -12.58 -37.49 29.21 2f9z_c01 source 2f9z PROTEIN (CHEMOTAXIS METHYLATION PROTEIN) : 2 hits 2f9z_c01 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 6 PHE^? 14.20 C1 PEG A2001 A 263 ASP A 70 ASP^? 25.92 O1 PEG A2001 A 292 LYS A 77 LYS.? 28.85 O1 PEG A2001 coo 51.51 50.32 16.39 52.13 49.68 13.75 -19.07 -12.04 19.47 -18.07 -14.29 20.88 coo 54.43 44.82 23.74 55.21 45.06 21.80 -9.86 -5.53 16.91 -10.88 -4.17 15.65 coo 63.95 45.30 16.71 59.11 49.15 16.05 -10.44 -10.90 7.82 -13.04 -5.00 7.61 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 177 PHE A 86 PHE~? 20.17 C3 PEG B2003 A 263 ASP A 79 ASP~? 30.35 CA CA B1002 A 292 LYS B 81 LYS~? 24.83 O4 PEG B2003 coo 51.51 50.32 16.39 52.13 49.68 13.75 -14.10 -14.46 14.77 -14.06 -12.14 16.40 coo 54.43 44.82 23.74 55.21 45.06 21.80 -9.53 -15.68 5.14 -8.10 -15.06 3.67 coo 63.95 45.30 16.71 59.11 49.15 16.05 -13.27 -27.12 7.60 -17.56 -23.53 5.05 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 A 177 PHE B 86 PHE~? 17.32 O4 PEG B2003 A 263 ASP B 79 ASP~? 26.06 O4 PEG B2003 A 292 LYS A 81 LYS~? 24.71 CA CA B1002 coo 51.51 50.32 16.39 52.13 49.68 13.75 -9.38 -33.21 14.35 -9.40 -35.62 15.82 coo 54.43 44.82 23.74 55.21 45.06 21.80 -14.12 -31.44 4.95 -15.54 -32.00 3.54 coo 63.95 45.30 16.71 59.11 49.15 16.05 -10.43 -20.23 7.61 -6.19 -24.16 5.61 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 3 hits 2oat_c03 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE A 86 PHE~? 20.17 C3 PEG B2003 B 263 ASP A 79 ASP~? 30.35 CA CA B1002 B 292 LYS B 81 LYS~? 24.83 O4 PEG B2003 coo 49.99 26.05 6.28 51.46 26.87 8.49 -14.10 -14.46 14.77 -14.06 -12.14 16.40 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -9.53 -15.68 5.14 -8.10 -15.06 3.67 coo 60.53 31.67 0.97 57.79 27.51 3.63 -13.27 -27.12 7.60 -17.56 -23.53 5.05 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 177 PHE B 86 PHE~? 17.32 O4 PEG B2003 B 263 ASP B 79 ASP~? 26.06 O4 PEG B2003 B 292 LYS A 81 LYS~? 24.71 CA CA B1002 coo 49.99 26.05 6.28 51.46 26.87 8.49 -9.38 -33.21 14.35 -9.40 -35.62 15.82 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -14.12 -31.44 4.95 -15.54 -32.00 3.54 coo 60.53 31.67 0.97 57.79 27.51 3.63 -10.43 -20.23 7.61 -6.19 -24.16 5.61 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 2 hits 2oat_c04 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 6 PHE^? 14.20 C1 PEG A2001 C 263 ASP A 70 ASP^? 25.92 O1 PEG A2001 C 292 LYS A 77 LYS.? 28.85 O1 PEG A2001 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -19.07 -12.04 19.47 -18.07 -14.29 20.88 coo 19.84 12.02 9.33 18.68 11.23 7.75 -9.86 -5.53 16.91 -10.88 -4.17 15.65 coo 12.82 3.49 4.98 17.80 5.59 1.90 -10.44 -10.90 7.82 -13.04 -5.00 7.61 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE A 86 PHE~? 20.17 C3 PEG B2003 C 263 ASP A 79 ASP~? 30.35 CA CA B1002 C 292 LYS B 81 LYS~? 24.83 O4 PEG B2003 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -14.10 -14.46 14.77 -14.06 -12.14 16.40 coo 19.84 12.02 9.33 18.68 11.23 7.75 -9.53 -15.68 5.14 -8.10 -15.06 3.67 coo 12.82 3.49 4.98 17.80 5.59 1.90 -13.27 -27.12 7.60 -17.56 -23.53 5.05 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 177 PHE B 86 PHE~? 17.32 O4 PEG B2003 C 263 ASP B 79 ASP~? 26.06 O4 PEG B2003 C 292 LYS A 81 LYS~? 24.71 CA CA B1002 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -9.38 -33.21 14.35 -9.40 -35.62 15.82 coo 19.84 12.02 9.33 18.68 11.23 7.75 -14.12 -31.44 4.95 -15.54 -32.00 3.54 coo 12.82 3.49 4.98 17.80 5.59 1.90 -10.43 -20.23 7.61 -6.19 -24.16 5.61 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 3 hits 2oat_c05 naa= 3 ULMN 3 2phk_c03 MC-PEPTIDE user 1 3 # 1 A 149 ASP A 79 ASP~? 30.35 CA CA B1002 A 151 LYS A 77 LYS.? 28.85 O1 PEG A2001 A 154 ASN A 76 ASN.? 27.74 O1 PEG B2002 coo 41.42 17.90 44.98 43.39 18.36 45.61 -9.53 -15.68 5.14 -8.10 -15.06 3.67 coo 45.75 16.58 39.61 47.43 18.26 45.54 -10.44 -10.90 7.82 -13.04 -5.00 7.61 coo 44.77 13.10 43.25 45.01 14.21 45.03 -6.69 -12.45 4.90 -5.54 -13.05 6.59 ULMN 3 2phk_c03 MC-PEPTIDE user 2 3 # 2 A 149 ASP B 79 ASP~? 26.06 O4 PEG B2003 A 151 LYS B 77 LYS.? 27.21 O4 PEG B2003 A 154 ASN B 76 ASN.? 23.89 O4 PEG B2003 coo 41.42 17.90 44.98 43.39 18.36 45.61 -14.12 -31.44 4.95 -15.54 -32.00 3.54 coo 45.75 16.58 39.61 47.43 18.26 45.54 -13.11 -36.51 7.32 -10.61 -42.26 6.72 coo 44.77 13.10 43.25 45.01 14.21 45.03 -16.90 -35.01 4.40 -18.02 -34.43 6.12 2phk_c03 source 2phk MC-PEPTIDE : 2 hits 2phk_c03 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 52 ASP.? 24.46 O1 PEG B2002 166 GLY B 11 GLY.? 22.11 CA CA B1002 169 GLU B 14 GLU^? 25.81 O4 PEG B2002 coo 8.28 6.87 1.62 10.08 5.77 1.34 -2.05 -17.27 6.89 -0.38 -16.21 6.11 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -1.60 -36.38 6.74 -2.22 -36.78 7.03 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -7.72 -40.18 10.13 -8.30 -41.79 8.90 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 60 ASP^? 23.70 C1 PEG B2003 166 GLY A 25 GLY.? 12.96 O1 PEG B2003 169 GLU A 102 GLU.? 7.49 O1 PEG B2003 coo 8.28 6.87 1.62 10.08 5.77 1.34 -5.40 -4.16 30.61 -7.36 -3.38 30.96 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -15.42 -15.19 42.04 -14.71 -15.60 42.28 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -24.41 -18.40 37.33 -24.92 -20.20 36.28 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP A 70 ASP^? 25.92 O1 PEG A2001 166 GLY A 92 GLY~? 9.36 C3 PEG B2003 169 GLU A 98 GLU~? 2.29 CA CA A1001s coo 8.28 6.87 1.62 10.08 5.77 1.34 -9.86 -5.53 16.91 -10.88 -4.17 15.65 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -18.31 -21.80 22.45 -18.72 -21.11 22.30 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -27.16 -20.48 25.10 -28.97 -19.42 25.39 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP B 30 ASP~? 11.37 C2 PEG B2003 166 GLY A 92 GLY~? 9.36 C3 PEG B2003 169 GLU A 98 GLU~? 2.29 CA CA A1001s coo 8.28 6.87 1.62 10.08 5.77 1.34 -10.72 -29.17 38.90 -10.74 -31.13 39.77 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -18.31 -21.80 22.45 -18.72 -21.11 22.30 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -27.16 -20.48 25.10 -28.97 -19.42 25.39 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP B 52 ASP.? 24.24 O4 PEG B2003 166 GLY A 11 GLY.? 22.07 CA CA A1001 169 GLU A 14 GLU^? 25.75 O1 PEG A2001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -21.39 -30.03 6.82 -22.77 -31.26 5.81 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -21.95 -10.87 7.44 -21.33 -10.48 7.71 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -15.45 -7.36 10.85 -15.33 -5.53 9.81 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP B 70 ASP^? 21.22 O4 PEG B2003 166 GLY B 92 GLY~? 13.28 C4 PEG B2002 169 GLU B 98 GLU~? 2.35 CA CA B1002s coo 8.28 6.87 1.62 10.08 5.77 1.34 -13.56 -42.18 16.17 -12.44 -43.52 14.94 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -5.06 -26.04 22.12 -4.64 -26.71 21.94 coo -16.67 7.89 2.78 -17.65 6.56 1.49 3.98 -26.85 24.71 5.74 -27.99 25.05 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 6 hits 2tdt_c00 naa= 3 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 A 59 ARG A 8 ARG^? 17.40 CA CA A1001 A 130 SER A 15 SER^? 21.14 O1 PEG A2001 A 159 LYS A 10 LYS.? 26.99 O1 PEG A2001 coo 18.35 45.84 20.99 16.20 47.83 21.89 -22.63 -11.55 11.44 -21.49 -14.30 12.11 coo 15.14 43.67 10.77 15.61 44.43 13.04 -14.21 -8.14 16.70 -15.25 -5.93 17.19 coo 11.57 48.49 22.18 13.51 49.99 17.21 -21.43 -7.28 6.26 -19.99 -2.17 7.33 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 A 59 ARG B 8 ARG^? 17.27 CA CA B1002 A 130 SER B 15 SER^? 20.57 O4 PEG B2003 A 159 LYS B 10 LYS.? 28.13 CA CA B1002 coo 18.35 45.84 20.99 16.20 47.83 21.89 -0.83 -35.82 10.68 -1.93 -33.11 11.68 coo 15.14 43.67 10.77 15.61 44.43 13.04 -9.16 -39.49 15.93 -8.11 -41.66 16.33 coo 11.57 48.49 22.18 13.51 49.99 17.21 -1.99 -39.94 5.49 -0.05 -44.29 3.04 2tps_c00 source 2tps THIAMIN PHOSPHATE SYNTHASE : 2 hits 2tps_c00 naa= 3 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 B 59 ARG A 8 ARG^? 17.40 CA CA A1001 B 130 SER A 15 SER^? 21.14 O1 PEG A2001 B 159 LYS A 10 LYS.? 26.99 O1 PEG A2001 coo 58.72 31.58 20.45 60.80 29.39 20.94 -22.63 -11.55 11.44 -21.49 -14.30 12.11 coo 61.66 35.17 10.39 61.29 34.14 12.56 -14.21 -8.14 16.70 -15.25 -5.93 17.19 coo 65.38 28.77 21.17 63.49 28.03 16.12 -21.43 -7.28 6.26 -19.99 -2.17 7.33 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 B 59 ARG A 8 ARG^? 17.40 CA CA A1001 B 130 SER A 72 SER.? 25.71 O1 PEG A2001 B 159 LYS A 10 LYS.? 26.99 O1 PEG A2001 coo 58.72 31.58 20.45 60.80 29.39 20.94 -22.63 -11.55 11.44 -21.49 -14.30 12.11 coo 61.66 35.17 10.39 61.29 34.14 12.56 -11.42 -4.87 11.47 -12.93 -4.20 13.23 coo 65.38 28.77 21.17 63.49 28.03 16.12 -21.43 -7.28 6.26 -19.99 -2.17 7.33 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 3 3 # 3 B 59 ARG B 8 ARG^? 17.27 CA CA B1002 B 130 SER B 15 SER^? 20.57 O4 PEG B2003 B 159 LYS B 10 LYS.? 28.13 CA CA B1002 coo 58.72 31.58 20.45 60.80 29.39 20.94 -0.83 -35.82 10.68 -1.93 -33.11 11.68 coo 61.66 35.17 10.39 61.29 34.14 12.56 -9.16 -39.49 15.93 -8.11 -41.66 16.33 coo 65.38 28.77 21.17 63.49 28.03 16.12 -1.99 -39.94 5.49 -0.05 -44.29 3.04 2tps_c01 source 2tps THIAMIN PHOSPHATE SYNTHASE : 3 hits 2tps_c01 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 42 ASN~? 14.52 C3 PEG B2003 coo 5.80 63.03 55.85 5.52 65.03 56.45 -7.85 -22.02 21.46 -7.56 -23.56 20.01 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 45 ASN~? 13.73 O1 PEG B2002 coo 5.80 63.03 55.85 5.52 65.03 56.45 -2.96 -19.90 19.51 -1.93 -19.02 21.16 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 76 ASN.? 27.74 O1 PEG B2002 coo 5.80 63.03 55.85 5.52 65.03 56.45 -6.69 -12.45 4.90 -5.54 -13.05 6.59 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 95 ASN~? 7.12 O4 PEG B2003 coo 5.80 63.03 55.85 5.52 65.03 56.45 -21.88 -23.40 24.41 -22.32 -25.10 25.62 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN A 99 ASN~? 7.66 O1 PEG B2003 coo 5.80 63.03 55.85 5.52 65.03 56.45 -24.23 -23.83 29.86 -24.62 -25.28 28.37 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN B 42 ASN~? 10.30 O4 PEG B2003 coo 5.80 63.03 55.85 5.52 65.03 56.45 -15.54 -25.88 21.48 -16.00 -24.28 20.16 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN B 45 ASN~? 8.85 O4 PEG B2003 coo 5.80 63.03 55.85 5.52 65.03 56.45 -20.51 -27.95 19.63 -21.35 -28.92 21.38 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN B 76 ASN.? 23.89 O4 PEG B2003 coo 5.80 63.03 55.85 5.52 65.03 56.45 -16.90 -35.01 4.40 -18.02 -34.43 6.12 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN B 95 ASN~? 10.07 O1 PEG B2002 coo 5.80 63.03 55.85 5.52 65.03 56.45 -1.16 -24.31 23.77 -0.16 -23.55 22.03 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN B 99 ASN~? 7.82 C2 PEG B2002 coo 5.80 63.03 55.85 5.52 65.03 56.45 0.85 -23.90 29.59 1.20 -22.57 27.92 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 10 hits 1kbk_p00 naa= 1 ULMN 4 1ux7_p00 ENDO-1,4-BETA-XYLANASE D user 1 4 # 1 A 40 TYR A 27 TYR~? 9.22 O1 PEG B2003 A 116 ASP B 30 ASP~? 11.37 C2 PEG B2003 A 118 GLY B 28 GLY~? 14.17 O2 PEG B2003 A 121 ASP A 30 ASP~? 11.64 C1 PEG B2003 coo 1.23 20.09 -8.77 -1.43 19.35 -9.06 -14.90 -24.31 42.27 -14.00 -26.56 40.85 coo 8.44 21.40 -4.34 8.12 19.68 -5.55 -10.72 -29.17 38.90 -10.74 -31.13 39.77 coo 9.75 15.96 -6.06 9.75 15.96 -5.24 -5.19 -26.62 39.73 -5.79 -27.20 39.75 coo 1.59 17.86 -4.64 2.63 16.93 -6.25 -12.34 -20.31 39.33 -11.75 -18.93 40.82 ULMN 4 1ux7_p00 ENDO-1,4-BETA-XYLANASE D user 2 4 # 2 A 40 TYR A 66 TYR^? 22.56 C1 PEG B2003 A 116 ASP A 63 ASP.? 23.22 C1 PEG B2003 A 118 GLY A 64 GLY.? 18.50 C1 PEG B2003 A 121 ASP A 60 ASP^? 23.70 C1 PEG B2003 coo 1.23 20.09 -8.77 -1.43 19.35 -9.06 -10.60 -4.44 27.95 -11.26 -3.41 25.42 coo 8.44 21.40 -4.34 8.12 19.68 -5.55 -11.50 -2.39 37.13 -13.46 -2.26 37.99 coo 9.75 15.96 -6.06 9.75 15.96 -5.24 -12.15 -7.23 36.15 -11.45 -6.96 35.85 coo 1.59 17.86 -4.64 2.63 16.93 -6.25 -5.40 -4.16 30.61 -7.36 -3.38 30.96 ULMN 4 1ux7_p00 ENDO-1,4-BETA-XYLANASE D user 3 4 # 3 A 40 TYR B 27 TYR~? 13.40 C1 PEG B2003 A 116 ASP A 30 ASP~? 11.64 C1 PEG B2003 A 118 GLY A 28 GLY~? 6.46 O1 PEG B2003 A 121 ASP B 30 ASP~? 11.37 C2 PEG B2003 coo 1.23 20.09 -8.77 -1.43 19.35 -9.06 -8.19 -24.57 42.59 -8.72 -22.12 41.34 coo 8.44 21.40 -4.34 8.12 19.68 -5.55 -12.34 -20.31 39.33 -11.75 -18.93 40.82 coo 9.75 15.96 -6.06 9.75 15.96 -5.24 -17.99 -21.92 39.59 -17.39 -21.34 39.70 coo 1.59 17.86 -4.64 2.63 16.93 -6.25 -10.72 -29.17 38.90 -10.74 -31.13 39.77 ULMN 4 1ux7_p00 ENDO-1,4-BETA-XYLANASE D user 4 4 # 4 A 40 TYR B 66 TYR^? 16.34 O4 PEG B2003 A 116 ASP B 63 ASP~? 19.91 O4 PEG B2003 A 118 GLY B 64 GLY~? 14.60 C4 PEG B2003 A 121 ASP B 60 ASP^? 15.62 O4 PEG B2003 coo 1.23 20.09 -8.77 -1.43 19.35 -9.06 -12.77 -43.45 27.28 -12.10 -44.44 24.75 coo 8.44 21.40 -4.34 8.12 19.68 -5.55 -11.65 -45.32 36.37 -13.02 -46.95 36.09 coo 9.75 15.96 -6.06 9.75 15.96 -5.24 -11.18 -40.43 35.51 -11.83 -40.72 35.13 coo 1.59 17.86 -4.64 2.63 16.93 -6.25 -17.89 -43.42 30.19 -15.92 -44.27 30.31 1ux7_p00 source 1ux7 ENDO-1,4-BETA-XYLANASE D : 4 hits 1ux7_p00 naa= 4 ULMN 3 2p3i_p00 VP4 user 1 3 # 1 A 101 ARG A 9 ARG^? 23.91 O1 PEG A2001 A 188 TYR A 73 TYR.? -31.47 O1 PEG A2001s A 190 SER A 72 SER.? 25.71 O1 PEG A2001 coo 37.69 7.64 13.51 38.82 8.84 16.11 -17.92 -3.27 10.91 -16.40 -3.09 13.61 coo 47.14 12.10 13.73 48.75 12.33 16.01 -8.12 -1.41 10.87 -9.66 0.82 11.59 coo 43.77 6.93 15.46 45.49 7.21 17.11 -11.42 -4.87 11.47 -12.93 -4.20 13.23 ULMN 3 2p3i_p00 VP4 user 2 3 # 2 A 101 ARG B 9 ARG^? 23.79 O4 PEG B2002 A 188 TYR B 73 TYR.? -26.42 O4 PEG B2003s A 190 SER B 72 SER.? 23.35 O4 PEG B2003 coo 37.69 7.64 13.51 38.82 8.84 16.11 -5.44 -44.19 10.09 -7.02 -44.36 12.75 coo 47.14 12.10 13.73 48.75 12.33 16.01 -15.40 -46.09 10.22 -13.89 -48.32 11.05 coo 43.77 6.93 15.46 45.49 7.21 17.11 -12.06 -42.72 10.71 -10.61 -43.41 12.48 2p3i_p00 source 2p3i VP4 : 2 hits 2p3i_p00 naa= 3 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 1 3 # 1 A 459 ASN A 42 ASN~? 14.52 C3 PEG B2003 A 460 GLY B 92 GLY~? 13.28 C4 PEG B2002 A 461 ASN B 95 ASN~? 10.07 O1 PEG B2002 coo 15.00 94.38 6.97 13.00 93.59 6.99 -7.85 -22.02 21.46 -7.56 -23.56 20.01 coo 19.48 94.04 5.03 19.26 94.00 5.78 -5.06 -26.04 22.12 -4.64 -26.71 21.94 coo 20.23 95.69 9.16 21.55 97.37 9.20 -1.16 -24.31 23.77 -0.16 -23.55 22.03 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 2 3 # 2 A 459 ASN A 95 ASN~? 7.12 O4 PEG B2003 A 460 GLY A 92 GLY~? 9.36 C3 PEG B2003 A 461 ASN B 42 ASN~? 10.30 O4 PEG B2003 coo 15.00 94.38 6.97 13.00 93.59 6.99 -21.88 -23.40 24.41 -22.32 -25.10 25.62 coo 19.48 94.04 5.03 19.26 94.00 5.78 -18.31 -21.80 22.45 -18.72 -21.11 22.30 coo 20.23 95.69 9.16 21.55 97.37 9.20 -15.54 -25.88 21.48 -16.00 -24.28 20.16 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 3 3 # 3 A 459 ASN B 42 ASN~? 10.30 O4 PEG B2003 A 460 GLY A 92 GLY~? 9.36 C3 PEG B2003 A 461 ASN A 95 ASN~? 7.12 O4 PEG B2003 coo 15.00 94.38 6.97 13.00 93.59 6.99 -15.54 -25.88 21.48 -16.00 -24.28 20.16 coo 19.48 94.04 5.03 19.26 94.00 5.78 -18.31 -21.80 22.45 -18.72 -21.11 22.30 coo 20.23 95.69 9.16 21.55 97.37 9.20 -21.88 -23.40 24.41 -22.32 -25.10 25.62 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 4 3 # 4 A 459 ASN B 95 ASN~? 10.07 O1 PEG B2002 A 460 GLY B 92 GLY~? 13.28 C4 PEG B2002 A 461 ASN A 42 ASN~? 14.52 C3 PEG B2003 coo 15.00 94.38 6.97 13.00 93.59 6.99 -1.16 -24.31 23.77 -0.16 -23.55 22.03 coo 19.48 94.04 5.03 19.26 94.00 5.78 -5.06 -26.04 22.12 -4.64 -26.71 21.94 coo 20.23 95.69 9.16 21.55 97.37 9.20 -7.85 -22.02 21.46 -7.56 -23.56 20.01 2qv4_p00 source 2qv4 PANCREATIC ALPHA-AMYLASE : 4 hits 2qv4_p00 naa= 3 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 1 3 # 1 D 23 LYS A 107 LYS^? 14.69 O1 PEG A2001 D 25 THR A 105 THR^? 7.70 C1 PEG A2001 D 27 SER A 100 SER~? 3.90 O1 PEG B2003 coo 86.60 33.38 44.00 87.05 39.52 42.71 -24.09 -9.54 22.80 -23.65 -3.96 24.23 coo 81.20 31.58 48.03 79.23 32.24 47.54 -23.59 -12.52 29.06 -24.89 -11.07 29.94 coo 79.09 29.82 54.20 77.17 28.90 53.05 -23.99 -20.35 32.61 -22.13 -21.83 33.13 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 2 3 # 2 D 23 LYS B 107 LYS^? 14.71 O4 PEG B2002 D 25 THR B 105 THR^? 7.36 C4 PEG B2002 D 27 SER B 100 SER~? 9.30 C3 PEG B2002 coo 86.60 33.38 44.00 87.05 39.52 42.71 0.77 -38.34 22.11 0.18 -43.97 23.67 coo 81.20 31.58 48.03 79.23 32.24 47.54 0.42 -35.31 28.37 1.77 -36.76 29.26 coo 79.09 29.82 54.20 77.17 28.90 53.05 0.85 -27.49 32.31 -1.03 -26.05 32.94 1mjo_d00 source 1mjo TRANSCRIPTION/DNA : 2 hits 1mjo_d00 naa= 3 ULMN 4 1zrf_d00 GENE REGULATION/DNA user 1 4 # 1 A 170 GLN B 111 GLN.? 21.14 O4 PEG B2002 A 179 SER B 15 SER^? 20.57 O4 PEG B2003 A 180 ARG B 9 ARG^? 23.79 O4 PEG B2002 A 181 GLU B 14 GLU^? 25.81 O4 PEG B2002 coo 1.45 7.07 4.95 2.68 8.54 5.89 -1.71 -45.08 13.24 -2.33 -46.09 15.02 coo -3.43 8.18 -1.54 -5.76 8.81 -1.23 -9.16 -39.49 15.93 -8.11 -41.66 16.33 coo -1.38 9.52 4.42 -3.09 11.26 6.30 -5.44 -44.19 10.09 -7.02 -44.36 12.75 coo -6.78 10.36 3.32 -4.99 11.32 2.66 -7.72 -40.18 10.13 -8.30 -41.79 8.90 1zrf_d00 source 1zrf GENE REGULATION/DNA : 1 hits 1zrf_d00 naa= 4 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 B 34 SER A 40 SER~? 13.43 O2 PEG B2003 B 37 ASN A 42 ASN~? 14.52 C3 PEG B2003 B 45 THR A 54 THR.? 24.54 O1 PEG B2002 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -10.00 -16.89 23.63 -11.41 -15.57 25.07 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -7.85 -22.02 21.46 -7.56 -23.56 20.01 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -2.24 -11.47 12.22 -1.43 -9.50 11.62 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 B 34 SER A 100 SER~? 3.90 O1 PEG B2003 B 37 ASN A 99 ASN~? 7.66 O1 PEG B2003 B 45 THR A 38 THR~? 9.35 O2 PEG B2003 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -23.99 -20.35 32.61 -22.13 -21.83 33.13 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -24.23 -23.83 29.86 -24.62 -25.28 28.37 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -8.95 -21.12 26.90 -8.78 -23.13 27.67 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 B 34 SER B 100 SER~? 9.30 C3 PEG B2002 B 37 ASN B 99 ASN~? 7.82 C2 PEG B2002 B 45 THR B 38 THR~? -4.31 C3 PEG B2003s coo -19.49 41.97 71.08 -17.37 40.80 71.17 0.85 -27.49 32.31 -1.03 -26.05 32.94 coo -23.05 39.62 69.74 -22.86 39.59 67.61 0.85 -23.90 29.59 1.20 -22.57 27.92 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -14.33 -26.74 26.85 -14.43 -24.77 27.69 2z3x_d00 source 2z3x DNA BINDING PROTEIN/DNA : 3 hits 2z3x_d00 naa= 3 ULMN 3 3pta_d00 TRANSFERASE/DNA user 1 3 # 1 A 682 SER A 78 SER.? 29.96 CA CA A1001 A 683 LYS A 77 LYS.? 28.85 O1 PEG A2001 A 684 GLN A 83 GLN~? 23.05 CA CA A1001 coo -8.24 -20.23 36.50 -7.44 -18.27 37.68 -13.07 -12.34 5.42 -12.90 -11.48 3.24 coo -5.30 -22.52 37.30 -6.47 -26.26 32.30 -10.44 -10.90 7.82 -13.04 -5.00 7.61 coo -3.80 -18.22 38.13 -1.93 -17.88 37.17 -14.86 -14.93 8.21 -15.33 -13.67 9.86 ULMN 3 3pta_d00 TRANSFERASE/DNA user 2 3 # 2 A 682 SER B 78 SER.? 28.23 O4 PEG B2003 A 683 LYS B 77 LYS.? 27.21 O4 PEG B2003 A 684 GLN B 83 GLN~? 22.59 O4 PEG B2003 coo -8.24 -20.23 36.50 -7.44 -18.27 37.68 -10.61 -34.92 4.88 -11.23 -35.54 2.64 coo -5.30 -22.52 37.30 -6.47 -26.26 32.30 -13.11 -36.51 7.32 -10.61 -42.26 6.72 coo -3.80 -18.22 38.13 -1.93 -17.88 37.17 -8.60 -32.34 7.87 -8.11 -33.73 9.38 3pta_d00 source 3pta TRANSFERASE/DNA : 2 hits 3pta_d00 naa= 3 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 1 3 # 1 A 130 SER A 37 SER~? 12.09 C1 PEG B2003 A 166 PHE A 89 PHE~? 14.08 C3 PEG B2003 A 182 PHE A 6 PHE^? 14.20 C1 PEG A2001 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -9.67 -17.81 28.57 -9.20 -16.58 30.64 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -14.04 -17.23 20.11 -13.92 -15.61 22.41 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -19.07 -12.04 19.47 -18.07 -14.29 20.88 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 2 3 # 2 A 130 SER A 72 SER.? 25.71 O1 PEG A2001 A 166 PHE A 86 PHE~? 20.17 C3 PEG B2003 A 182 PHE A 6 PHE^? 14.20 C1 PEG A2001 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -11.42 -4.87 11.47 -12.93 -4.20 13.23 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -14.10 -14.46 14.77 -14.06 -12.14 16.40 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -19.07 -12.04 19.47 -18.07 -14.29 20.88 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 3 3 # 3 A 130 SER B 37 SER~? -4.72 O4 PEG B2003s A 166 PHE B 89 PHE~? 11.80 O4 PEG B2003 A 182 PHE B 6 PHE^? 14.06 C4 PEG B2002 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -13.50 -30.16 28.32 -13.76 -31.55 30.19 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -9.29 -30.51 19.98 -9.48 -32.13 22.26 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -4.25 -35.63 18.90 -5.30 -33.50 20.44 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 4 3 # 4 A 130 SER B 37 SER~? -4.72 O4 PEG B2003s A 166 PHE B 89 PHE~? 11.80 O4 PEG B2003 A 182 PHE B 86 PHE~? 17.32 O4 PEG B2003 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -13.50 -30.16 28.32 -13.76 -31.55 30.19 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -9.29 -30.51 19.98 -9.48 -32.13 22.26 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -9.38 -33.21 14.35 -9.40 -35.62 15.82 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 5 3 # 5 A 130 SER B 56 SER^? 19.17 O4 PEG B2003 A 166 PHE B 86 PHE~? 17.32 O4 PEG B2003 A 182 PHE B 89 PHE~? 11.80 O4 PEG B2003 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -18.67 -40.78 16.18 -17.98 -43.06 16.58 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -9.38 -33.21 14.35 -9.40 -35.62 15.82 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -9.29 -30.51 19.98 -9.48 -32.13 22.26 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 6 3 # 6 A 130 SER B 72 SER.? 23.35 O4 PEG B2003 A 166 PHE B 86 PHE~? 17.32 O4 PEG B2003 A 182 PHE B 6 PHE^? 14.06 C4 PEG B2002 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -12.06 -42.72 10.71 -10.61 -43.41 12.48 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -9.38 -33.21 14.35 -9.40 -35.62 15.82 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -4.25 -35.63 18.90 -5.30 -33.50 20.44 2r11_o00 source 2R11 CARBOXYLESTERASE NP : 6 hits 2r11_o00 naa= 3 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 1 3 # 1 B 130 SER A 37 SER~? 12.09 C1 PEG B2003 B 166 PHE A 89 PHE~? 14.08 C3 PEG B2003 B 182 PHE A 6 PHE^? 14.20 C1 PEG A2001 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -9.67 -17.81 28.57 -9.20 -16.58 30.64 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -14.04 -17.23 20.11 -13.92 -15.61 22.41 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -19.07 -12.04 19.47 -18.07 -14.29 20.88 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 2 3 # 2 B 130 SER A 37 SER~? 12.09 C1 PEG B2003 B 166 PHE A 89 PHE~? 14.08 C3 PEG B2003 B 182 PHE A 86 PHE~? 20.17 C3 PEG B2003 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -9.67 -17.81 28.57 -9.20 -16.58 30.64 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -14.04 -17.23 20.11 -13.92 -15.61 22.41 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -14.10 -14.46 14.77 -14.06 -12.14 16.40 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 3 3 # 3 B 130 SER A 56 SER^? 27.14 O1 PEG B2002 B 166 PHE A 86 PHE~? 20.17 C3 PEG B2003 B 182 PHE A 6 PHE^? 14.20 C1 PEG A2001 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -4.80 -7.12 16.84 -5.40 -4.83 17.27 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -14.10 -14.46 14.77 -14.06 -12.14 16.40 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -19.07 -12.04 19.47 -18.07 -14.29 20.88 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 4 3 # 4 B 130 SER A 56 SER^? 27.14 O1 PEG B2002 B 166 PHE A 86 PHE~? 20.17 C3 PEG B2003 B 182 PHE A 89 PHE~? 14.08 C3 PEG B2003 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -4.80 -7.12 16.84 -5.40 -4.83 17.27 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -14.10 -14.46 14.77 -14.06 -12.14 16.40 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -14.04 -17.23 20.11 -13.92 -15.61 22.41 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 5 3 # 5 B 130 SER A 72 SER.? 25.71 O1 PEG A2001 B 166 PHE A 86 PHE~? 20.17 C3 PEG B2003 B 182 PHE A 6 PHE^? 14.20 C1 PEG A2001 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -11.42 -4.87 11.47 -12.93 -4.20 13.23 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -14.10 -14.46 14.77 -14.06 -12.14 16.40 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -19.07 -12.04 19.47 -18.07 -14.29 20.88 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 6 3 # 6 B 130 SER A 72 SER.? 25.71 O1 PEG A2001 B 166 PHE A 86 PHE~? 20.17 C3 PEG B2003 B 182 PHE A 89 PHE~? 14.08 C3 PEG B2003 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -11.42 -4.87 11.47 -12.93 -4.20 13.23 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -14.10 -14.46 14.77 -14.06 -12.14 16.40 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -14.04 -17.23 20.11 -13.92 -15.61 22.41 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 7 3 # 7 B 130 SER A 78 SER.? 29.96 CA CA A1001 B 166 PHE A 86 PHE~? 20.17 C3 PEG B2003 B 182 PHE A 6 PHE^? 14.20 C1 PEG A2001 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -13.07 -12.34 5.42 -12.90 -11.48 3.24 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -14.10 -14.46 14.77 -14.06 -12.14 16.40 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -19.07 -12.04 19.47 -18.07 -14.29 20.88 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 8 3 # 8 B 130 SER B 37 SER~? -4.72 O4 PEG B2003s B 166 PHE B 89 PHE~? 11.80 O4 PEG B2003 B 182 PHE B 6 PHE^? 14.06 C4 PEG B2002 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -13.50 -30.16 28.32 -13.76 -31.55 30.19 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -9.29 -30.51 19.98 -9.48 -32.13 22.26 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -4.25 -35.63 18.90 -5.30 -33.50 20.44 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 9 3 # 9 B 130 SER B 37 SER~? -4.72 O4 PEG B2003s B 166 PHE B 89 PHE~? 11.80 O4 PEG B2003 B 182 PHE B 86 PHE~? 17.32 O4 PEG B2003 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -13.50 -30.16 28.32 -13.76 -31.55 30.19 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -9.29 -30.51 19.98 -9.48 -32.13 22.26 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -9.38 -33.21 14.35 -9.40 -35.62 15.82 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 10 3 # 10 B 130 SER B 56 SER^? 19.17 O4 PEG B2003 B 166 PHE B 86 PHE~? 17.32 O4 PEG B2003 B 182 PHE B 89 PHE~? 11.80 O4 PEG B2003 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -18.67 -40.78 16.18 -17.98 -43.06 16.58 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -9.38 -33.21 14.35 -9.40 -35.62 15.82 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -9.29 -30.51 19.98 -9.48 -32.13 22.26 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 11 3 # 11 B 130 SER B 72 SER.? 23.35 O4 PEG B2003 B 166 PHE B 86 PHE~? 17.32 O4 PEG B2003 B 182 PHE B 6 PHE^? 14.06 C4 PEG B2002 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -12.06 -42.72 10.71 -10.61 -43.41 12.48 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -9.38 -33.21 14.35 -9.40 -35.62 15.82 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -4.25 -35.63 18.90 -5.30 -33.50 20.44 2r11_o01 source 2R11 CARBOXYLESTERASE NP : 11 hits 2r11_o01 naa= 3 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 1 3 # 1 C 130 SER A 37 SER~? 12.09 C1 PEG B2003 C 166 PHE A 89 PHE~? 14.08 C3 PEG B2003 C 182 PHE A 6 PHE^? 14.20 C1 PEG A2001 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -9.67 -17.81 28.57 -9.20 -16.58 30.64 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -14.04 -17.23 20.11 -13.92 -15.61 22.41 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -19.07 -12.04 19.47 -18.07 -14.29 20.88 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 2 3 # 2 C 130 SER A 72 SER.? 25.71 O1 PEG A2001 C 166 PHE A 86 PHE~? 20.17 C3 PEG B2003 C 182 PHE A 6 PHE^? 14.20 C1 PEG A2001 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -11.42 -4.87 11.47 -12.93 -4.20 13.23 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -14.10 -14.46 14.77 -14.06 -12.14 16.40 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -19.07 -12.04 19.47 -18.07 -14.29 20.88 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 3 3 # 3 C 130 SER B 37 SER~? -4.72 O4 PEG B2003s C 166 PHE B 89 PHE~? 11.80 O4 PEG B2003 C 182 PHE B 6 PHE^? 14.06 C4 PEG B2002 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -13.50 -30.16 28.32 -13.76 -31.55 30.19 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -9.29 -30.51 19.98 -9.48 -32.13 22.26 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -4.25 -35.63 18.90 -5.30 -33.50 20.44 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 4 3 # 4 C 130 SER B 37 SER~? -4.72 O4 PEG B2003s C 166 PHE B 89 PHE~? 11.80 O4 PEG B2003 C 182 PHE B 86 PHE~? 17.32 O4 PEG B2003 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -13.50 -30.16 28.32 -13.76 -31.55 30.19 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -9.29 -30.51 19.98 -9.48 -32.13 22.26 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -9.38 -33.21 14.35 -9.40 -35.62 15.82 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 5 3 # 5 C 130 SER B 40 SER~? 8.16 O4 PEG B2003 C 166 PHE B 86 PHE~? 17.32 O4 PEG B2003 C 182 PHE B 6 PHE^? 14.06 C4 PEG B2002 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -13.24 -30.95 23.50 -11.93 -32.52 24.66 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -9.38 -33.21 14.35 -9.40 -35.62 15.82 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -4.25 -35.63 18.90 -5.30 -33.50 20.44 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 6 3 # 6 C 130 SER B 56 SER^? 19.17 O4 PEG B2003 C 166 PHE B 86 PHE~? 17.32 O4 PEG B2003 C 182 PHE B 89 PHE~? 11.80 O4 PEG B2003 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -18.67 -40.78 16.18 -17.98 -43.06 16.58 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -9.38 -33.21 14.35 -9.40 -35.62 15.82 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -9.29 -30.51 19.98 -9.48 -32.13 22.26 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 7 3 # 7 C 130 SER B 72 SER.? 23.35 O4 PEG B2003 C 166 PHE B 86 PHE~? 17.32 O4 PEG B2003 C 182 PHE B 6 PHE^? 14.06 C4 PEG B2002 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -12.06 -42.72 10.71 -10.61 -43.41 12.48 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -9.38 -33.21 14.35 -9.40 -35.62 15.82 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -4.25 -35.63 18.90 -5.30 -33.50 20.44 2r11_o02 source 2R11 CARBOXYLESTERASE NP : 7 hits 2r11_o02 naa= 3 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 1 3 # 1 D 130 SER A 37 SER~? 12.09 C1 PEG B2003 D 166 PHE A 89 PHE~? 14.08 C3 PEG B2003 D 182 PHE A 6 PHE^? 14.20 C1 PEG A2001 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -9.67 -17.81 28.57 -9.20 -16.58 30.64 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -14.04 -17.23 20.11 -13.92 -15.61 22.41 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -19.07 -12.04 19.47 -18.07 -14.29 20.88 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 2 3 # 2 D 130 SER A 37 SER~? 12.09 C1 PEG B2003 D 166 PHE A 89 PHE~? 14.08 C3 PEG B2003 D 182 PHE A 86 PHE~? 20.17 C3 PEG B2003 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -9.67 -17.81 28.57 -9.20 -16.58 30.64 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -14.04 -17.23 20.11 -13.92 -15.61 22.41 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -14.10 -14.46 14.77 -14.06 -12.14 16.40 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 3 3 # 3 D 130 SER A 56 SER^? 27.14 O1 PEG B2002 D 166 PHE A 86 PHE~? 20.17 C3 PEG B2003 D 182 PHE A 6 PHE^? 14.20 C1 PEG A2001 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -4.80 -7.12 16.84 -5.40 -4.83 17.27 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -14.10 -14.46 14.77 -14.06 -12.14 16.40 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -19.07 -12.04 19.47 -18.07 -14.29 20.88 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 4 3 # 4 D 130 SER A 56 SER^? 27.14 O1 PEG B2002 D 166 PHE A 86 PHE~? 20.17 C3 PEG B2003 D 182 PHE A 89 PHE~? 14.08 C3 PEG B2003 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -4.80 -7.12 16.84 -5.40 -4.83 17.27 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -14.10 -14.46 14.77 -14.06 -12.14 16.40 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -14.04 -17.23 20.11 -13.92 -15.61 22.41 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 5 3 # 5 D 130 SER A 72 SER.? 25.71 O1 PEG A2001 D 166 PHE A 86 PHE~? 20.17 C3 PEG B2003 D 182 PHE A 6 PHE^? 14.20 C1 PEG A2001 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -11.42 -4.87 11.47 -12.93 -4.20 13.23 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -14.10 -14.46 14.77 -14.06 -12.14 16.40 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -19.07 -12.04 19.47 -18.07 -14.29 20.88 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 6 3 # 6 D 130 SER A 72 SER.? 25.71 O1 PEG A2001 D 166 PHE A 86 PHE~? 20.17 C3 PEG B2003 D 182 PHE A 89 PHE~? 14.08 C3 PEG B2003 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -11.42 -4.87 11.47 -12.93 -4.20 13.23 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -14.10 -14.46 14.77 -14.06 -12.14 16.40 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -14.04 -17.23 20.11 -13.92 -15.61 22.41 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 7 3 # 7 D 130 SER A 78 SER.? 29.96 CA CA A1001 D 166 PHE A 86 PHE~? 20.17 C3 PEG B2003 D 182 PHE A 6 PHE^? 14.20 C1 PEG A2001 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -13.07 -12.34 5.42 -12.90 -11.48 3.24 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -14.10 -14.46 14.77 -14.06 -12.14 16.40 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -19.07 -12.04 19.47 -18.07 -14.29 20.88 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 8 3 # 8 D 130 SER B 37 SER~? -4.72 O4 PEG B2003s D 166 PHE B 89 PHE~? 11.80 O4 PEG B2003 D 182 PHE B 6 PHE^? 14.06 C4 PEG B2002 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -13.50 -30.16 28.32 -13.76 -31.55 30.19 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -9.29 -30.51 19.98 -9.48 -32.13 22.26 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -4.25 -35.63 18.90 -5.30 -33.50 20.44 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 9 3 # 9 D 130 SER B 37 SER~? -4.72 O4 PEG B2003s D 166 PHE B 89 PHE~? 11.80 O4 PEG B2003 D 182 PHE B 86 PHE~? 17.32 O4 PEG B2003 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -13.50 -30.16 28.32 -13.76 -31.55 30.19 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -9.29 -30.51 19.98 -9.48 -32.13 22.26 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -9.38 -33.21 14.35 -9.40 -35.62 15.82 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 10 3 # 10 D 130 SER B 56 SER^? 19.17 O4 PEG B2003 D 166 PHE B 86 PHE~? 17.32 O4 PEG B2003 D 182 PHE B 89 PHE~? 11.80 O4 PEG B2003 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -18.67 -40.78 16.18 -17.98 -43.06 16.58 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -9.38 -33.21 14.35 -9.40 -35.62 15.82 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -9.29 -30.51 19.98 -9.48 -32.13 22.26 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 11 3 # 11 D 130 SER B 72 SER.? 23.35 O4 PEG B2003 D 166 PHE B 86 PHE~? 17.32 O4 PEG B2003 D 182 PHE B 6 PHE^? 14.06 C4 PEG B2002 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -12.06 -42.72 10.71 -10.61 -43.41 12.48 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -9.38 -33.21 14.35 -9.40 -35.62 15.82 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -4.25 -35.63 18.90 -5.30 -33.50 20.44 2r11_o03 source 2R11 CARBOXYLESTERASE NP : 11 hits 2r11_o03 naa= 3 ULMN 3 3hde_o02 LYSOZYME user 1 3 # 1 C 35 GLU A 14 GLU^? 25.75 O1 PEG A2001 C 44 ASP A 79 ASP~? 30.35 CA CA B1002 C 50 THR A 75 THR.? 31.76 O1 PEG B2002 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -15.45 -7.36 10.85 -15.33 -5.53 9.81 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -9.53 -15.68 5.14 -8.10 -15.06 3.67 coo 25.48 4.87 1.60 23.90 4.95 0.15 -6.45 -7.77 5.23 -4.76 -8.32 3.95 3hde_o02 source 3HDE LYSOZYME : 1 hits 3hde_o02 naa= 3 ULMN 3 3tu8_o00 BURKHOLDERIA LETHAL FACTOR 1 (BLF1) user 1 3 # 1 A 88 THR A 19 THR^? 17.40 C1 PEG A2001 A 94 CYH A 33 CYH~? 10.72 C1 PEG B2003 A 106 HIS A 21 HIS.? 16.23 C1 PEG B2003 coo 29.73 -7.52 13.32 29.45 -5.70 12.17 -14.60 -7.97 30.22 -15.86 -6.22 29.97 coo 31.46 -1.21 4.47 31.00 -3.95 4.28 -13.26 -18.01 33.48 -11.40 -16.21 34.23 coo 27.96 -4.35 8.55 29.78 -5.07 7.70 -9.66 -11.83 31.16 -7.90 -10.69 31.12 ULMN 3 3tu8_o00 BURKHOLDERIA LETHAL FACTOR 1 (BLF1) user 2 3 # 2 A 88 THR B 19 THR^? 16.39 O4 PEG B2003 A 94 CYH B 33 CYH~? 9.84 C4 PEG B2003 A 106 HIS B 21 HIS.? 9.56 O4 PEG B2003 coo 29.73 -7.52 13.32 29.45 -5.70 12.17 -8.63 -39.92 29.57 -7.43 -41.72 29.21 coo 31.46 -1.21 4.47 31.00 -3.95 4.28 -9.83 -30.15 33.15 -9.47 -32.30 34.84 coo 27.96 -4.35 8.55 29.78 -5.07 7.70 -11.59 -35.81 29.96 -12.58 -37.49 29.21 3tu8_o00 source 3TU8 BURKHOLDERIA LETHAL FACTOR 1 (BLF1) : 2 hits 3tu8_o00 naa= 3 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 1 3 # 1 A 29 ASP A 52 ASP.? 24.46 O1 PEG B2002 A 117 LYS A 81 LYS~? 24.71 CA CA B1002 A 150 CYH A 53 CYH.? 25.46 O1 PEG B2002 coo 37.97 47.82 5.46 38.65 48.02 7.40 -2.05 -17.27 6.89 -0.38 -16.21 6.11 coo 41.02 51.33 13.36 40.18 47.06 9.99 -10.43 -20.23 7.61 -6.19 -24.16 5.61 coo 39.17 42.30 8.54 40.94 44.26 7.78 -3.99 -14.24 10.25 -6.51 -13.04 10.75 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 2 3 # 2 A 29 ASP B 52 ASP.? 24.24 O4 PEG B2003 A 117 LYS B 81 LYS~? 24.83 O4 PEG B2003 A 150 CYH B 53 CYH.? 19.65 O4 PEG B2003 coo 37.97 47.82 5.46 38.65 48.02 7.40 -21.39 -30.03 6.82 -22.77 -31.26 5.81 coo 41.02 51.33 13.36 40.18 47.06 9.99 -13.27 -27.12 7.60 -17.56 -23.53 5.05 coo 39.17 42.30 8.54 40.94 44.26 7.78 -19.64 -33.35 10.08 -17.03 -34.49 10.54 3uao_o00 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o00 naa= 3 ULMN 3 3uao_o01 PUTATIVE ISOCHORISMATASE user 1 3 # 1 B 29 ASP A 52 ASP.? 24.46 O1 PEG B2002 B 117 LYS A 81 LYS~? 24.71 CA CA B1002 B 150 CYH A 53 CYH.? 25.46 O1 PEG B2002 coo 33.94 43.16 45.29 35.02 43.05 43.47 -2.05 -17.27 6.89 -0.38 -16.21 6.11 coo 38.53 39.60 38.22 36.76 43.89 41.37 -10.43 -20.23 7.61 -6.19 -24.16 5.61 coo 35.77 48.61 42.57 37.40 46.62 43.48 -3.99 -14.24 10.25 -6.51 -13.04 10.75 ULMN 3 3uao_o01 PUTATIVE ISOCHORISMATASE user 2 3 # 2 B 29 ASP B 52 ASP.? 24.24 O4 PEG B2003 B 117 LYS B 81 LYS~? 24.83 O4 PEG B2003 B 150 CYH B 53 CYH.? 19.65 O4 PEG B2003 coo 33.94 43.16 45.29 35.02 43.05 43.47 -21.39 -30.03 6.82 -22.77 -31.26 5.81 coo 38.53 39.60 38.22 36.76 43.89 41.37 -13.27 -27.12 7.60 -17.56 -23.53 5.05 coo 35.77 48.61 42.57 37.40 46.62 43.48 -19.64 -33.35 10.08 -17.03 -34.49 10.54 3uao_o01 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o01 naa= 3 ULMN 3 3uao_o02 PUTATIVE ISOCHORISMATASE user 1 3 # 1 C 29 ASP A 52 ASP.? 24.46 O1 PEG B2002 C 117 LYS A 81 LYS~? 24.71 CA CA B1002 C 150 CYH A 53 CYH.? 25.46 O1 PEG B2002 coo 54.62 -9.81 68.84 52.97 -9.23 67.61 -2.05 -17.27 6.89 -0.38 -16.21 6.11 coo 46.74 -10.34 64.36 51.80 -7.96 65.19 -10.43 -20.23 7.61 -6.19 -24.16 5.61 coo 55.78 -5.03 64.48 55.52 -7.79 64.07 -3.99 -14.24 10.25 -6.51 -13.04 10.75 ULMN 3 3uao_o02 PUTATIVE ISOCHORISMATASE user 2 3 # 2 C 29 ASP B 52 ASP.? 24.24 O4 PEG B2003 C 117 LYS B 81 LYS~? 24.83 O4 PEG B2003 C 150 CYH B 53 CYH.? 19.65 O4 PEG B2003 coo 54.62 -9.81 68.84 52.97 -9.23 67.61 -21.39 -30.03 6.82 -22.77 -31.26 5.81 coo 46.74 -10.34 64.36 51.80 -7.96 65.19 -13.27 -27.12 7.60 -17.56 -23.53 5.05 coo 55.78 -5.03 64.48 55.52 -7.79 64.07 -19.64 -33.35 10.08 -17.03 -34.49 10.54 3uao_o02 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o02 naa= 3 ULMN 3 3uao_o03 PUTATIVE ISOCHORISMATASE user 1 3 # 1 D 29 ASP A 52 ASP.? 24.46 O1 PEG B2002 D 117 LYS A 81 LYS~? 24.71 CA CA B1002 D 150 CYH A 53 CYH.? 25.46 O1 PEG B2002 coo 25.05 13.27 54.10 26.66 12.10 53.60 -2.05 -17.27 6.89 -0.38 -16.21 6.11 coo 33.45 10.03 51.76 28.31 9.37 53.37 -10.43 -20.23 7.61 -6.19 -24.16 5.61 coo 24.32 7.20 55.59 24.80 8.07 53.08 -3.99 -14.24 10.25 -6.51 -13.04 10.75 ULMN 3 3uao_o03 PUTATIVE ISOCHORISMATASE user 2 3 # 2 D 29 ASP B 52 ASP.? 24.24 O4 PEG B2003 D 117 LYS B 81 LYS~? 24.83 O4 PEG B2003 D 150 CYH B 53 CYH.? 19.65 O4 PEG B2003 coo 25.05 13.27 54.10 26.66 12.10 53.60 -21.39 -30.03 6.82 -22.77 -31.26 5.81 coo 33.45 10.03 51.76 28.31 9.37 53.37 -13.27 -27.12 7.60 -17.56 -23.53 5.05 coo 24.32 7.20 55.59 24.80 8.07 53.08 -19.64 -33.35 10.08 -17.03 -34.49 10.54 3uao_o03 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o03 naa= 3 ULMN 3 3uao_o04 PUTATIVE ISOCHORISMATASE user 1 3 # 1 E 29 ASP A 52 ASP.? 24.46 O1 PEG B2002 E 117 LYS A 81 LYS~? 24.71 CA CA B1002 E 150 CYH A 53 CYH.? 25.46 O1 PEG B2002 coo 54.17 11.77 49.20 52.64 11.40 50.63 -2.05 -17.27 6.89 -0.38 -16.21 6.11 coo 45.83 11.66 53.42 50.97 10.25 52.77 -10.43 -20.23 7.61 -6.19 -24.16 5.61 coo 55.28 7.50 53.67 54.71 10.14 54.01 -3.99 -14.24 10.25 -6.51 -13.04 10.75 ULMN 3 3uao_o04 PUTATIVE ISOCHORISMATASE user 2 3 # 2 E 29 ASP B 52 ASP.? 24.24 O4 PEG B2003 E 117 LYS B 81 LYS~? 24.83 O4 PEG B2003 E 150 CYH B 53 CYH.? 19.65 O4 PEG B2003 coo 54.17 11.77 49.20 52.64 11.40 50.63 -21.39 -30.03 6.82 -22.77 -31.26 5.81 coo 45.83 11.66 53.42 50.97 10.25 52.77 -13.27 -27.12 7.60 -17.56 -23.53 5.05 coo 55.28 7.50 53.67 54.71 10.14 54.01 -19.64 -33.35 10.08 -17.03 -34.49 10.54 3uao_o04 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o04 naa= 3 ULMN 3 3uao_o05 PUTATIVE ISOCHORISMATASE user 1 3 # 1 F 29 ASP A 52 ASP.? 24.46 O1 PEG B2002 F 117 LYS A 81 LYS~? 24.71 CA CA B1002 F 150 CYH A 53 CYH.? 25.46 O1 PEG B2002 coo 41.67 65.37 28.64 40.76 63.70 27.74 -2.05 -17.27 6.89 -0.38 -16.21 6.11 coo 38.34 58.97 23.05 39.26 61.42 28.02 -10.43 -20.23 7.61 -6.19 -24.16 5.61 coo 39.64 61.25 32.92 38.08 62.62 31.22 -3.99 -14.24 10.25 -6.51 -13.04 10.75 ULMN 3 3uao_o05 PUTATIVE ISOCHORISMATASE user 2 3 # 2 F 29 ASP B 52 ASP.? 24.24 O4 PEG B2003 F 117 LYS B 81 LYS~? 24.83 O4 PEG B2003 F 150 CYH B 53 CYH.? 19.65 O4 PEG B2003 coo 41.67 65.37 28.64 40.76 63.70 27.74 -21.39 -30.03 6.82 -22.77 -31.26 5.81 coo 38.34 58.97 23.05 39.26 61.42 28.02 -13.27 -27.12 7.60 -17.56 -23.53 5.05 coo 39.64 61.25 32.92 38.08 62.62 31.22 -19.64 -33.35 10.08 -17.03 -34.49 10.54 3uao_o05 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o05 naa= 3 ULMN 3 3uao_o06 PUTATIVE ISOCHORISMATASE user 1 3 # 1 G 29 ASP A 52 ASP.? 24.46 O1 PEG B2002 G 117 LYS A 81 LYS~? 24.71 CA CA B1002 G 150 CYH A 53 CYH.? 25.46 O1 PEG B2002 coo 26.53 -14.13 63.27 28.07 -12.63 63.49 -2.05 -17.27 6.89 -0.38 -16.21 6.11 coo 34.28 -10.03 65.81 29.08 -9.98 63.85 -10.43 -20.23 7.61 -6.19 -24.16 5.61 coo 25.24 -8.30 61.46 25.55 -9.17 63.98 -3.99 -14.24 10.25 -6.51 -13.04 10.75 ULMN 3 3uao_o06 PUTATIVE ISOCHORISMATASE user 2 3 # 2 G 29 ASP B 52 ASP.? 24.24 O4 PEG B2003 G 117 LYS B 81 LYS~? 24.83 O4 PEG B2003 G 150 CYH B 53 CYH.? 19.65 O4 PEG B2003 coo 26.53 -14.13 63.27 28.07 -12.63 63.49 -21.39 -30.03 6.82 -22.77 -31.26 5.81 coo 34.28 -10.03 65.81 29.08 -9.98 63.85 -13.27 -27.12 7.60 -17.56 -23.53 5.05 coo 25.24 -8.30 61.46 25.55 -9.17 63.98 -19.64 -33.35 10.08 -17.03 -34.49 10.54 3uao_o06 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o06 naa= 3 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 1 3 # 1 H 28 VAL A 49 VAL~? 16.02 CA CA B1002 H 117 LYS A 81 LYS~? 24.71 CA CA B1002 H 150 CYH A 53 CYH.? 25.46 O1 PEG B2002 coo 45.82 27.58 23.40 45.30 28.87 21.66 -0.81 -20.64 13.26 -0.04 -22.05 14.77 coo 38.01 32.08 28.20 39.46 29.85 23.57 -10.43 -20.23 7.61 -6.19 -24.16 5.61 coo 41.19 29.62 18.76 39.21 28.51 20.32 -3.99 -14.24 10.25 -6.51 -13.04 10.75 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 2 3 # 2 H 28 VAL B 49 VAL~? 16.15 CA CA A1001 H 117 LYS B 81 LYS~? 24.83 O4 PEG B2003 H 150 CYH B 53 CYH.? 19.65 O4 PEG B2003 coo 45.82 27.58 23.40 45.30 28.87 21.66 -22.76 -26.90 13.39 -23.57 -25.48 14.92 coo 38.01 32.08 28.20 39.46 29.85 23.57 -13.27 -27.12 7.60 -17.56 -23.53 5.05 coo 41.19 29.62 18.76 39.21 28.51 20.32 -19.64 -33.35 10.08 -17.03 -34.49 10.54 3uao_o07 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o07 naa= 3 ULMN 3 4dqk_o00 BIFUNCTIONAL P-450/NADPH-P450 REDUCTuser 1 3 # 1 A 966 SER A 72 SER.? 25.71 O1 PEG A2001 A 967 ARG A 9 ARG^? 23.91 O1 PEG A2001 A 975 TYR A 73 TYR.? -31.47 O1 PEG A2001s coo 82.02 40.88 31.11 79.88 41.56 30.18 -11.42 -4.87 11.47 -12.93 -4.20 13.23 coo 78.94 44.79 33.75 77.86 47.56 32.82 -17.92 -3.27 10.91 -16.40 -3.09 13.61 coo 83.57 40.86 25.45 83.15 43.18 26.91 -8.12 -1.41 10.87 -9.66 0.82 11.59 ULMN 3 4dqk_o00 BIFUNCTIONAL P-450/NADPH-P450 REDUCTuser 2 3 # 2 A 966 SER B 72 SER.? 23.35 O4 PEG B2003 A 967 ARG B 9 ARG^? 23.79 O4 PEG B2002 A 975 TYR B 73 TYR.? -26.42 O4 PEG B2003s coo 82.02 40.88 31.11 79.88 41.56 30.18 -12.06 -42.72 10.71 -10.61 -43.41 12.48 coo 78.94 44.79 33.75 77.86 47.56 32.82 -5.44 -44.19 10.09 -7.02 -44.36 12.75 coo 83.57 40.86 25.45 83.15 43.18 26.91 -15.40 -46.09 10.22 -13.89 -48.32 11.05 4dqk_o00 source 4DQK BIFUNCTIONAL P-450/NADPH-P450 REDUCTASE : 2 hits 4dqk_o00 naa= 3